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Abstract
Microdosimetry has been used for decades to characterise radiation fields using gas detectors with effective volume similar to that of human cells. The tissue-equivalent proportional counter (TEPC) is the gold-standard microdosimetric device, however silicon
microdosimeters have shown to be a viable replacement which offer many advantages including a slimline form factor and submillimeter resolution. This thesis continues the development of silicon-on-insulator (SQQ microdosimeters for use in hadron therapy beams
and mixed radiation fields, designed at the Centre for Medical Radiation Physics (CMRP),
University of Wollongong, Australia.
Three new SOI microdosimeters were investigated, including two based on state of the art
3D silicon technology, utilising deep reactive ion etching. This technology was used to
provide well-defined sensitive volumes with enhanced charge collection properties, which
were lacking in previous CMRP microdosimeters. Electrical characterisation was undertaken as well as scanning electron microscopy and energy-dispersive x-ray spectroscopy,
revealing the physical and chemical properties of the microscopic detection volumes. Using the ion beam induced charge collection technique, the spectroscopic response to high
LET alpha particles was measured and the charge collection geometry mapped.
Equipped with the knowledge of previous simulations which investigated the tissue equivalence and angnlar dependence of silicon microdosimeters in hadron therapy beams, measurements with each device were performed in a 290 MeV/u
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C ion spread-out Bragg

peak beam. Microdosimetric spectra were obtained and using the microdosimetric-kinetic
model, RBE 10 values were derived. Good agreement with previous results obtained using
a TEPC was observed for most devices. Due to the high spatial resolution of the microiv

V

dosimeters which the TEPC lacks, detailed measurements were possible at the end of the
Bragg peak, where the LET of primary particles changes rapidly. Measurements were
also performed using mono-energetic 290 MeV/u and 70 MeV

12C

ion beams.

With the development of in-house electronics and remote controlled motion stage, the
microdosimetric effects of motion were investigated in 290 MeV/u

12C

beams produced

using passive scattering and active delivery. Static microdosimetric spectra were obtained
and compared to when the detector was undergoing motion representative of the trajectory that a hypothetical organ might undergo during treatment. The impact of motion
on microdosimetric quantities varied and was dependent on the motion characteristics,
acquisition location and delivery technology.
Application in proton therapy was also undertaken with microdosimetric measurements
performed in-field with beams produced using double scattering and pencil beam scanning techniques. Using the microdosimetric-kinetic model, the RBE distribution along
the depth of a water phantom deviated from the value ~1.1, which is commonly used in
proton therapy treatment planning. Radiation protection quantities were also produced
for out-of-field locations using pencil beam scanning proton fields.
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Chapter 1
Introduction
This chapter provides an overview of the relevant concepts and literature that are discussed
and investigated in this thesis in the context of charged particle therapy. A number of
concepts are explored including the physical interactions of charged particles with matter,
modelling the radiobiological effects of radiation, microdosimetric techniques used to
characterise radiation fields, as well as an overview of the previous silicon-on-insulator
(SQQ microdosimeters, and new 3D SOI microdosimeters.

1.1 Literature Review
1.1.1 Charged Particle Interactions with Matter
The term energy deposition is used ubiquitously throughout this thesis to describe the
interactions of charged particles within microscopic silicon volumes. The purpose of
utilising solid state detectors for the measurement of radiation is to relate the energy
deposited within them to interactions that occur within human tissue. This can be relevant
in countless scenarios from simply characterising a radiation field in a potentially harmful
environment to predicting biological effects of the charged particles in hadron therapy.
As such, an understanding of how charged particles interact with matter is necessary and
presented in this section.

1
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1.1.1.1 Electronic Interactions
Electrons are light charged particles that are subject to Coulomb interactions imposed by
the medium they traverse. The incident electrons primarily interact with the orbital electrons of the medium. Due to these particles having the same mass, large energy transfers
are possible which can cause significant deflections during the electrons journey in the
medium. Inelastic interactions can also occur when the incident electron imparts enough
energy to raise the energy of the bounded electrons to a higher energy state, or ionise it
from the target atom completely. If an ionised electron has sufficient energy it can produce further cascades of electron excitations or ionisations within the medium, depositing
energy away from the initial collision site - these are known as delta electrons or o-rays.
The energy loss due to collisional interactions within the medium has been described by
Bloch in equation 1.1. It can be seen from this equation that the collisional energy loss is
proportional to the atomic number and electron density, and inversely proportional to the
square of the electron velocity. As a result, the highest energy loss occurs when very low
energy electrons interact with high Z materials.

dE)
21r'1eNZ
(
mov2E
- ( dx col= mov2 In 2l2 (1-/32)

2
2
(ln2) (2✓1-/3 2 -1+{3 ) + (1-f3 )+~

2

(1- ✓1-132) )
(1.1)

Where:

e = charge of an electron

= number density of medium atoms
Z = atomic number of the medium
v = velocity of the incident charged particle
mo= reset mass of an electron
I = mean ionisation energy of the medium
/3 = v/ c where c is the speed of light
N

Electrons also emit radiation when they are accelerated/deflected when undergoing coulombic interactions with the medium nuclei, known as bremsstrahlung or "stopping radia-
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tion". The rate at which the incident electrons lose energy via radiative means has been
described by Bethe in equation 1.2. Due to the 1/ m2 dependence, Bremsstrahlung is generally only of significance for very light charged particles, and is greatest for high energy
electrons interacting in a high Z material.

-(dE)
dx

= NEZ(Z+l)e
rad

137m5c4

4
(

4 1n(~)- 2
moc

~)
3

(1.2)

where all symbols are defined as per equation 1.1.
The resultant Bremsstrahlung has the possibility of interacting with the medium at some
distance from its point of origin, potentially escaping the medium completely in the case
of high energy incident electrons. The escape of photons has significant implications for
small volume x-ray and gamma-ray detectors.

1.1.1.2 Uncharged Hadronic Interactions
The primary uncharged hadronic particles responsible for depositing energy within media
relevant to biological tissue are neutrons. Unlike charged particles, they do not undergo
Coulomb interactions when traversing material. Instead, they interact through a variety of
different processes that may result in a significant portion escaping the medium, without
transferring any energy to the medium. Neutrons interact with the nucleus of atoms, not
the orbital electrons, and these interactions depend on the energy of the particle and the
composition of the medium. Neutrons can be classified by their kinetic energy, listed in
table 1. 1. In general, neutrons are always born with high energies, and lose their interactions with surrounding materials, and lose this energy through interactions with surrounding materials, differing from both photons and electrons that are often generated at low
energies.
Neutrons can interact with matter in a variety of ways, with elastic and inelastic scattering being the primary mechanisms at higher energies. Elastic interactions occur when the
neutron scatters off a target nucleus with little to no energy lost, while inelastic scattering
occurs when the neutron causes the recoiling target nucleus to become excited, resulting
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Neutron Type

Energy

Cold
Thermal
Epithermal
Cadinium
Epicadmium
Slow
Resonance
Intermediate
Fast
Relativistic

0-0.025 eV
0.025 eV
0.025-0.4 eV
0.4-0.6eV
0.6-1.0 eV
1-10 eV
10-300eV
300eV-1 MeV
1-20MeV
20MeV

Table 1.1: Neutron classification based on energy[2]

in the loss of energy through secondary emissions upon dexcitation. The neutron will
eventually lose most of its energy from these process and before interacting with matter
through neutron capture, where the target nucleus absorbs the neutron. This often produces an unstable atom which will eventually decay or undergo fission, emitting daughter
products in the form of gamma rays or lighter nuclei. A common example of this is the
1H(n,y)2H

reaction, emitting a 2.2 MeV gamma ray which can then be detected using

conventional spectroscopic detectors (e.g. Scillnator with PMT, HPGe, etc). Another is
neutron capture in

10B

which can produce a 1.47 MeV

a particle

and 0.84 MeV lithium

nucleus, which deposit energy in close proximity to the interaction site. This describes
the primary mechanism used in boron neutron capture therapy, used in the treatment of
hypoxic cancers [3].

1.1.1.3 Charged Hadronic Interactions
In contrast, when a charged particle enters a medium, energy loss occurs immediately
and continuously through Coulomb interactions between the heavy charged particle and
atomic electrons in the medium. Coulomb forces exerted on these bound electrons may
be excited to higher energy states, or if transferred sufficient energy, be ejected from their
atom through ionisation [4]. As mentioned previously, these delta rays can cause further
cascades of ionisation and energy transfer within the medium.
Due to the relatively large mass of hadrons compared to electrons, the energy loss through
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each of these interactions is small, in the order of electron volts. As a result, the paticle
trajectory is much less affected by these interactions when compared to electrons. However, these energy losses decrease the charged particle velocity and lengthen the time that
electrons are acted upon by the Coulomb force. The result is an increasing rate of charged
particle energy loss as it traverses deeper into the medium. After slowing down, the heavy
charged particle will begin to attract electrons from the medium, effectively reducing the
charge of the particle, resulting in increasingly smaller energy losses before eventually
coming to rest within the medium as a stable atom.

Stopping Power
The rate at which a charged particles loses an infinitesimally small amount of energy dE
occurs through a medium of particular thickness dx is called its stopping power S, defined
in equation 1.3. Stopping power is more commonly expressed per unit physical density
as the mass stopping power Sm, defined in equation 1.4).

S=-dE
dx

(1.3)

sm-----pldEdx

(1.4)

For charged hadrons, the semi-empirical Bethe-Block formula describes the energy loss,
defined in equation 1.5, and takes into account the properties of both the incident particle
and the medium it is traversing [5]. From this equation, it is clear that the greatest rate of
energy loss will occur for ions with higher electric charge (oc z2),and in media with the
greatest atomic number and density (ocNZ).

- dE
dx

=(

4
2
n-ez2)
NZ [zn ( mov2)-ln
2
mov
I

4

(1-v2)- v2]
c2

c2

(1.5)

where all symbols are defined as per equation 1.1 and z is the integer multiple of electronic
charge of the incident charged particle.

Linear Energy Transfer
The term linear energy transfer (LEn is a more practical quantity used to describe the
rate at which charged particles deposit energy in media. LET is defined as the amount
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Figure 1.1: An illustrative example of a Bragg curve generated from 270 MeV/u carbon
ions. Adapted from [8].

of energy that a charged particle of energy E deposits per unit length within a medium,
expressed in units of keV/ µm. LET values of interest vary between the order of

~10

keV/µm for typical a-electrons [6], to hundreds and thousands of keV/µm for very low
energy charged particles used in hadron therapy [7].
The Bragg Peak
The Bragg Curve describes how charged hadrons deposit their energy as a function of
depth within a medium; it is the key characteristic which differentiates heavy charged
particles from photons in the context of therapeutic application of radiation. From equation 1.5, the rate at which energy is lost to matter is inversely proportional to the square of
the charged particle velocity, 1/ v2.This property plays a crucial role in the way charged
particles deposit energy in matter, as charged particles are constantly slowing down when
travelling through the media.
For an approximately monoenergetic beam of ions, the energy deposition profile is known
as a pristine Bragg peak. As seen in figure 1.1, the curve can be broken up into three
distinct regions:
A. The build-up. The high energy charged ion interacts very mildly with the medium,
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depositing energy through the generation of o-electrons. Little dose is deposited
per cm of medium travelled and is often called entrance dose. However, for heavier
ions, the nuclear process of fragmentation can occur, whereby an incident ion interacts with a nucleus in the medium, causing a nuclear excitation. Upon de-excitation,
the emission of low-Z fragments can occur, as well as neutrons. One advantage of
the fragmentation process is the generation of positron-emitting nuclides within
the medium, providing an interesting method for in-vivo dose verification using
conventional PET techniques [9]. In addition, heavier high energy ions can also
produce neutrons by stripping them from medium nuclei [10].
B. The Bragg Peak. As the ion slows down, it expends more and more energy to the
medium as per equation 1.5, depositing a significant portion of its energy within
a localised volume within the medium, after which it comes to a complete stop.
In addition, this maximum energy loss is proceeded by the coulombic attraction of

medium electrons, causing the effective charge of the ion (z in equation 1.5) to decrease. For a particular species of ion and medium, the depth of the Bragg peak is
primarily determined by the initial energy of the incident ion; increasing ion energy
results in decreased stopping power due to the 1/..Jl dependence, allowing the ions
to travel farther through a medium. The width of the Bragg peak is primarily determined by a process called straggling, which describes the variation in ion range
due to the statistical nature of interactions within the medium [5]. If the number of
interactions and overall energy loss of an ion is higher than others, it will stop earlier within the medium compared to ions that interact less. Generally, the number
of interactions is proportional to:? jv2, as seen in equation 1.5. Hence, for different
ion species that the same range, the ions with a higher atomic number will have a
much sharper Bragg peak, due to less straggling.
C. The Tail. For lighter hadrons such as protons, little to no dose is deposited after the
particles stop in the medium, except the relatively small contribution from neutrons
that have been generated by inelastic reactions with the medium. For heavier ions,
the fragments and secondary particles that were created at shallower depths can de-
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posit dose away from where they were generated before coming to a complete stop.
In charged particle therapy, the delocalised energy deposition is of significance, es-

pecially at the distal edge of the Bragg peak, due to the potential to deposit energy
in healthy critical organs, known as organs at risk (OAR).

1.1.2 Utilising Hadrons in Charged Particle Therapy
The treatment of cancer with radiation (radiotherapy) started long ago, with the first medical use of x-rays occurring in 1896 to treat breast cancer [11]. The use of radiation in
cancer treatment expanded, however the biological impact of radiation was poorly understood, resulting in adverse effects and poor treatment efficacy. With the advancement
of power supplies and x-ray tube technology in the 1930s, the production of therapeutic
beams consisting of up to 200 kV x-rays and electrons was made possible [12]. At the
same time, Van de Graff and others developed the first particle accelerators that formed
the basis of producing and accelerating high energy charged particles, although not originally created for oncology. A linear accelerator that could accelerate electrons up to 4
MeV was invented in the 1940s, allowing the generation of electron beams and mega-

voltage x-rays for the treatment of deep seated tumours [13]. It was clear at this stage
that while effect, x-rays characteristics could not be controlled effectively, which allowed
large dose build-up in healthy tissues.
Meanwhile, in 1946 Robert Wilson put forward the idea that protons were the simplest and
most practical means for the external treatment of cancer [14]. Medical physicists around
the world investigated the plausibility of protons as an advantageous treatment alternative
and in 1954 the first clinical proton facility was opened at Lawrence Berkeley National
Lab in the USA [15]. Shortly after, more facilities opened, including the first hospital
based facility at Loma Linda University Medical Centre in 1970. Whilst proton therapy
has been extremely widespread, with over 21,000 patients having been treated at Loma
Linda to date [16], others at the time thought that the low relative biological effectiveness

~

of protons ( 1.1) could be improved [17]. The use of heavier charged particles for therapy
was suggested in the 1960's and 1970's with pi-mesons being clinically tested at the Los
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Figure 1.2: An illustrative example of the composition of a Spread-out Bragg curve. The
red spread-out Bragg peak profile is created from the superposition of all other pristine
Bragg peak profiles. Adapted from [23].

Alamos National Lab and the Paul Scherrer for years after [18]. But this method, as well
as helium ion therapy and heavier ions such as neon, nitrogen and oxygen, did not come
to fruition clinically [19]. Heavier ion studies however were undertaken in Germany and
Japan, showing carbon ions to be effective in obtaining effective treatment outcomes [20].
Carbon therapy was first implemented in 1994 at the National Institute of Radiological
Sciences (NIRS) in Japan. Today, there are 92 proton therapy and 12 carbon therapy
facilities operating clinically worldwide [21]; a testament to the amazing properties of
these ions.
While the Bragg peak profile that these charged particles exhibit is favourable for the
localised deposition of dose for tumour treatments, it in fact too localised to be used for
therapeutic purposes in humans [14]. To utilise ions to treat malignant tumours, high
conformal doses need to be delivered to volumes spanning multiple centimetres. The
solution to this problem is to create a spread-out Bragg peak dose profile, which is the
superposition of a combination of Bragg peaks of different ranges/energies. For each
tumour treatment, depending on the size, location and depth of the tumour, a precisely
weighted set of different ion energies is required [22].
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In practice, the patient is treated using a) passive delivery, which requires the modification

of a mono-energetic ion beam after it has been generated, or b) active delivery, which
delivers the treatment using different ion energies which are generated directly from the
cyclotron/synchrotron with minimal modification.

1.1.2.1 Passive Delivery of Hadrons
Passive scattering involves the transformation of a high energy monochromatic pencil
beam of ions into a variable energy beam, using insertions device downstream from where
the particle is generated and extracted. As the ions pass through the insertion device, their
energy is selectively degraded to produce the appropriate variation of energies to achieve
the desired dose profile within the body. Of course, the ions are also scattered laterally to
ensure a uniform field over a clinical field size, comparable to that of the treatment site.
The Heavy Ion Medical Accelerator at Chiba (HIMAC) at NIRS is a notable example
where passive scattering delivery has been used (many of the results in this thesis are
obtained at this facility).
In proton therapy, lateral spreading of the ion beam is often done using a double scattering

technique. The beam passes through a single scattering foil which results in a wider
Gaussian beam profile and is then scattered off a second foil which produces a larger
uniform field. Designs often include composite scattered with contoured to provide a
field with a flat dose response [24]. In

12

C ion therapy, lateral spreading can be achieved

using beam wobbling. This technique uses two dipole magnets, placed one after another
along the beam axis and are oriented such that their magnetic fields are orthogonal. An
alternating current is applied to the magnets, with a phase shift between them [25]. When
an ion enters the wobbling magnet, its trajectory is altered due to the Lorenz force. The
time dependent magnetic field causes the ion beam to be spread out over a larger area [26].
The ions then enter a scattering material such as tantalum to produce a laterally uniform
broad beam. In all passive delivery methods, the beam is defined with high-Zjaws, then
reduced to a size similar to the treatment volume using a patient specific cut-out, before
entering the body.
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Depth dose modulation can be achieved using the following insertion devices:
• A ridge filter is an upstream insertion device that converts an approximately monoenergetic laterally spread ion field and produces a SOBP dose distribution within
a medium. While there are many types of ridge filters [27, 28], they are all generally made from a solid bar of low-Z material (e.g. aluminium, brass), machined
down to produce a set of steps of different thickness. As the ions traverse the different thickness of each step, they will exit with different energies. The relative area
of each step thickness is designed to produce the correct proportion of ions with a
particular energy in order to produce the desired flat dose response.
• A modulation wheel follows the same principal as the ridge filter, however the
wheels are generally made from lower-Z materials with some high-Z to reduce and
account for scatter across different energy ranges [24]. They are also often only
used for modulating protons [29]. The wheel is constructed to have a set of radially
distributed steps of different thickness. The wheel is rotated at constant velocity
and the pencil beam traverses a static point which lies along the radial sequence
of steps. Due to this constant rotation, the thickness through which the ions travel
changes temporally, hence, the relative arc length of each step is made to match the
appropriate weighting of the pristine Bragg peak required to produce the desired
flat SOBP. The speed of the wheel is

~10 Hz, sufficiently fast to prevent interplay

effects between the delivery of each pristine Bragg peak due to organ motion.
• Range shifters involve simplistic range modification by the downstream insertion
of a set thickness of low-Z material e.g. different thickness sheets or adjustable
water column. The ions exit the range shifter material with a known lower energy.
By using an optimised set of absorber thicknesses, the correct set of pristine Bragg

peakscan be produced to generate the required flat SOBP at a specified depth within
the patient.
• A patient specific range compensator (also called a bolus or applicator) is a piece
of machined low-Z material generally made from polyethylene, lucite or wax. It is
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placed close to the patient and ensures that there is a highly conformal dose delivered to the distal edge of the tumour volume. As such, its form is very similar to
the shape of the tumour. The ions travelling through the thickest parts of the bolus
will stop proximally within the target volume and the ions travelling through the
thinnest will stop at the distal edge of the volume. Generally, for each treatment
angle, there is a unique compensator that needs to be mounted in the beam head,
which makes this technique quite expensive in terms of fabrication, but also in both
the therapist's and patient's time. A technique using a single patient-specific compensator has been proposed to increase efficiency and reduce costs which involves
combining the geometry of the compensators at each angle into a single bolus, and
using multi-leaf collimators for lateral beam shaping [30].
These modulation devices are designed to conform the dose profile to the distal edge of
the treatment volume, however this naturally affects the proximal distribution as well, often resulting in poor proximal conformity. In addition, the modification of the beam using
insertion devices produces neutrons, and for heavy ions, produces fragments. These contribute to the out-of-field dose in treatment delivery which is undesirable and detrimental
to the treatment [31]. However, passive scattering has been used for decades and has
proven to be simple and robust.

1.1.2.2 Active Delivery of Hadrons
Significant benefits can be obtained when avoiding the modification of the beam and
utilising the pencil beam directly. Active delivery technology utilises two orthogonal sets
of magnets to laterally steer a pencil beam over the tumour volume, with depth modulation
achieved with the generation of specific ion energies directly from the synchrotron. The
3D tumour geometry is broken up into voxels where the beam is to be delivered. In each
voxel, the set of ion energies and weightings required to deliver the prescription dose to
the tumour are determined, with a high degree of both distal and proximal conformity
[32]. Each energy layer is then delivered one at a time. This is performed using spot
scanning, where the beam is turned off in between voxels, or using continuous scanning,
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where the beam remains on during the delivery of each energy layer.
Due to the high conformity of this treatment modality, it is much more sensitive the interplay effect that occurs due to respiratory motion [33]. The interplay effect describes
the distortion of the delivered dose profile due to the movement of the treatment volume,
often when its motion occurs over a period of time that is comparable to that in which the
beam is delivered. While the treatment of a single energy occurs almost instantaneously,
the time taken to change energy layers can cause subsequent energy layers to be delivered
in a different phase of motion. This can result in volumes of tumour and healthy tissue
that are overdosed and underdosed, as well as a general blurring effect on the dose profile
[34]. Rescanning is a common mitigation technique that involves delivering the energy
layers to the tumour volume multiple times at different phases of the motion cycle, effectively averaging the dose distribution and decreasing the risk of large dose discrepancies
[35]. Recent strategies involve 4DCT tracking and delivering the beam during a particular
motion phase, having been implemented in both proton therapy [36] and carbon ion therapy [37]. Studies have also been performed to investigate adjusting the lateral position
and range of the ions in real time, based on the position the target [38].

1.1.3 Microdosimetry
Microdosimetry was developed around 50 years ago and involves the investigation and
quantification of stochastically deposited energy from radiation within small volumes in
matter[39]. A motivation for its formation is the fact that different types of radiation will
interact differently and cause different amounts damage, even with the same absorbed
dose[40]. Most importantly, it attempts to relate the type of radiation and the way it
deposits energy within matter to a biological effect or damage. Scales of the order of
micrometres are considered as these small sizes are comparable to the size of cells where
DNA is located; destruction of the DNA in cells is the mechanism for cell death and
treatment success.
There are two types of microdosimetry: regional and structural. The former uses the
concept of small volume elements within matter called sites, and is implied when using the
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term microdosimetry; the latter will not be considered here. Microdosimetry differs from
conventional dosimetry mainly due the stochastic nature of energy depositions within
matter and the microscopic nature of the interactions considered.

1.1.3.1 Specific Energy
Specific energy z is the stochastic analogue to the quantity used in conventional dosimetry,
absorbed dose D. Absorbed dose is defined as the average energy de deposited in an
element of mass dm, defined in equation 1.6. Specific energy is defined as the energy
deposited

e per unit mass m for a single

site, defined in equation 1.7.

D= de
dm

z=-

E

m

(1.6)

(1.7)

1.1.3.2 Lineal Energy
A better, more informative quantity for characterising a particular type of radiation is lineal energy; this stochastic quantity is defined in equation 1.8 where the energy deposited

e represents the energy deposited in a single event[39]. Like, LET, it too is expressed in
units ofkeV/µm.

y=~

E

l

(1.8)

The quantity e is the energy deposited along the particles track in one event and [ is the
mean chord length of the volume being investigated. According to work done by Cauchy,
the mean chord length for any convex surface in an isotropic radiation field [41] can be
expressed in terms of its surface area (S) and volume (V), as per equation 1.9.

-

l=-

4V

S

(1.9)

CHAPTER 1. INTRODUCTION

15

1.1.3.3 Microdosimetric Distributions
Bothy and z have their own continuous probability distributions, f(y) and f(z), respectively. The frequency mean lineal energy and specific energy are defined below[39]:

YF=

lo~

yf(y)dy

ZF=

(1.10)

lo~

zf(z)dz

(1.11)

While these distributions are useful, the dose weight distribution d(y) and d(z) for each
quantity is often used where the relationship between the two distributions are as follows[42]:

d(y) = yf(y)
YF

d(z) = zf(z)
ZF

(1.12)

(1.13)

Hence it can be seen that the dose mean lineal energy, defined below, can be expressed in
terms of the frequency mean lineal energy:

lo~
= - lo~

YD=

yd(y)dy

1

YF

/J(y)dy

0

(1.14)
(1.15)

lo~

(1.16)

=~[rt(z)dz
ZF 0

(1.17)

ZD=

yd(y)dy

1.1.3.4 Microdosimetric Spectra
Due to fact that for a given microdosimetric survey of some radiation, both the values
of lineal energy y and its distribution f(y) may exist over multiple orders of magnitude,
it is important to display microdosimetric spectra in a manner that is easy to interpret
with all information accessible to the reader. As a result, using a linear scale on either
axis will result in the display of very little information. Using a log-log plot will allow
the distribution of lineal energy events to be seen, but lacks the ability to be interpreted
usefully. By using a semi-log representation, where the x-axis represents yin log-scale
and the y-axis represents y. f (y), the area under the curve in a specific range is proportional
to the fraction of events in this region. The same property exists when plotting y on the
x-axis in log-scale and/ f(y) (equation 1.12) on the y-axis to obtain the dose distribution.
Figure 1.3 shows appropriate representation of this spectra.
The microdosimetric spectra is generally normalised, such that its integral is equal to YD
, however this makes comparison of spectra difficult. As such, all yd(y) distributions in
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representation[39]
this thesis have been normalised to unity, in order to facilitate intuitive comparison.

1.1.4 Estimating the Biological Effect of Radiation
The LET for each radiation type and energy varies significantly, resulting in different
biological effects when interacting with tissue. For example, Co-60 gamma-rays have an
LET of ~0.2 keV/µm, while heavy ions can have LET of the order of ~1000 keV/µm
[43]. Physically, the difference in LET will result in vastly different ionisation densities
of the tissue in which the radiation interactions, resulting in differing amounts of DNA
damage. As a result, for the same absorbed dose delivered to a volume of tissue, the
biological effects of the higher LET radiation will be much greater. An example of this
can be seen in figure 1.4, showing the vastly different effect of using high LET radiation
compared to low LET radiation for various cell lines.
The goal of charged particle therapy is to ideally induce complete cell death within the
tumour volume while minimising damage done to the surrounding healthy tissue. The
absorbed dose is the quantity that is physically measured in all facets of radiotherapy to
determine the appropriate beam parameters to deliver the treatment plan. However, for
high LET radiation, this measured physical dose must be scaled by some factor which
takes into account its enhanced biological effect. This quantity is known as the relative
biological effectiveness (RBE), defined as the ratio of the dose required produce some
biological effect using a radiation of interest to that using a known reference, often 200
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kV x-rays or Co-60. This quantity is defined in equation 1.18.

RBEs=

DR,S

(1.18)

Ds
where:
DR,S

= Dose delivered with reference radiation

Ds

= Dose delivered to produce cell survival S

to produce cell survival S

The RBE is fundamentally determined through in vitro cell experiments, where specific
cell lines are irradiated with the radiation of interest at different absorbed doses, and the
proportion of surviving cells is quantified using techniques such as clonogenic assay [44].
This is repeated for the reference radiation and the RBE is determined for a particular
survival percentage. A common representation used in

12

C therapy is the RBE10 , which

is the ratio of the dose required to achieve 10 % survival. While the RBE heavily depends
on LET which is determined by radiation type and energy, it also depends on the cell
line and its current state within its cell cycle, the oxygen concentration, dose rate used
as well as the treatment fractionation regime [43]. Some of the various models that have
been developed to describe the biological response to radiation in cells will be described
below.
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The Linear Quadratic Model (LQM)
It has been known since the days of Curie in the early 1900s that radiation caused damage

to living cellular organisms [45], putting forward the hypothesis that this effect increased
with dose. This was verified through studies in chromosome aberration in the early 40's
[46], with the subsequent development what is known as the linear-quadratic model. This
was further developed and confirmed with theoretical models which included radiations
response from single events and multiple events [47].
While there are many different approaches to estimating the effects of radiation on tissue,
the linear-quadratic model is the most fundamental and ubiquitous tool in characterising
a particular radiation field's effect on cell death. It states that the probability of cell
surviving exposure to a particular dose of radiation is dependent on two parameters,
and

/3,as per equation

1.19 [48]. The

a parameter

a

describes the cells survival response

at low doses and is generally reflects the cells response to single radiation events and the

/3parameter

describes the curvatures of the cells response at higher doses and generally

reflects the cells response to multiple radiation events. The a/{3 ratio is the quantity often
used to describe a cell lines response to a particular radiation. An example is shown in
figure 1.5 of a cell line with varying al f3ratios.

(1.19)
where:

= Probability of cell survival
a = LQM a parameter, dependent
f3= LQM /3parameter, dependent
D = Dose delivered to cell
S

on cell radiosensitivity
on cell radiosensitivity

The Microdosimetric Kinetic Model (MKM)
The microdosimetric kinetic model was developed by Hawkins in 1996 [49], used to
describe the relationship between dose and cell death for radiations of all LET values,
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and is extremely similar to the theory of dual radiation action [50]. The model describes
breaking down a cell into a number of microscopic volumes referred to as domains. Each
domain is a homogeneous tissue volume in which the contained DNA can be damaged
(lesions), the extent of which is proportional to the dose deposited within the domain.
The number of domains that that have received a dose D of a population of domains is

The model assumes the following:
• There exists a type of lesion (primary type I) which will kill the cell
• There exists a type of lesion (primary type II) which may result in being:
(a) non-repairable resulting in cell death, proportional to nn,
(b) non-repairable due to combination with another type II event within some

distance (e.g. double strand break), resulting in cell death, proportional to

nb.

This distance is characteristic of the cell and is dependent on it's cellular cycle
state,
(c) repairable, proportional to nn, or
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(d) remain dormant until after time t, where it results in cell death
• Type I and II lesions are uniformly distributed in the DNA of domains that received
doseD
Based on these assumptions (and many more), Hawkins showed that the survival of a
population of cells is of the same form as the LQM, however with

a and /3parameters

dependent on the number of type II lesions, the rate of formation of type II lesions from
processes dependent nn and nb and the time t, after which these lesions can tum lethal.
Equation 1.20 shows the general expression which describes the model in terms of cell
survival. The model is valid for doses less than 125 Gy which is of course is much
greater than the doses required to kill human cells, of which all this research is founded
upon.

s=

e-(aD-JlIY)

= e-((ao+r/l)D-JlIY)

(1.20)

where:
l'.l()= parameter proportional to the number of domains per nucleus

r = parameter which describes
f3 = LQM /3parameter

the microscopic dose to the nucleus

From the MK model came the modified microdosimetric model (MKM) which further
modelled the

a component

in equation 1.20 in terms of quantities that in part could be

measured with a microdosimeter [51]. The

a term was derived in terms

a particular cell

characteristics and microdosimetric quantities, defined in equation 1.21.

•

a=l'.l(i+/3Y?

p1r:'d

where:
l'.l()= LQM

a parameter

f3 = LQM /3parameter
p = Density of tissue
rd = Domain radius
y* = Saturation-correction

dose-mean lineal energy

(1.21)
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The overkilling effect results in a decrease in RBE for particles with LET above

~1()() -

150 keV/µm, whereby the desired biological effect has been achieved and increased dose

is "wasted" [52]. The saturation-corrected dose-mean lineal energy y* takes into account
this saturation effect and is defined in equation 1.22.

y* =

rof[1-e-rlro]

f(y)dy

(1.22)

Jyf(y)dy
where:

Yo= Factor dependent on cell MK model parameters including nucleus radius Rn,

domain radius rd and LQM parameter

/3(empirically determined

[51])

Substituting these terms into the LQM, the cell survival can be expressed as in equation
1.23.

(1.23)

The RBE (equation 1.18) can now be expressed in terms of the survival, dose,
modified

a parameter. The RBE for 10% survival is expressed in equation

RBErn = D10,R =

D10

1.24.

2/3D10

Ja

2

/3 and

-4{31n(0.1)-a

(1.24)

where:
D10,R = Dose delivered with 200 kVp x-rays to produce 10 % survival
D10

a

f3

= Dose delivered with radiation of interest to produce
= a as per equation 1.21
= LQM /3parameter

10 % survival

For human salivary gland (HSG) tumour cells, considered to be a reference cell line,
values of D10,R = 5.0 Gy,
been determined for

f3= 0.05

Gy- 2 , rd= 0.42 µm and Yo = 150 keV/µm have

12

C ions [51]. Using this equation, the MKM model allows for the

estimation of RBE 10 for HSG cells based on measurements from a microdosirneter.
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The Local Effect Model (LEM)
The Local Effect Model (LEM) describes the biological effects of radiation within cells
in terms of the local energy deposition and was introduced in 1996 by Scholz and Kraft
[53]. The model sought to overcome limitations of previous models from Katz and Kiefer
which described the biological effect only in terms of integral dose within a volume of
interest, without regard for the fine track structure that was produced at the cellular level
[54]. In contrast, the LEM hypothesised that the biological effect was dependent on the
total length of the tracks that were generated within a cell.
The model assumes a homogeneous distribution of sensitive sites within a cell, that in the
occurrence of a lethal event within any of them, the cell would die. With the assumption
that the distribution of lethal events is Poisson and the number of these events N is determined by the dose D deposited within, the survival probability S can be expressed in
terms of LQM parameters:

S(D)

= e-N(D)

(1.25)

⇒ N(D) = -ln(S(D)) = aD+f3d2

(1.26)

Since the distribution of sites is assumed to be homogeneous within the cell, the number
of events per volume of the nucleus within the cell V is constant and dependent on dose,
expressed as:

v(D) = N(D) = -ln(S(D))
V
V

= aD+

V

{3D2

(1.27)

Since the event density is constant with the cell, the average number of lethal events N
produced from any arbitrary local dose distribution D(x,y,z) can then be expressed in the
form of a volume integral:

N

= !_111-ln(SD(x,y,z))dxdydz
V

X

y z

(1.28)
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The survival probability can then be expressed as:

(1.29)
If the dose distribution can be quantified and the volume of the cell is known, then by using

the x-ray cell survival curve, the average number of lethal events can be determined. The
RBE can then be calculated by first determining the dose which produced the calculated
the cell survival (equation 1.19), then calculating RBE using equation 1.18. This model
prides itself on being based on solely on measurable quantities such as

a and /3for low

LET x-ray radiation, however in reality the dose distribution in the nucleus produced
by tracks from heavy charged particles is generally modelled using simulations. The
LEM model has showed good agreement for carbon ions and has been used in clinical
trials at GSI and is currently used clinically at the Heidelberg Ion Beam Therapy Center
[55].

1.1.S Using Microdosimetry for Radiation Protection
The dose equivalent is defined as the product of the absorbed dose and a quality factor
and is used to estimate the dose received by a person upon radiation exposure. Using the
lineal energy dependent quality factor Q(y ), defined in the ICRU-40 report for radiation
protection [56], the dose is scaled to be proportional to the biological effects it causes
with respect to effects produced by a reference radiation. This dimensionless quantity is
defined in equation 1.30.

(1.30)
where:
a1
a2

a3

= 5510 keV/µm
= 5x 10- 5 µm 2/keV 2
= 2x 10- 7 µm 3/keV 3
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To calculate the dose equivalent for a microdosimetric spectrum, the average quality factor

Q is first determined by integrating the product of the dose-weighted microdosimetric
distribution d(y) and quality factor across all lineal energies, seen in equation 1.31.

Q=

lo~

Q(y)d(y)dy

(1.31)

Previous studies using silicon microdosimeters have been performed previously, able to
measure out-of-field dose-equivalents and quality factors in proton therapy [57]. In this
case, the tissue-equivalent dose DT was calculated by first obtaining the dose deposited
it in the silicon microdosimeter. To achieve this, the total energy deposited in the silicon
sensitive volumes is found by integrating the MCA energy spectra counts over all channels. To convert this to dose, the total energy deposited is divided by the mass of the
sensitive volumes which is simply the product of the density of silicon p and the volume
of these sensitive volumes V.
Previously, the dose in silicon was converted to that in tissue using a factor determined
through comparison with TEPC results and Geant4 simulations, however more recent
developments with improved Geant4 simulations have determined ,

= 0.57 is most

ap-

propriate [58]. The dose equivalent is calculated using these quantities as seen in equation
1.32 and is normalised to the dose received at isocentre in order to establish values with
respect to dose delivered to a patient, with units mSv/Gy.

H=QDT
=Q,Ds;

(1.32)

= Q''f,;C;E;
pV
where:
C; = counts in the ith channel
E; = centre of the ith energy bin in the MCA spectrum
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1.2 Microdosimetric Technology
The design and fabrication of microdosimeters at the Centre for Medical Radiation Physics
(CMRP), University of Wollongong, Australia, has been ongoing for almost two decades.
Its motivation for this effort is to replace the current gold standard microdosimetric detector, the tissue-equivalent proportional counter (TEPC). This chapter will explore microdosimetric theory as well as previous, current and future microdosimetric technologies,
and summarise their properties and roles in microdosimetry.

1.2.1 The Tissue-Equivalent Proportional Counter
1.2.1.1 Operation and Construction
The TEPC is a radiation detection device that measures the charge liberated by radiation
within its gaseous volume by individual energy deposition events from radiation. It was
first developed by Harold Rossi in the 1950s and was and still is the gold standard microdosimetric measurement instrument. Ranging from a physical size of the order of 10 mm 3
[59][60] to tens of centimetres, the device deceivingly mimics a microscopic cell-sized
volume with its detection volume consisting of very low pressure tissue-equivalent (TE)
gas. The simulation of the cellular-sized tissue volume is achieved by adjusting the density of the gas such that [pd]038

= [pdJnssue•
where p is the density

and d is the diameter

of each volume. Based on the desired simulated tissue volume, the pressure of the TE
gas is adjusted to ensure the mass of TE gas is equal to the mass of the simulated tissue
volume. Given these operating conditions are maintained, the interactions within each
volume is for the most part equivalent.
As illustrated in fignre 1.6, a TEPC stripped down to its core is comprised of a spherical
or cylindrical cavity with a cathode coating its walls and an anode wire running through
the centre of the cavity. In the case of a TEPC, its wall is made from a TE plastic (generally A-150 [61]) and the TE gas used is normally a propane-based mixture [62]. As with
normal proportional counters, a voltage is applied between the anode and cathode (generally :C::500 V) such that electron-ion pairs generated from single ionisation events can
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Figure 1.6: An example of the construction of a spherical tissue-equivalent proportional
counter [8].

be collected and measured through a multiplication process. This multiplication process
occurs in close proximity to the centralised anode, ensuring that the magnitude of the total
released charge is independent of the initial ionisation site location.
Since the average chord length [ for any convex body with volume V and surface area A
is equal to 4V / A [63], through this charge collection, the TEPC effectively measures the
lineal energy, y, event-by-event. As with any other microdosimeter it is used to determine
microdosimetric quantities discussed in section 1.1.3.
The TEPC has been used in a wide range of applications including radiation protection,
particle therapy, space, mixed field dosimetry, etc. While the idea of gamma-subtracted
distributions have been able to be obtained for known fields, implementation of a separate
gamma-sensitive proportional counter has the potential to be able to distinguish the whole
neutron spectrum in mixed gamma-neutron field [64].

1.2.1.2 TEPC Shortcomings
While the TECP is a robust, long-standing radiation detection device, it is not without
its limitations. Accurate determination of microdosimetric quantities is essential for interpretation and application of the TEPC data to fields such as radiation protection and
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particle therapy.
The fundamental TEPC technology departs from really what it is designed to simulate energy deposition within a cell in the body. One of the more obvious differences is that
the TEPC uses a gas to simulate energy deposition within tissue and while TE gas does for
the most part provide an equivalence, there many be differences in mass stopping powers
of solids due to the polarisation effect [65]. Most of its issues however lie in its relatively
large single physical volume and the relatively high density wall which encapsulates it.
This departure results in discrepancies in the microdosimetric measurement, and while
these effects can be compensated using correction factors (in known fields), they present
inherent problems with the technology design [39].
The delta-ray effect describes the scenario whereby a primary charged particle and its
delta-ray(s) may not traverse the same microscopic volume but both may traverse the
large volume of the TEPC (figure 1.7a). This results in the TEPC measuring an increased

YFvalue compared to that in the true microscopic site - Yn is relatively immune to this
effect in low-medium energy cases [47]. The V-effect is the same as the delta-ray effect
but the two (or more) particles of interest are two heavy charged particles produced from
an inelastic nuclear interaction (figure 1.7b), resulting in a large increase in both

YFand

Yn . The re-entry effect occurs where an unpredictable, winding track of an electron
would cause it to interact with the microscopic volume just once, however in a TEPC, it
may enter its volume, exit and then return through the TEPC again (figure 1.7c). This
effect results in increased lineal energy measurement and is only relevant for delta-rays of
energy less than 1 MeV. While these are inherent problems with the technology, correction
factors can be calculated to compensate for these effects. Finally, the scattering effect
occurs when an uncharged particle generates multiple charged particles along its track
and these particles interact with the single TEPC volume, but would interact in separate
sites on the microscopic level (figure 1.7d).
As discussed, the TEPC volume physically takes up a relatively large volume compared
to a cell, but also compared to many beam features in hadron therapy such as pencil
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b) V-effect,c) Re-entry Effect / Backscatterand d) Scatteringeffect.

beam spot size, penumbra width, Bragg peak width, etc. An example is the measurement of the a scattered proton field (14 cm range, 10 cm modulation) width which has a
penumbra width of approximately 2 mm (20-80%) [24], illustrated in figure 1.8. Within
a lateral distance of less than 10 mm, the dose is both at its highest and is almost nil. The
large volume of the TEPC means it cannot physically measure many beam characteristics without volume-averaging. As such, its performance in charged particle therapy is
put into question in many scenarios due to its poor spatial resolution. There are however
small numbers of mini-TEPCs in development which may overcome this particular limitation with volumes < 1 mm 3 , suitable for measurement in charged particle beams [66]
[67].
Not only is the TEPC size often large, many earlier TEPC systems are even more cumbersome due to the gas flow systems that accompany them [62]. These gas flow systems
serve many functions, namely a) providing the TEPC with a constant supply of pure TE
gas, b) maintaining the required pressure to simulate the desired microscopic volume and
c) clearing of contaminants from out-gassing within the TEPC which can have significant
impact on the gas amplification. This cumbersome setup can be avoided by using sealed
TEPCs, which can be filled with gas and then sealed for use where it would be impractica-
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ing the 50% of the a proton lateral penumbra. Adapted from [24].
ble for gas flow apparatus to be used. This however still requires regular refilling and care
when handling to ensure out-gassing and physical damage to seals are avoided. The large
of most TEPCs has been motivation for recent innovation of TEPC design. This effort
to reduce their physical size has been driven by use in applications such as deep space
missions [60] as well as measurements in Boron Neutron Capture Therapy where higher
count rates and hence lower volumes are required [59]. Multi-element TEPCs have also
been designed to tackle the TEPC size while also increasing sensitivity [68] [69].
While the size of the TEPC may decrease, its reliance on a carefully maintained gaseous
detector volume creates the need for significant design and engineering effort to ensure
robustness and practicality for many applications. This among its other limitations may
make solid state microdosimeters a more desirable detector.

1.2.2 Silicon Microdosimeters
Solid state devices have been used in microdosimetry since 1980[70] due its compact
and portable nature, low power requirements, high count rate capabilities, and of course
the ubiquity of its underlying technology[71]. There exists a long-standing knowledge of
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silicon's physical characteristics, and due to its ubiquity in the world of electronics, with
it comes a widespread international net of fabrication capability and facilities. But like
all microdosimeters, they have requirements that need to be satisfied in order to be used
for microdosimetry: tissue equivalence, volume comparable to that of a cell (

~µm), low

noise and a capability of recording single events[72].

1.2.2.1

Theory of Operation and Characteristics

Silicon microdosimeters, like most silicon devices in most of the technology industry, rely
heavily on the underlying physics of P-N junction. P-N junctions, as the name suggests
requires P-type and N-type silicon. P-type silicon is created by the doping of silicon with
group ill elements, creating an excess of holes, and n-type silicon is created by the doping
of silicon using group IV elements, creating an excess of electrons.
When these two are put into thermodynamic contact with each other, two processes occur
simultaneously: 1) the excess electrons in then-type silicon diffuse into the p-type silicon
and combine with its excess holes, and 2) the excess holes in the p-type silicon diffuse
into the n-type silicon and combine with its excess electrons. As this process occurs,
an electric field forms in the region between the two types from n-type to p-type which
impedes the rate of diffusion between charge carriers. Eventually, equilibrium is reached
whereby charge diffusion halts and a region free from mobile charge carriers is formed,
known as the depleted region. The depleted region gives the P-N junction its rectifying
properties i.e. each type of charge carrier can only flow in one direction.
The existence of a depleted region enables silicon devices to be used as radiation detectors
when operated in reverse bias. As illustrated in figure 1.9, The lack of any significant
current flowing through the device when no radiation is present means that when charge is
generated within the P-N junction, it can be detected and measured in an external circuit.
With a small depletion region, the detector will lack the efficiency to detect mid to high
energy gammas and neutrons, and charge particles will only deposition small amounts
of energy. Naturally, larger depletion volumes result in the opposite effect, giving the
detector greater sensitivity.
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Figure 1.9: P-N semiconductor device in reverse bias

For a PN-junction with donor concentration Nn and acceptor concentration NA, the width
of its depletion region due to its built-in potential VB1is presented in equation 1.33.

Wn=

2e
-VBJ

q

( -+1

Nn

1)
NA

(1.33)

Often silicon microdosimeters are designed with a one-sided abrupt junction, in which the
one side of the junction has a significantly lower relative doping concentration NB than
the other. In this case, the depletion width is described in equation 1.34 [73]. Figure 1.10
shows how this depletion region varies with applied reverse bias, as well as the effect of
the relative dopant concentration. For a set doping concentration, the depletion width and
hence the sensitive volume of a microdosimeter can be changed with the applied reverse
bias such that Wn oc

v'V.
2e

-(VB1-V)
qNB

(1.34)

Whilst it is assumed that there are no free charge carriers within the depleted reason, there
are still minority carriers within each silicon substrate that are able to flow i.e. electrons
in P-type and holes in N-type silicon. In addition, in normal operating temperatures,
thermal generation of electron-hole pairs and their subsequent acceleration by the elec-
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tric field also contributes to this current. The flow of these charge carriers brings about
the unwanted phenomenon called leakage current which rises with applied reverse bias.
Before breakdown, whilst normally of the order of n.Asfor silicon microdosimeters, the
leakage current causes a detrimental increase in the minimum detectable lineal energy by
essentially increasing the noise baseline on which real radiation events are detected. With
a high noise baseline, small energy deposition events cannot be detected and therefore detector leakage current should be as small as possible. If the applied reverse bias exceeds
the devices breakdown voltage VBn,it will go into breakdown whereby significant current
flows. While not permanently damaging if heat is removed from the device appropriately,
the device simply cannot be used as a radiation detector in this state.
As with any dielectric material, the capacitance of a silicon detector also changes with applied bias. For a one-sided abrupt PN-junction, its capacitance is only dependent upon its
dielectric properties and its volume [73]. Using equation 1.34, the capacitance for a onesided abrupt junction is expressed in figure 1.35. Figure 1.11 shows how the capacitance
varies with applied reverse bias, as well as the effect of the relative dopant concentration.
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Practically, as will be seen in later chapters, the shape of capacitance vs. voltage plot will
indicate whether sufficient bias has been applied to deplete the bulk of the microdosimeter' s sensitive volume.

C=-~

e

Wn

2 (VB1-V)

(1.35)

1.2.2.2 Tissue-Equivalent Chord Lengths
When discussing silicon detectors in the context of microdosimetry, it goes without saying
that there must be some consideration as to the lack of tissue equivalence of these devices.
TEPCs use tissue-equivalent gas to ensure the signal generated within the detection volume represents energy deposited in a volume that is equivalent to to tissue. However,
the signal measured in silicon is just that; without undergoing some sort of transform
on the signal (or spectrum produced within), it fundamentally does not represent energy
deposition within tissue.
To compensate for this material difference, a study was first undertaken aiming to assess
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the feasibility of conversion from silicon to that of ICRU muscle [74]. This was achieved
using Geant4 simulations to effectively scale the average chord length of a silicon volume, to that of a muscle volume which provided the same lineal energy deposition i.e.
y=

e/lTissue
= ,e/1s;.Further studies found that,=

0.56 was an appropriate conversion

factor to water for proton energies [75] and for aviation radiation fields which primarily
consisted of fast neutrons, , = 0.58 was found to be appropriate [76]. A further comprehensive study showed that for

12C

therapy, conversion from silicon to muscle is best

performed using , = 0.57[58]. Furthermore, this study also showed that due to the high
directionality of ions in 12C therapy, relevant to the work of this thesis, using the SY thickness as the mean chord length provided lineal energy responses more accurately than the
mean chord length in equation 1.9.

1.2.2.3 Planar SOI Microdosimeters
The use of silicon-on-insulator (SOQ devices began in the 1970's with their creation and
eventual industrialisation in the 1990's[77]. Their main difference with respect to conventional silicon devices is that there is a silicon oxide layer below the junction(s) of the
device. This insulating layer reduces parasitic capacitance by separating the sensitive region from the substrate, and hence reduces noise. Another important function of this layer
is physically preventing charge carriers produced in the substrate layer from diffusing into
the SY and being collected; this would produce enhanced energy depositions within the
device[78]. After the first solid state detector was used for microdosimetry in the early
1990's [79], the Centre for Medical and Radiation Physics (CMRP) at the University of
Wollongong has designed and manufactured SOI and 3D detectors for microdosimetry.

It has produced over 5 generations of SOI microdosimeters, with the last 3 generations
being investigated in this thesis.
First generation CMRP microdosimeters were developed in the earlier 2000's, fabricated
by Fujitsu Research Laboratories based on technology used to study single event upsets
(SEU). These SEUs are caused by secondary neutron cosmic radiation and can produce
irreversible defects in digital electrons (e.g. pacemakers)[42]. Each device consists of
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4800 diodes with a total area of 10 µm x 10 µm, depicted in figure 1.12. All SVs are
connected in parallel, giving a single read-out channel. Four SOI devices were made
having thickness 2 µm, 5 µm and 10 µm, as well as non-SOI bulk device[80]. A guard
ring was not included in the design and as a result, shown in charge collection studies,
lateral diffusion and funnelling from outside the SVs dominated the desired drift process.
Funnelling occurs in the depletion layer and is due to high LET particles locally distorting
the electric field, allowing charge collection from outside the depletion layer[81]. One of
the necessities of a microdosimeter is a well-defined SV[72], hence this device needed
improving with either insulated boundaries or a guard ring.

DP+Si
-N+Si

□ contact
p-typeSi
Oxide Layer

SiliconSubstrate

Figure 1.12: Cell configuration of the CMRP first generation microdosimeter (adapted
from [42])

The second generation microdosimeters were designed to overcome the problems seen in
first generation, and to assess radiobiological effectiveness of mixed radiation fields. Two
main designs were produced to isolate and prevent charge being collected from outside
the SVs. The first design utilises mesa structures which are physically isolated to further
define the SV, seen in figure 1.13. The sensitive region is 2 µm thick and is raised above
the oxide and substrate layers, and isolated from adjacent SV s to prevent unwanted charge
collection[82]. The device also included two electrically isolated arrays of diodes, called
odd and even. One odd SV is surrounded by four even SV s and vice versa. This enables
particles with the same LET but different delta electron properties to be differentiated
from one another. Charge collection results, however showed that lateral diffusion still

CHAPTER 1. INTRODUCTION

36

Al

P+

p-type
Si

P+

Oxide layer
Silicon Substrate

Figure 1.13: Schematic cross-section of the second generation mesa microdosimeter
(adapted from [82])

occurred in the mesa structures. But more importantly the fabrication of the devices had a
prohibitively low yield. This was due to difficulties in evaporating the aluminium contacts
over the raised structures[83].
The design was analysed and changed to a standard planar device with no mesa structures as the fabrication complications were unavoidable at the time. Two types of guard
rings were incorporated to isolate and further define the SV to prevent lateral diffusion.
The first guard ring being a standard annulus guard ring that surrounded each SV and the
other design is known as guard ring everywhere, which exists in all regions outside the
SVs. Differences can be seen in figure 1.14. Devices with thicknesses of 2 µm and 10
µm were produced with 4 different versions, each having variation in guard ring design
and doping method. The two doping methods used were dopant diffusion and ion implantation, with the latter able to produce smaller doped regions. Charge collection studies
showed revealed that incomplete charge collection occurred at the edge of each SV, and
that fabrication yield was still not 100%. However it was seen that each SV was isolated
from one another, meaning parallel whole-array readout was possible.
The third generation microdosimeters were designed with a different use in mind; its purpose was to predict single event upsets in electronics such as those in space as well as
high energy, mixed radiation fields and real-time dosimetry[84]. Due to the very small
sensitive area size of less than lmm 2 in the previous generation devices, the microdosimeters were made with a total area of 4.25mm x 3.60mm and thickness of lOµm, seen in
figure 1.15. Each SV has a width between 6-lOµm, compared to 2µm previously, in-
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Figure 1.15: Schematic cross-section of the third generation microdosimeter (adapted
from [84])

creasing probability of interaction and hence its sensitivity. It also includes a guard ring
everywhere configuration as seen in figure 1.14 to reduce charge sharing through coincidences between the SV and guard ring channels. One main difference between previous
generations is the use of high-resistivity n-type silicon and a p+ core surrounded by n+
electrodes. Other factors such as odd and even array readout and array configuration have
remained the same. Charge collection studies showed that the devices had 100% yield
which showed that some fabrication difficulties were eliminated. There was however
larger than expected charge collection resulting from displacement current from charge
carriers being produced in the lower layers of the substrate[85], below the oxide layer.
This was thought to occur in this generation only due to the comparatively high-resistivity
of the n-type silicon of the supporting silicon wafer[86].
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1.2.2.4 3D Silicon Microdosimeters
The concept of 3D radiation detectors was first proposed in 1997 by Sherwood Parkerin
[87]. The primary benefits of having small diameter electrodes running through the thickness of a silicon wafer instead of along the transverse plane of the wafer come from the
fact that the distance between electrodes is greatly reduced. This produces the favourable
effects of lower bias voltage required for depletion, faster charge collection times, greater
charge collection efficiency (CCE), better radiation hardness, and more perhaps most pertinent to microdosimetry, greater definition in the charge collection geometry. These advantages are particularly improve inherent problems in typical planar devices such as high
count rates and radiation-induced depletion voltage increase[87].
The U3DTHIN detector is one such detector that was designed for high flux at the JET
tokamak in 2009 [88]. It was designed to overcome the high count rate incapability, low
sensitivity, poor energy resolution and low signal-to-noise characteristics of the scintillatorPMT system that was previously employed. The most important cause for concern is the
saturation of the detectors, preventing ions being detected that carry information about
the plasma[88]. As illustrated in figure 1.16, vertical 5µm diameter p+ and n+ electrodes
are placed in etched holes lOµm deep from the top of the substrate down to extremely
thin oxide layer below. This is made possible due to high etch rate selectivity of 300: 1
between the two materials, allowing the etching process to be stopped at the boundary
in a relatively controller manner [89]. The n+ and p+ electrodes are etched and filled
separately with their respective doped silicon, followed by a thin layer of thermal oxide.
The distance between each electrode is much smaller than that of planer devices, enabling
a much shorter charge collection time and hence reduced trapping potential[90]. In addition, a smaller inter-electrode distance means that reduced applied bias is required to
reach full depletion. Vertical junctions mean that depletion occurs laterally, enabling a
very thin detector that can operate under high fluence conditions. This is extremely desirable for microdosimetric devices. This detector has previously been characterised and
utilised for applications in Microdosimetry [91][92].
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Figure 1.16: Schematic cross-section of the U3DTHIN silicon detector (adapted from
[88])

A similar design has been built by Guardiola et. al. in 2012 [71] however applied in
neutron detection and gamma rejection (figure 1.17). Normal detectors such as those
with sensitive volumes composed Helium-3 or Li-6, whilst possessing much high neutron
capture cross-sections for thermal neutrons, suffer from problems such as greater power
requirements, bulkiness, as well as material transport restrictions (Li-6) and diminishing
supplies (He-3). Whilst not intended for microdosimetry, the wafer sensitive volume
thickness was selected to be on the microscopic scale of 10 µm, rendering the detector
relatively insensitive to gamma rays. Due to robustness and versatility of silicon, a

10B

converter layer was placed atop of the detector to capture thermal and cold neutrons and
convert them to detectable charged particles.
One of the advantages with the thin, lateral depletion is a decreased capacitance leading to
increased SNR compared to planar devices. There are however considerations that must
be taken into account in the design. Whilst reducing the space between the electrodes
will decrease the depletion voltage and cause less charge trapping, the capacitance will
increase giving a much noisier signal. Furthermore, the electrodes are sensitive to radiation hence it is desirable to minimise their size which may cause material and etching
issues[93].
These problems aside, using a thin detector means that heavier particles such as protons,
neutrons and heavy ions won't be stopped by support layers before reaching the SV. Other,
usually unwanted radiation, such as gamma radiation will have low probability of inter-
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Figure 1.17: Thin silicon device by Guardiola et al (adapted from [71])

action due to relatively low-Z of silicon and the thinness of the detector. The use of a thin
boron neutron conversion layer on the detector shows the feasibility of this detector as
a thermal neutron detection with gamma rejection capabilities[71]. However, this detector was not designed for microdosirnetry as the bulk volume was monolithic, and hence
did not possess individual SVs. This meant that oblique ion tracks could deposit large
amounts of energy in the bulk silicon which has previously been shown with similar 3D
detectors [94].
The same group developed this concept further and successfully fabricated a microdosirneter with cylindrical SVs [95]. Based on a high resistivity n-type substrate, the p+ electrodes of each SV were created using planar processes. After using deep reactive ion
etching (DRIB) to remove an annulus region of silicon, n+ polysilicon was deposited
along the depth of the wafer to create the n+ electrode. Charge collection studies [96]
showed 100 % yield and successful charge collection, however well defined geometry
was not observed. In addition, enhanced response was seen for 2 MeV protons, most
likely due to contribution from the supporting silicon wafer.
Meanwhile, the CMRP also ventured to produce its own truly 3D detector, called the
Mushroom microdosirneter, with initial modelling and proof of concept performed in

2014 [76]. The design consisted of arrays of 10 x 10 x µm cylindrical SVs on a 10

µm thick SOI wafer. The more novel aspect of this design featured the etching of all
silicon outside the SVs, and replacing it with PMMA to better mimic a tissue response
and prevent external charge collection seen in previous generations. The PMMA would
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also provide a suitable surface for the deposition of the aluminium buses. Modelling
of this PMMA-embedded microdosimeter revealed very good agreement with a tissueequivalent spherical SY of the same size. More details of the first round of development
of this patented technology [97] are discussed shortly.

1.3 New Silicon Microdosimeters
Three different types of microdosimeters are investigated in terms of their characteristics
and use in microdosimetric applications in this thesis. All 3 designs are vastly different
and all attempt to overcome the limitations and problems related to charge collection seen
in previous generation devices .
The Etched microdosimeter was created at SINTEF MiNaLab in Oslo using less sophisticated planar technology, with the use of a guard ring to prevent external charge collection.
While this technology has been shown to have flaws, the fabrication of this simpler device provided insight and direction at SINTEF for future fabrication of the Mushroom
microdosimeter. Unfortunately, as will be shown in chapter 3, this device had poor charge
collection characteristics due to silicon surrounding the SYs.
The Bridge Yl Microdosimeter which was then fabricated at SPA-BIT in Ukraine, which
had the surrounding silicon physically removed, making charge collection from outside
the SYs impossible. Due to issues in fabrication, only ~5 µm of its 10 µm thickness was
successfully etched, however its charge collection properties still outperformed previous
generations [98]. This etching process was refined and the Bridge Y2 Microdosimeter
was created. While charge collection characteristics were impressive (chapter 4), this
microdosimeter still had relatively large, charge-collecting bridge regions in between the
SYs which supported the aluminium bus; this deviated from the ideal microdosimetric
concept of small, individual sensitive volumes.
Meanwhile, processing parameters were refined and DRIB was utilised at SINTEF to fabricate the first revision of CMRP-designed Mushroom microdosimeters at SINTEF. To
assess and characterise this new technology, the first 3D mushroom microdosimeter de-
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vices were produced without PMMA-embedding or the removal of external silicon.
This section provides more detailed descriptions of each of these microdosimeters used
throughout this thesis.

1.3.1 Etched Microdosimeter
In 2013, CMRP started its collaboration with SINTEF to realise the patented 3D Mush-

room microdosimeter with well-defined, free-standing SYs. Located in Oslo, Norway,
the SINTEF MiNaLab is one of only very few facilities in the world with expertise in
3D technology for applications such as microdosimetry. The early prototype design came
in the form of the planar Etched microdosimeter which, while based on planar processes
only, helped gnide the various fabrication setup for future 3D devices.
Its design is based on a high resistivity (10 kn.cm) p-type SOI substrate of 500 µm
thickness and a total footprint of 10 x 10 mm 2 • The back side of the wafer is etched
down to 20 µm to produce the very thin sensitive volume required of a microdosimeter.
Each SY is created using ion implantation to make an n+ core with 7 µm diameter on the
front, with a continuous p+ implant on the back side, common to all SYs. In addition, a
7 µm thick annular n+ implant is also created around each the SY which acts as a guard
ring (GR) to help create a well-defined cylindrical SY. These GR electrodes are connected
in parallel across the whole device. A p-spray layer also exists to compensate the positive
charge trapping in the top oxide layer, preventing a surface inversion layer and a short
between then+ electrodes [99]. A total of 9600 SYs are created on the 10 x 10 mm 2
footprint, yielding a total thinned area of 5.7 x 5.7 mm 2 • A schematic of its structure is
presented in fignre 1.18.
As per its design, the microdosimeter contains well-defined SYs when the core and guard
ring are biased such that the sensitive region is fully depleted. Under these conditions,
based on the doping and concentric geometry of each implant, the boundary of the SY
is approximately half way between the outer diameter (OD) of the n+ core implant and
the inner diameter (ID) of the n+ GR implant, giving the SY a diameter of approximately
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Figure 1.18: Schematic cross-section and top view of the planar Etched Microdosimeter
(aluminium tracks not depicted for clarity)

12.5 µm. The distance from the centre of each of these 12.5 µm SVs is 50 µmin both X
and Y directions.
The SVs are divided into arrays of 600 which are electrically connected in parallel. Alternating arrays are given the descriptor odd or even based on their position from the
first array (top). As described previously, the production yield of these microelectronic
devices can be poor and hence by separating the SVs into electrically separated arrays,
potentially poorly performing SV s can be excluded from the data acquisition process by
simply not connecting that array to readout electronics. In addition, separating the SVs
into odd and even arrays reduces the input capacitance of the each preamplifying circuit,
which increases signal-to-noise. This separation can also help reduce the probability of a
charged particle depositing energy in multiple SVs, which would otherwise be recorded
as a single event with enhanced energy deposition (cross-talk).
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During fabrication, the implantation process is quite complicated and requires multiple
thermal treatments to prevent thermal donors. Based on process simulations during the
design and fabrication of the device, it was estimated that due to the design of the n+ and
p+ implants, extreme recombination along the wafers depth would exist 1 - 2 µm on top
of the backside implant and below the surface implants. In terms of charge collection,
this essentially describes a dead layer in the detector, giving an average SY thickness of
approximately 16 µm.

1.3.2 Bridge V2 Microdosimeter
The Bridge Y2 microdosimeter was collaboratively designed and fabricated at SPA-BIT,
Ukraine. The Bridge Y2 design is technically an SOI device, fabricated with a 300 µm
thick low resistivity 100 n.cm n-type supporting layer and a 10 µm thick, high resistivity
3 kn.cm n-type layer on top of a silicon oxide layer. In order to isolate the detector
from ambient effects and reduce surface leakage [100], a thin layer of phosphorus silicate
glass and silicon oxide on top of device was deposited. The majority of interstitial silicon
surrounding the SY s is removed via ion plasma etching, isolating the 30 x 30 µm SY s and
20 x 15 µm bridge between them. This bridge is required to support the aluminium bus
and is kept at a thickness of 10 µm to avoid fabrication complications seen in previous
microdosimeters [82]. As shown in fignre 1.19, a 10 x 10 µmp+ electrode placed in
the centre of the SY is used to bias and collect generated charge with a grounded 5 µm
n+ strip that surrounds the SY and extends over the total area of the bridges. In contrast
with Bridge Yl microdosimeter [98], angled ion implantation was used to extend this n+
electrode along the walls of the SY and bridge structures, in an attempt to improve the
electric field shape and enhance charge collection.
The 4.1 x 3.6 mm 2 device die houses a total of 4,248 SYs, each 30 x 30 x 10 µmin size.
In order to reduce capacitance and leakage, the die is divided into 3 larger segments, each

consisting of two SY s arrays. Using the same convention as in chapter 3, these two arrays
are called odd and even due to the alternating nature of their SY rows. Having alternating
independently read out arrays allows for the possibility of using coincidence techniques
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Figure 1.19: Schematic top view of the Bridge V2 Microdosimeter with cross-section
view through the centre of an SV. A picture of each array row can be visualised by
tiling the top-view schematic in the vertical direction. Matching colours represent like
materials in both views.

to ignore events where a obliquely incident charged particles traverse multiple SV s (in
low dose rates).

1.3.3 Mushroom Microdosimeter
The Mushroom microdosimeter was designed and fabricated in collaboration with SINTEF MiNaLab in Oslo, Norway and was CMRP's first concrete implementation of truly
3D silicon technology, as discussed in section 1.2.2.4. The Mushroom microdosimeter
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consists of 2,500 free-standing cylindrical SY s, broken up into two arrays, odd and even,
consisting of 1,250 SY s each. High resistivity (10 kQ.cm) p-type SOI substrate of 300

µm thickness is used, with a 10 µm thick sensitive layer on top.
The main variants investigated in this work are the air-trench device and the poly-trench
device. For both of these devices, there are design variants which are listed below:
• 18 µm diameter/ 30 µm diameter
• Nop-spray layer/ p-spray layer/ p-stop layer on the device surface used as isolation
betweenSYs
• Device has 2400 SYs for low-medium dose rates/ device has just a single SY for
high dose rates
Further revisions of this device have included the deposition of PMMA [101], as discussed
in the previous section, however are not apart in this thesis.

1.3.3.1

Air-'Irenched Mushroom Microdosimeter

A plan and cross-section view of a air-trenched Mushroom SY is show in figure 1.20. To
describe the microdosimeter geometry, the main fabrication steps will be described.
First, a p-spray layer was applied uniformly to the top. Ion implantation was then used
to create two surface implants, an annular p+ implant on the periphery of the SY, and a
circular n+ implant in the centre of the SY. DRIB was used to create two voids in the
form of annular sectors on the outside of the SY (known as trenches), producing a nearfree-standing cylindrical silicon volume. The trench walls were then converted to p-type
silicon using gas doping, establishing electrical conductivity to the p+ surface implant. An
oxidation process was then performed. A circular channel in the centre of the device was
then created along its depth using DRIB. Gas doping was again used to convert the inside
walls of this central channel to n-type silicon, establishing electrically conductivity with
the surface n+ implant. Another oxidation process was then performed. Small circular
regions of the oxide layer were then etched away on the central n+ implant and one side
of the of the p+ implant. Aluminium was deposited and patterned, making contact with
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Figure 1.20: Schematic top view of the air-trench Mushroom microdosimeter with crosssection view through the centre of an SV (horizontally with respect to the plan view
image). The diameter 52f is 18 or 30 µm, depending on the SV variant. Top oxide layer
not shown in plan view.

the exposed implants, as well as connecting to all other SV s.
This electrode configuration, as with all 3D devices, creates a strong electric field that
propagates laterally from the core to the outside of the SV, creating a well-defined charge
collection region. However, as can be seen from figure 1.20, the annular trench which
defines the SV is not completely etched away, but has two small silicon bridges on either
side of the SV remaining, which support the aluminium bus that runs centrally along the

sv.
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1.3.3.2 Poly-Trench Mushroom Microdosimeter
A plan and cross-section view of a poly-trench Mushroom SY is show in figure 1.20.
The fabrication steps are similar to the air-trenched device, however instead of leaving a
small bridge of silicon in the outer trench, the trench is completely etched and filled with
p-doped poly-silicon, which supports the aluminium bus that runs along the centre of the
SY. In addition, in this early revision of the poly-trench device, the central n+ electrode
is planar - not 3D as seen with the air-trench device. This design choice was made to
improve fabrication yield with this developing technology and fabrication technique at
SINTEF. This electrode confignration is similar to the Bridge Y2 rnicrodosimeter (section
1.3.2) and, while not truly 3D, provides an isolated, well defined sensitive volume.
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Figure 1.21: Schematic top view of the poly-trench Mushroom microdosimeter with
cross-section view through the centre of an SV (horizontally with respect to the plan
view image). The diameter !2f is 18 or 30 µm, depending on the SV variant. Top oxide
layer not shown in plan view.

Chapter 2
Microdosimeter Characterisation
Techniques
Multiple microdosimeters have been characterised in order to understand their operating
properties, performance and suitability for their use as a microdosimeter. While they are
all designed to perform as microdosimeters on paper, the properties they exhibit after the
fabrication process may render them unsuitable. These flaws may be revealed and assessed through many different techniques, and only well performing devices are selected
to assess their microdosimetric properties. Initial characterisation techniques allows samples that don't meet expected specifications to be excluded from further characterisation
and application early on.
The microdosimeters discussed in section 1.2 have undergone specification testing, including visual or spectroscopic inspection via microscopy, electrical characterisation of
current-voltage (1-V) and capacitance-voltage (C-V) relationships, and charge collection mapping; the latter of which describes the functionality fundamental to a dosimeter. This chapter contains descriptions of the methods used for characterisation of all
sample types. As the actual tests performed were microdosimeter-dependent, specific
characterisation techniques and steps undertaken may be omitted or different between
microdosimeters.
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2.1 Electrical Characterisation
Electrical characterisation was performed at the ANSTO Ionising Radiation Lab in order to determine operating properties of the microdosimeters such as depletion voltage,
breakdown voltage, leakage current. With this information, it is possible to assess the
suitability of each device as a microdosimeter. Multiple samples of each microdosimeter
were characterised however only a limited subset of these will be reported on.
1-V plots were obtained using a Keithley 237 high voltage source measurement unit,

driven by ICS software (Metrics Technology). A range of bias voltages were applied
and the corresponding current measured, starting from O V and increasing until a current compliance limit of 500 nA was reached. 1-V measurements were conducted in a
sealed vacuum chamber (unpressurised), preventing spurious pickup of electromagnetic
radiation. C-V plots were performed over the same voltage range and under the same
conditions using a Boonton 7200 capacitance meter.
Typically, 1-V/C-V measurements are performed by biasing the core electrode (p+ for
n-type silicon, n+ for p-type silicon) and grounding the backside or opposite electrode.
Some designs require these characteristics to be measured by biasing the GR instead. In
some cases, due to the close proximity of the GR and core, the punch-through effect is
observed. When the GR region becomes depleted, it "latches" onto the built-in depletion
region under the cores at a very low voltage which, in effect, biases all the cores on
the device. As a result, this method overestimates the magnitude of leakage current and
capacitance, however provides insight into the quality of each device.

2.2 Design Verification using Microscopy and Spectroscopic Techniques
Regional microdosimetry requires the geometry of detector SVs to be well defined in
terms of charged charged collection. Using various characterisation methodologies allows the microscopic structure of each SY, as well as the whole device to be better under-
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stood.
Optical images were obtained through the use of an digital optical microscope at the Australian Nuclear Science and Technology Organisation (ANSTO), Ionising Radiation lab.
The macroscopic structure and construction of the device and packaging were visualised,
as well as the arrays of SYs, allowing basic structural properties and superficial fabrication quality to be qualitatively estimated.
A JEOL 7001F scanning electronic microscope (SEM) was used to measure the micron
sized geometry and quality of the microdosimeters. Using voltages of 5 kV and 15 kV and
working distances between 9-13 mm, imaging of plan and cross-sectional views was performed. An XMax Oxford Instruments energy dispersive X-ray spectrometer (EDS) was
used to map the elemental spatial distribution of some devices, providing both spatial and
chemical/elemental information in both plan and cross-sectional views. Microdosimeter
samples chosen for destructive imaging were heated and detached from the PCB. Some
samples were selected for external imaging, allowing the surface geometry to be visualised and others were fractured along the depth of the waver to reveal its cross-section.
Due to the fragile nature of the latter samples and the potentially damaging effect that
mechanical polishing posed, the cross-sectional surfaces were polished using ion milling,
providing an unobstructed view of the internal structure of the microdosimeters. These
observations where carried out at the Australian Institute for Innovative Materials (AIIM),
University of Wollongong, with assistance from Dr. Mitchell Nancarrow and Prof. Elena
Pereloma.

2.3 Ion Beam Induced Charge Collection
Charge collection of the microdosimeters was investigated using ion beam induced charge
collection (IBICC) with the ANTARES heavy ion microprobe at ANSTO, Australia (figure 2.1). Detailed technical description of the microprobe components and function has
been thoroughly described previously [102][103][104]. In the context of the acquisition
process, a generalised description of the IBICC technique is provided below:
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1. A beam of stripped ions is accelerated out of the ANTARES 10 MV tandem accel-

erator into the microprobe beamline
2. The beam enters through multiple slits along the evacuated beamline with Faraday
cups and beam profile monitors used to fine tune the beam
3. A beam scanning system and quadrupole triplet is used to focus the beam down to
a diameter of 1 µm and accurately scan the ion beam over a sample. This system
also controls the field-of-view and magnification of the target sample.
4. The beam enters a hexagonal evacuated chamber where a sample is placed, and
where required electrical inputs/outputs are interfaced
5. Within each sampling period, the (X,Y) coordinate on the sampling plane is recorded
6. Using spectroscopic equipment (described below), the charge deposited within the
detector is measured and is binned into an MCA channel proportional to its magnitude
7. For each acquisition, a list file is produced containing the X and Y coordinate for
each detection event, along with the MCA channel number
8. For each (X,Y) pixel, the median energy of all energy deposited at this coordinate
are used to generate a median energy map (MEM).
These maps are the main product of the IBICC technique, allowing the localised visualisation of the spatial charge collection distribution over different parts of the microdosimeter.
Each microdosimeter sample was mounted within the evacuated sample chamber at normal incidence to the beam, connected to a low-noise Amptek A250 charge-sensitive
preamplifier. A vacuum feed-through with breakout box provided the interface for biasing
the detector and collecting the signal from the detector. The detector bias was provided by
an Ortec 710 quad bias supply. A Canberra 2050 AFT research amplifier was connected
directly to the preamplifer output and used to shape the raw detector tail pulse into an
amplified Gaussian pulse. The Gaussian pulse was then injected into a Canberra 8076

CHAPTER 2. MICRODOSIMETER CHARACTERISATION

TECHNIQUES

54

Figure 2.1: Photograph of the ANSTO Heavy Ion Microprobe. The sample chamber is
shown in the right-foregroundand the acceleratorand beamline in the background.

ADC to produce an MCA spectrum.
IBICC investigations were conducted for each microdosimeter sample between O V and
their maximum operating bias (generally between ±6 V and ±10 V) in order to understand how biasing affects the charge collection in and around its SV s. The effect of the
GR was also investigated for some microdosimeters using both a floating configuration as
well as being biased through a separate spectroscopic and biasing channel. This ensured
that charge directly collected through the GR contact did not contribute to the core charge
collection. Multiple magnification settings were used to capture the charge collection over
multiple SV s, single SV s, and in some cases the bonding pads.
To convert the MCA spectrum into an energy spectrum, a 300 µm thick Hamamatsu windowless PIN diode was used. Using the same ion beam configuration and spectroscopic
configuration that was used for irradiation of the microdosimeters, an MCA spectrum was
obtained. Due to its large wafer thickness and windowless design, it is assumed that all
5.5 MeV of the He 2+ ion is collected, resulting in a full energy peak. The centroid channel of this peak was used to normalise the "pulse height" setting of a Ortec 419 pulse
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Figure 2.2: Energy calibration spectrum using pulse generator, showing injected peaks
which correspond to energy 1000, 2000, 3000, 4000 and 5000 keV.

generator, where a dial value of 5.5 would inject a peak into this same channel. With the
microdosimeter in place (which has similar capacitance to the PIN diode) and connected
in the chamber, a spectrum acquisition was started (no beam). Using the pulse generator with the previously normalised settings, pulse heights of 1000, 2000, 3000, 4000 and
5000 keV were injected into the spectrum, resulting in 6 well-defined peaks (figure 2.2).
Using the known energy of these peaks, linear calibration factors were calculated and
used to convert MCA channel to measured energy deposited.
To provide a scale for the (X,Y) coordinates of each charge collection map, a 1000
lines/inch copper grid was mounted atop a surface barrier diode. For each magnification
setting used to characterise the microdosimeter, a charge collection map was obtained
using the diode. The grid lines collimate the beam and prevent most ions from reaching
the detector. Since the spacing of these lines are known and the beam scanning system X
and Y axes are calibrated equally, the pixels of the charge collection map can be binned
spatially on a microscopic scale, seen in the median channel map in figure 2.4a. The pink
structures are caused by attenuation of the beam through the grid lines which correspond
to the smaller peak seen at around channel 600 in figure 2.4b. The higher energy peak corresponds to the yellow areas where the full energy of the He2+ ions have been deposited
within the diode.
Median energy maps are traditionally displayed using a colour map such as jet, which is
quite visually pleasing. However it was found that for charge collection maps the transition of these colours provides an unintuitive visual display and can affect interpretation,
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Figure 2.3: Spatial calibration data for IBICC results

especially at lower energies. The slow transition from black to dark blue hides structures which have low charge collection. A custom map has been chosen for all median
energy maps which thresholds very low energy events to black (near O keV), highlights
low energy events in cyan and distinctly transitions through to higher energies with pink,
red and yellow, followed by white which saturates energies greater than the displayed
range. While this colour scheme is at odds with visual finesse, it provides a basis for clear
visualisation of median energy maps.
Software was written to convert and process the output binary files of the IBICC data
acquisition system, called the CMRP IBICC Toolkit, shown in figure 2.4. This facilitated
batch importation of files, energy and spatial calibration, adjustment of energy ranges and
windows of the spectra and maps, and measurement of physical geometry and CCE - all
with a user-friendly GUI. Previous processing methods involved performing a spatial and
energy calibration manually, running four separate Matlab scripts on each file, and then
formatting the figure for image output. This was an extremely time consuming task and
small adjustments required repeating many of the steps. With the CMRP IBICC Toolkit, a
batch of 30 files could be calibrated and displayed for output in approximately 5 minutes
with minimal human input.
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Figure 2.4: Screenshots of the CMRP IBICC Toolkit software, used for rapid and simple
data processing and output for IBICC experiments

2.4 Geant4 Simulation to Determine CCE
Geant4 simulations were created to determine the expected energy deposition from 5.5
Me V He 2 + ions at normal incidence, used to determine charge collection efficiency for
specific microdosimeters.

These simulations were carried out by colleague David Bolst

(UOW). The Geant4 toolkit version 10.0 with the Quantum Molecular Dynamic and G4
Standard EM option 3 (1 µm electron cuts) models were used to simulate hadronic and
electromagnetic interactions, respectively. A single SV was constructed using geometrical and material composition information from obtained from SEM and EDS data. For
simplicity, the length of the aluminium tracks were not modelled.

In the simulation, 5.5 MeV He 2 + ions were normally incident on the microdosimeter top
surface and the energy deposited within the SV recorded. An energy spectrum was con-
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structed and the centroid of the energy deposition peakEsim was determined. The average
energy deposited within an SY Esv, was measured from IBICC results and equation 2.1
was used to calculate an approximate CCE value.

CCE(%)

=

Esv x 100
Esim

(2.1)

Chapter 3
Characterisation of the Etched
Microdosimeter
A collaboration with the SINTEF MiNaLab, a microelectronics fabrication and research
facility, was established in the early 2010's with a view to create a new generation of microdosimetric devices that overcome fabrication and design flaws seen with previous generation technology. The collaborations first microdosimeter was a planar microdosimeter
designed to be used both in space and particle therapy. It features a large sensitive area for
detection of ions in low dose rate fields and a GR in a vertical PIN diode configuration to
better define the SY geometry. In contrast to previous SOI devices, a 20 µm thick sensitive volume was produced using tetramethylammonium hydroxide (TMAH) etching with
individual n+ core implants and common back-side p+ implant to achieve an improved
uniform electric field.
This chapter presents the characterisation of multiple device samples electrical and physical properties, as well as its charge collection characteristics. Refer to section 1.3.1 for a
description of the Etched microdosimeter. The methods used for the characterisation have
been described in chapter 2.
The work described in this chapter has been published [105] with data collection performed in collaboration with Dr. Linh Tran (CMRP, UOW), with simulations undertaken
by Dr. David Bolst (UOW).
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Figure 3.1: 1-V (black) and C-V (blue) characteristics of the Etched Microdosimeter
(single SV), measured from the GR contact due to the punch-through effect (refer to
section 2.1).

3.1 Electrical Characterisation
The leakage current as a function of voltage for an Etched microdosimeter SV is shown
in figure 3.1. The leakage current between 0.5 - 13 Vis approximately 1 pA with breakdown occurring at approximately 14 V. Based on manufacturer pre-packaged testing and
simulation, breakdown was expected to occur at between 40 and 50 V. This discrepancy
is thought to be due to a few defective SV s or from the wire-bonding / packing process
carried out after device manufacture. Since 10 V is the typical operating voltage of thin
SOI microdosimeters, this lower than expected breakdown voltage will have little impact
on its microdosimetric capability. At its operating voltage, the leakage current was

~1

pA per SV or ~0.6 nA per array.
The C-V characteristics for the typical SV can also be seen in figure 3.1. As expected,
capacitance decreases with voltage as the silicon diodes becomes depleted. A standard
method for determining the depletion voltage using this data is by finding the intersection
of two linear lines which approximately describe a 1/C2 vs. voltage plot. This is shown in
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Figure 3.2: Graph showing approximate depletion voltage of the Etched Microdosimeter.

figure 3.2, yielding a depletion voltage of~ 1 V. The p-spray layer exists on the surface
of the silicon which continues to deplete laterally past the bulk depletion voltage, hence
why the C-V curve never truly plateaus.

3.2 Design Verification using Microscopy and Spectroscopic Techniques
Figure 3.3 shows optical images of the large area thinned microdosimeter obtained via
optical digital microscope. However slightly blurry, these images clearly show the arrayed
nature of the device and its extremely small circular SVs. No significant defects such as
discontinuities in aluminium tracks or physical damage to the wafer were observed.
Figure 3.4 shows a plan view of the microdosimeter top surface. Each SV is clearly
defined by the the annular ring (GR) and central circular region (core). The aluminium
tracks connecting each SV in an array can be seen to connect to the core and GR via
small openings in the passivation of each SV. Whilst there are small edge defects in these
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Figure 3.3: Optical microscope image showing device layout and arrays of Etched microdosimeter SV s.

aluminium tracks, no defects were observe that would inhibit conduction. Figure 3.5
shows an isometric view of another set of SV s.
Figure 3.6 shows a polished cross-sectional view of the device. The background (top)
shows the top surface of the device and the foreground (bottom) shows the silver adhesive
used to secure the device in the SEM. The fracture lines along the device surface that were
created in the process of removing the device from its packaging can still be seen after
polishing. The total thickness of the device was found to be less than the designed 20 µm,
having an average measurable thickness of (19.1

± 0.6) µm.

Figure 3.7 shows a plan view SEM image of the microdosimeter, with pitch measurements
for each SV, yielding an equal pitch of rv48 µmin both X and Y directions. Figure 3.8
displays measurements of a single SV core OD, and GR ID and OD, yielding 5.85 µm,
19.42 µm and 32.85 µm, respectively.
Figure 3.9 shows an EDS image of the microdosimeter cross-section. The cross section
shows a layered structure of silicon nitride, silicon oxide, aluminium, a thin oxide layer
and bulk silicon. There was no evidence of elemental doping in the silicon substrate.
Concentrations of phosphorus or boron in doped regions is likely to be below the limit
of detection of the instrument (limits of detection 0.1 atomic % per 500 nm 3 ). The
geometry and thickness of these layers were seen to be quite uneven, which is not unexpected due to modification of the oxide layer thickness during the various implantation
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Figure 3.4: SEM image (plan view) showing the top surface of the etched microdosimeter.

Figure 3.5: SEM image (isometric view) showing the top surface of the etched microdosimeter.
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Figure 3.6: SEM image of the cross-section of the etched microdosimeter, showing the
measured thickness of the active area of the device.

Figure 3.7: SEM image (plan view) of the top surface of the etched microdosimeter,
showing the measured pitch and separation between adjacent SVs.
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Figure 3.8: SEM image (plan view) of the top surface of the etched microdosimeter,

showingthe measured SV dimensions.
process. Furthermore, potential distortion may have occurred due to the SEM preparation
processes. The thickness of material on top of microdosimeter surface reached
over the aluminium contacts and

~1.4 µm over remainder of the device.

~ 2 µm

These layers,

which are often called over-layers, can cause large changes to particle LET (depending
on the particle energy) and can significantly affect charge deposited within the device
SVs.

3.3

Charge Collection Characterisation

3.3.1

Ion Beam Induced Charge Collection

The response of the Etched Microdosimeter to normally incident 5.5 MeV He2 + ions
is shown in figures 3.10a and 3.10b. This response was measured from a single odd
array and GR grounded, with the remaining 15 even and odd arrays left floating as in all
subsequent measurements. The area irradiated with this scan was approximately 550 x
550 µm 2 , so most of the incident ions hit outside of the microdosimeter SV s, shown as
pink circular regions in the median energy maps. A large low energy peak was observed
at ~580 keV, which resulted in the median energy map being dominated by low energy
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Figure 3.9: EDS image (cross-section) showing the detected spatial distribution of elements existing inside the detector. The top EDS image is a combination of all the
detected elemental distributions below it

events, originating from outside of the SVs. The events that occurred within the SVs were
between ~ 1000 - 2000 ke V, which is much less than the expected energy that 5.5 Me V
He 2+ ions would deposit in ~20 µm of silicon, showing the undepleted nature of the
SVs.
When biasing the odd array cores to 6 V and keeping the GR grounded, as seen in figure
3.10d, charge collection was more defined, occurring primarily in the circular SVs. This
is extremely important as the events occurring within an ideal microdosimeter should
originate from charge generated along a particles passage through an SV, not outside of
it. The corresponding peak created by He 2+ ions crossing the thickness of the SV can
be seen at ~2700 ke V in figure 3.1 0a. Biasing the cores produced a dramatic charge
collection enhancement due to a larger depleted region in the SVs. However, this energy
was still lower than expected, which will be discussed in section 3.3.1.1.
With the scanning area reduced to approximately 30 x 30 µm2 , a single SV was localised
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Figure 3.10: IBICC data produced from 44 odd array SY s of the Etched Microdosimeter
with GR grounded, showing the effect of biasing the cores.

to understand its charge collection characteristics. As seen in figure 3.llb, with the core
and GR biased at 6 V, the SV geometry was defined to a

~18 µm

diameter circular

region, with minimal external charge collection. The charge collection in the central
region of the SV relatively uniform as it is directly under the 7 µm diameter n+ core,
which produces a strong electric field which decreases radially towards the GR electrode.
The charge collection geometry is similar to the design specifications shown in figure
1.18, however the total charge collection area is significantly larger than the expected

~12.5 µm diameter due to lateral diffused charge collection.
Figure 3 .1 la shows the median energy map of the same single SV with core biased at 6 V,
however with its guard ring grounded. As seen from these median energy maps, as well as
the spectrum obtained in each configuration (figure 3.1 ld), the differences that biasing the
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GR has on charge collection behaviour are significant. One notable difference is that with
the GR grounded, there was a significantly larger charge contribution at greater distances
from the centre of the SY. This degrades the geometrically definition of the SY and is
a highly undesirable property of any microdosimeter, as previously discussed in section
1.2.2.3. The energy deposited by He 2+ ions within the SY was reduced by approximately
300 keY when the GR was grounded, as seen in figure 3.lld. This can be explained by the
absence of the punch-through effect when the GR is biased, which increases the electric
field under and in close proximity to the n+ core. This enhances the vertical component
of the electrical field due to lateral depletion under the biased GR. Finally, as seen by the
shaded region of the spectrum in figure 3.lld and the median energy map showing only
750- 1250 keY events in figure 3.llc, a wide peak at ~1000 keY was observed when the
GR was grounded. The events causing this peak broadly occurred outside of the expected

~12.5 µm diameter charge collection region.

When the charge is produced around this

region, the built-in electrical field of the GR causes a build up of charge which is able
to be collected by the n+ core due to the parasitic capacitance between these structures
(charge sharing phenomena).
In order to investigate the low magnitude charge collection properties of the device, the
lower level threshold (LLT) was reduced to a level which under normal operational conditions would allow the injection of noise into the spectrum and reduce its integrity. Shown
in figure 3.12a is the median energy map produced from irradiation with the cores and
GRs biased at 6 V. It should be noted that every even row of SYs were left floating. With
a decreased LLT, energy deposition was observed in the even array SY s, but the generated
charge was being collected by the biased odd array SY s. These events correspond to very
low energy events of the order of 30 keY. Seen in the median energy map showing only
events

< 30 keY in figure 3.12b, these events are confined to annular rings on the periph-

ery of the biased odd SYs (close to then+ GR electrode) and are widely and relatively
evenly distributed across each of the floating even SY s.
This effect can be explained by the capacitance-resistive charge sharing effect between the
core and GR n+ electrodes, which is driven by a number of factors including: the applied

69

CHAPTER 3. ETCHED MICRODOSIMETER CHARACTERISATION
3000

3000

25

25
2500

2500

20

20
2000

E
3

2000

,>'

15

~

E

1500 >- :t
<»l;; >,
C
w
1000

>,

10

5

15

,soo

2!

w

10

1000

5

500

500

0

5

10

15

20

Ie

0

25

10

5

x(µm)

15

20

25

x(µm)

(a) Median Energy Map (6 V core, GR grounded)

(b) Median Energy Map (6 V core, 6 V GR)

3000

10• r.---,--"""T"--r---,-----,..---;::::::::!:==:::!:::::::;i
-6V
-6V

25
2500

Core, OVGR
Core, 6V GR

103

20
2000

E
3

>'
15
1500

>,

!
e.,
C

w

10

1000

5

500

!!l

§
0

102

0

10'

0
5

10

15

20

25

x (µm)

100...... ___..._____
0

500

1000

..._ ___ ....
1500 2000

2500

3000

3500

4000

Energy (keV)

(c) Median Energy Map (6 V core, GR grounded), (d) MCA Spectrum (6 V core), comparing grounded
showing only events between 750 and 1250 keV (see GR and GR biased at 6 V. The 750-1250 keV window
figure 3.1 ld)
mapped in figure 3.1 lc is shaded in grey.

Figure 3.11: IBICC data produced from a single odd array SV of the Etched Microdosimeter with core biased at 6 V, and comparing the effect of the GR biased at O V and

6V.

bias, geometry of the core and GR diodes, the parasitic capacitance between the core and
GR n+ electrodes (and their PIN diodes), and the resistance parallel to the core and GR.
The observed effect occurs when the distance between competitive electrodes is much
smaller than the diffusion length. This effect causes the measured signal to be dependent
not only on the actual energy deposited within the SV s, but rather by the physics of
charge sharing between the core and GR. The observed charge collection phenomena
has been observed in previous planar designs. The SV definition was improved using
coincidence techniques between the SV and veto electrode (GR) [86]. Detailed analysis
of the parameters of resistive-capacitive charge sharing can be investigated with TCAD,
however are outside the scope of this thesis.
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Figure 3.12: IBICC data produced from 12 odd array SV s of the Etched Microdosimeter
with cores and GR biased at 6 V with reduced LLT, showing charge contribution from
floating even SVs.

3.3.1.1

Geant4 Simulation

A Geant4 simulation was carried out on an Etched Microdosimeter SV using the geometry
shown in figure 3.13. Figure 3.14 shows the simulated spectrum of energy deposited by
5.5 MeV He2+ ions within a single Etched Microdosimeter SV, compared to that obtained
from IBICC with the odd array cores and GRs biased at 6 V. The y-axis (counts) has been
normalised to enable comparison between the spectra.
Unlike packages like TCAD, Geant4 is only designed to simulate physical processes,
hence the low energy charge collection seen in the experimental spectrum is not present
in the simulated spectrum. In contrast, the simulation is unburdened by electronic noise
or an acquisition LLT which has allowed very low energy events deposited by electrons,
seen in the first few keV of the spectrum.
The feature of the spectrum most relevant to charge collection efficiency is the peak produced from He 2+ ions crossing the SV thickness. In the simulation, two energy peaks
were observed, both slightly higher energy than the experimentally observed peak. The
lower energy peak at ~2700 keV was produced from the He2+ ions crossing the SV
thickness where over-layers are thinner. The peak at ~2900 keV was produced by ions
traversing the same volume, but with additional energy deposited within the aluminium
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over-layers, resulting in LET enhancement. In contrast, the experimental measurements
only showed a single high energy peak with energy 2630 keY, and with a significant low
energy energy component.
As discussed previously, the low energy events are caused by charge collection from the
periphery of the SY s as well as the unbiased SY s due to charge sharing between the GRs
and cores. The measured energy of the crosser peak was due to non-ideal CCE. Physical
SEM and EDS measurements (used to determine simulation geometry) showed that this
CCE shortcoming is not due to a lower than expected wafer thickness. Furthermore, capacitance measurements showed the device was sufficiently depleted at just 6 V. Reduced
CCE was likely due to charge sharing effects between the biased cores and GR. Peak
broadening may be due to slight device obliquity and/or ion range straggling, ultimately
contributing to the observation of a lone crosser peak.
The average energy deposited in the simulated SY was determined to be 2802 keY. Each
5.5 MeY He2+ ion crossing an ideal etched microdosimeter SY with 100 % CCE would
provide an average response of 2802 ke Y. As the Etched Microdosimeter clearly does not
provide this ideal response, using the average expected deposited energy, a spatial CCE
map was produced, shown in figure 3.15. A discrete colour scale was used to better visualise the regions of varying CCE. As expected, this map mimics figure 3.1 lb with highest
CCE of 92 % in the centre with rapidly decreasing CCE moving radially outward.
The median CCE value was calculated for the entire image (excluding pixels without registered events) and also within a circle of radius 6.25 µm, corresponding to the designed
SY geometry. The median CCE value of the desigued SY area was determined to be (81.8

± 3.0) %, and (64.1 ± 2.8)

% for the entire 18 µm SY. A 1-pixel vertical slice through the

CCE map is shown in figure 3.16, approximating a Gaussian charge distribution.

3.4

Conclusion

Electrical measurements showed the Etched Microdosimeter possessed at an extremely
low leakage current of approximately 0.6 nA per array over its operating range of 0.5-
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13 Y. In addition, C-Y measurements showed full depletion of its SY at a low voltage
of just 1 Y, relaxing requirements for powering this device. Overall, these results show
favourable properties of a single etched microdosimeter SY, allowing the use of an array
or many arrays connected in parallel to be used for radiation detection.
Physical SEM measurements allowed the actual geometry of the device to be determined,
which is often only assumed based on the design specifications.

The measurements

showed slight deviations between the design specifications and actual geometry, however
the magnitude of these deviations are within processing parameter error margins during
fabrication. The cross-sectional measurements were most important with respect to microdosimeter characteristics as they determine the average chord length of the device. The
microdosimeter thickness was measured and determined to be (19.11

± 0.61) µm.

The charge collection characteristics of the Etched Microdosimeter were found using
IBICC and unfortunately brought significant flaws of the device to light. The charge
collection distribution in the SY s was circular in shape as expected, but was reminiscent
of the previous generation microdosimeter with respect to charge collection: a lack of
localisation compared to the designed SY geometry definition, due to inefficient charge
collection on the periphery of the SY. In addition, due to common guard ring configuration and the punch-through effect, unbiased arrays of SYs significantly contributed to
charge collection, introducing a disproportionate weighting on the low energy component
of each spectra. Using Geant4 simulation and IBICC results, the average CCE in the defined SY region was determined to be (81.8

±

3.0) %, and (64.1

± 2.8)

% for the entire

SY volume.
This results of the characterisation have shown that the design and/or fabrication of this
planar device has not resolved the issues seen in previous generations of microdosimeters.
While implementing a separate gnard ring structure per array would potentially improve
part of the charge collection issues, the peripheral charge collection would still exist.
The observed flaws further emphasises the need to move to entirely different fabrication
techniques: 3D technology for silicon microdosimetry.

Chapter 4
Characterisation of the Bridge V2
Microdosimeter
The shortcomings of planar silicon microdosimeters that have been shown in chapter 3
and in the literature [82, 83, 86] are mainly due to charge sharing effects between adjacent SYs, which fundamentally result in poor SY definition. The first batch of 10 µm
thick Bridge microdosimeters produced in 2014 brought design aspects from the 2nd generation Mesa device [82] in order both electrically and physically define the SYs. This
was done through the removal of superfluous silicon outside the SY volume except for
"bridges" of silicon between the SY s to support the aluminium bus, biasing the SY s and
to collect the charge generated from within them. The first characterisation of the Bridge
microdosimeter was carried out in 2015, revealing that only half the external silicon was
removed in the etching process [98]. Despite incomplete etching of the silicon external
to the SY boundary, charge collection characteristics and utilisation in a 290 MeY/u

12

C

beam showed promise for its application as a microdosimeter.
The Bridge Y2 Microdosimeter was then produced to amend the poor etching processes
during fabrication and optimise charge collection efficiency through slight changes to the
electrode configuration as discussed in section 1.3.2. This chapter presents the characterisation of the Bridge Y2 microdosimeter in terms of its physical and electrical properties,
and its charge collection characteristics.
Refer to section 1.3.2 for a description of the Bridge microdosimeter. The term "Bridge
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microdosimeter" refers to the Bridge V2 microdosimeter and any mention of the Bridge
Vl microdosimeter will explicitly use its complete name. Methods used for the characterisation have been described in chapter 2.
Part of the work described in this chapter has been published [98][106], with data collection performed in collaboration with Dr. Linh Tran (CMRP, UOW).

4.1 Electrical Characterisation
The leakage current of many devices were measured by applying a bias voltage from
between O V and -10 V to the p+ core electrode while, grounding the n+ electrode on
the core boundaries and bridges. Each array was biased individually and no significant
punch-through effects were observed due to this unique electrode configuration. Shown
in figure 4.1 are the 1-V characteristics of nine Bridge microdosimeter samples, showing
the range ofl-V characteristics that occur a) within the same sample and b) within a batch
of samples. Each measurement was performed with just one array connected (~700 SVs)
with all other arrays left floating. Of all the arrays, ~53% reached a leakage current of
less than 250 nA at 10 V, showing desirable characteristics which would minimise noise
in obtained spectra. The proportion of arrays reaching a compliance current of 0.5 µA
before reaching 10 V was 32%, with the remaining 15% reaching compliance without
having a bias applied (0 V). The former arrays will have a high LLT and won't be able to
record low lineal energy events. The latter cannot be used and these results are evidence
of defective PN-junctions, most likely due to issues during implantation or defects in
the n-SO1 active layer. Based on the 1-V characteristics of the batch tested in this work,
the relatively low yield of well-performing arrays suggests there are fabrication issues to
be investigated and overcome. Despite this, out of the 6 arrays in each microdosimeter,
almost all devices contained on average 3-4 arrays which displayed desirable properties,
allowing them to be used.
The capacitance of the Bridge microdosimeters showed much less variation across devices and as such, a less comprehensive measurement set was obtained. For an ideal
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Figure 4.1: 1-V characteristics of multiple arrays of Bridge microdosimeter samples,

measured from p+ core contact. 1-V curves from the same sample have been plotted
in the same colour. Samples which reached compliance current at O V have not been
plotted.
PN-junction, the junction capacitance is inversely proportional to the depletion width.
While the junction geometry of the microdosimeter is much more complex, the capacitance of the microdosimeter is expected to decrease as the depleted volume increases.
Due to the depletion region being governed primarily by the microdosimeter SV's geometry and applied bias, the variation in capacitance was expected to be less across different
samples.
Figure 4.2 shows the C-V characteristics obtained from the tested 12 Bridge V2 arrays,
as well as 10 Bridge Vl arrays for comparison. The spread on both microdosimeter types
is quite small, ranging from between 2 - 3 pF across all voltages. Due to the relatively
complex nature of the junction(s) geometry, a unique capacitance profile is seen. The capacitance first decreases rapidly from OV and slowly decreases up until 3.5 -4V where the
capacitance more sharply drops off and eventually plateaus. For some Bridge Vl samples
the capacitance is seen to trough at 4 V and then increase slightly before plateauing. This
feature is not seen in the Bridge V2 samples and is most likely due to the incomplete SV
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etching and lack of n+ implantation on the SV/bridge sides in Bridge Vl samples.
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Figure 4.2: Comparison of Bridge V 1 and V2 Microdosimeters C-V characteristics

While ideal PN junction capacitance decreases smoothly with increasing bias (equation
1.35), the microdosimeters of course do not possess junction characteristics even close
to an ideal 2D PN junction. The lack of straightness in the 1/ C2 curves shown in figure
4.3 emphasise this expected departure from the model and show that depletion is reached
between 4-5 V across all samples.

4.2

Design Verification Using Microscopy Techniques

Figure 4.4 shows optical images of the Bridge microdosimeter device including bonding
pads, as well as a magnified view. These show the segmented nature of the silicon die, the
arrayed nature of the device and its rectangular SVs, and bridges connecting them. For
most samples, no significant defects were observed.
Figure 4.5 shows an isometric view of the top surface of two of the Bridge microdosimeter
samples. These images show the impressive definition of the SVs, and the bridges that
connect them, resulting from the successful removal of all silicon surrounding them. The

CHAPTER 4. BRIDGE V2 MICRODOSIMETER CHARACTERISATION

79

0.01
0.009
0.008
0.007
"-1-0.006

u.

So.005

"-I

(.)

~ 0.004

0.003
0.002
0.001
0
0

2

4
6
Reverse Bias (V)

8

10

Figure 4.3: Graph showing 1/ C2 vs. reverse bias, indicating depletion between 4-5 V.

(a)

(b)

Figure 4.4: Optical microscope images of the Bridge V2 microdosimeter a) device and
b) SV arrays.

lack of silicon is confirmed by being able to view the large dark regions that the SVs sit
upon; this is the oxide layer (hence, SOI), dark in colour due to the relatively low electrical
conductivity of silicon oxide. The aluminium tracks can be seen to penetrate through
the passivation into the n+ strip and p+ core in the SV s, with the bridges successfully
supporting them between each SV, as per the design in figure 1.19.
An interesting difference between these two Bridge V2 microdosimeter samples is the
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difference in etching quality. While the bulk of the silicon in both samples was removed
to expose the buried oxide layer, the uniformity and definition of the SV walls differs in
each sample. Sample 1 shows very uniform etching profile with minimal etching artefacts
seen. In contrast, sample 2 has very prominent lines on the SV walls, where it seems that
sections of silicon were not etched as precisely. This effect is known as notching and is
due to the deflection of the plasma due to locally varying electric fields [ 107]. The reason
for the presence of this effect in one sample and not others is unknown, however it is
unlikely to impact on their charge collection properties.

(a) Sample 1

(b) Sample 2

Figure 4.5: SEM image (isometric view) showing the top surface of two Bridge microdosimeter samples.

The physical dimensions of the Bridge microdosimeters were verified using these images
by comparing the actual device geometry with the design specification. Figure 4.6b shows
SEM images of a polished cross-section through an SV core. The average total thickness
of the device across a range of samples on different wafers was (9.62

± 0.18) µm,

devi-

ating slightly from the design by 3.8 %. Figure 4.6b shows the a cross-section through a
section of a bridge, with an adjacent SV core seen in the background. In both cases, the
aluminium contacts can be seen on top of the silicon layer and below the passivation. The
dark layer at the base of the SV/bridge is the buried oxide layer, completely revealed by
the successful etching of silicon above it. Figure 4.6c shows a plan few of the top surface
with measurements of the pitch and SV dimensions, deviating by 1-2 µm from the design,
mainly due to the passivation layer on all sides of the silicon.
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(a) Cross-section of SY core
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(b) Cross-section of SY bridge

(c) Top surface

Figure 4.6: SEM images of the Bridge Microdosimeter with physical measurements.

Figure 4.7 shows an EDS image of an SV cross-section. Using the EDS spectra, signatures of aluminium, oxygen, phosphorus and silicon were detected at high levels. Unlike
EDS images obtained of the Etched Microdosimeter in section chapter 3, the geometry of
the microdosimeter is much more structured, with high fidelity to the design. This is partly
due to the fact that the Bridge microdosimeter has a solid 300 µm substrate for support
through the entire fabrication process, including handling, wire-bonding, etc. The EDS
image shows that the aluminium deposition is confined to the core and bridge regions,
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and oxygen confined to the buried oxide layer and passivation, as expected. The existence
of silicon and phosphorus is seen throughout the entire device, except where aluminium
exists. It was known from the design specification that silicon was present in the SY bulk
volume, the Si02 buried oxide layer and surface passivation, as well as phosphorous existing in the n-type bulk volume. Interestingly, it appears as if the phosphorous has either
diffused into the buried Si0 2 layer or present due to the implantation process, creating a
form of silicon glass [ 108], albeit with less a lower phosphorous concentration than the
bulk n-type silicon.
Figure 4.8 shows the different results of the etching process.

Fignre 4.8a shows the

"Bridge" microdosimeter without any etching at all, effectively a purely planar device.
Figure 4.8b shows the Bridge Yl microdosimeter with only 5 µm of the silicon removed.
Figure 4.8c shows the complete etching of the Bridge Y2 microdosimeter. Finally, fignre
4.8d shows an example of an etching defect, resulting in sections of the bridge microdosimeter without its silicon completely removed. Not only will this create charge diffusion in these SY s (albeit small in comparison to the size of the microdosimeter), but it will
also effect capacitance and charge collection due to the n+ electrode not being implanted
properly in these surrounding SY s. However, due to the extremely low number of defects
observed, microdosimetric function is unlikely to be affected.

4.3

Charge Collection Characterisation

The Bridge Y2 microdosimeter was irradiated using 5.5 MeY He 2+ ions generated and
raster scanned across the microdosimeter surface using the ANTARES heavy ion microprobe at ANSTO. By logging the known position of the beam when an event is detected,
the charge collection geometry was mapped at biases between O - 10 Y. Figure 4.9 shows
the median energy maps and corresponding spectra of a sampling of Bridge Y2 microdosimeter SYs biased at 10 Y (nominal operating voltage). The Bridge Yl spectra and
map taken previously with identical parameters is included for comparison.
Figure 4.9a shows the Bridge Y2 median energy map, where the SY s are well-defined, and
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Figure 4.7: EDS image (cross-section) showing the detected spatial distribution of elements existing inside the Bridge microdosimeter. The top EDS image is a combination
of all the detected elemental distributions below it.

have crisp geometries with no charge collection in between adjacent SVs, greatly surpassing those of previous generations. The resulting charge collection regions has high fidelity
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(a) No etching

(b) Incomplete etching (Bridge V 1)

(c) Full etching (Bridge V2)

(d) Etching Defect (Bridge V2)
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Figure 4.8: SEM images (isometric view) showing the different types of etching states.

to both the design geometry (figure 1.19) and physical characteristics found using SEM
techniques (section 4.2). The well-defined, relatively uniform distribution is reflected in
the corresponding spectrum in figure 4.9c, showing a very flat low energy response and a
wide peak centred at approximately 1250 ke V, known as a crosser peak.
In comparison, the Bridge Vl map in figure 4.9b only vaguely resembles the Bridge V2
charge collection geometry, despite having the same design. The SV s are indeed defined
with connecting bridges, however the high charge collection regions are rounded in shape,
and a dynamic spectrum of events exists throughout the entire detecting volume. The
range of these events can be seen in the spectrum in 4.9d, which is more disconnected to
that of the Bridge V2 device. The high energy peak originated from events in the middle
of the SV s, the continuum to its left from the SV edges, the peak at l"V500ke V from the SV
edges and bridges, and the events between 0 - 250 ke V from the interstitial silicon [98].
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The biggest difference between the charge collection of these two devices is the existence
of very low energy events in the interstitial silicon between Bridge Vl SVs, which was
not removed completely during the etching process. Finally, the difference in geometry
sharpness between these geometries is in part attributed to the n+ electrode implanted in
the Bridge V2 SV and bridge edges.
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Figure 4.9: Median energy maps and spectra of the Bridge Vl and Bridge V2 microdosimeters, both biased at 10 V.

The effect of silicon removal is emphasised near the bonding pads as seen in figure 4.10,

showinga resolvedgeometryin the BridgeV2 while the BridgeVl geometryis drowned
by a sea of low energy events. These results emphasise the importance of removing the
silicon external to the SV s; even a small amount of residual silicon can result in significant
charge sharing between electrically connected SV s, which is impossible to completely
remove with guard ring configurations.
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Figure 4.10: Charge collection maps produced using the Bridge Vl and Bridge V2
microdosimeters, showing bonding pad locations.

The spectra shown in figure 4.11 was obtained by increasing the bias voltage from 0 - 10
V, in 2 V increments. Each spectrum was normalised to the total counts over all channels,
allowing for easy comparison. Two features can be seen among the spectra: a) one lower
energy peak that increases with bias ("lower energy peak") and b) a higher energy peak
that changes only very slightly with bias. At 0 V, the majority of the events are located
within the lower energy peak, spanning a wide energy range of around 600 ke V, with the
remaining events small proportion of events occurring within a region at approximately
1200 keV. When a 2 V bias was applied to the SV cores, the lower energy peak shifts
to approximately 200 keV and the higher energy peak was well-defined at approximately
1311 keV. As the bias was increased further, the lower energy peak shifted towards the
higher energy peak until at 10 V, where they combined. The higher energy peak did not
change position with bias after 2 V, but upon amalgamation with the lower energy peak,
became wider with a lower centroid energy.
Figure 4.12 displays the origins of these peaks through the corresponding median energy
maps. Relevant energy windows were chosen to include only events corresponding to the
changing peaks, while excluding all other events in each map. As a result, events from
the lower energy peak are shown on the left side of the figure, and events from the higher
energy peak are shown on the right. While the broad characteristics of energy maps were
similar, subtle variations in the maps acquired at different bias voltages were seen.
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Figure 4.11: 5.5 MeV He2+ ion MCA spectra of the Bridge Microdosimeter spectra at
various biases.

The low energy windows maps show that the lower energy peak events were produced
within the bridges that connect each SV, and the edges of the SV. Before depletion (10
V), the lowest energy events occurred within the bridge region due to the greater distance

between the biasing electrode and then+ electrode as seen by the distinct colour difference
in the maps for O V and 2 V. Once the bias was increased, the difference between event
energies in the bridge and SV edges decreased, with the lowest energy events occurring
on the edges of the detecting geometry, at 10 V. This is likely a recombination effect due
to defects on the SV edges, which is pronounced in this microdosimeter due to its very
large surface area to volume ratio in comparison to normal diodes such as the Hamamatsu
PIN diode.
The maps on the right of figure 4.12 show that the higher energy peak events were produced within the SVs themselves. Before depletion, these events were of distinctly lower
energy and were contained within the center of the SVs. After depletion, the collected
charge from He2+ ions was greater and remained constant, however the area in which
these events occurred increased laterally toward the SV edges with increasing bias. At 10
V, an increased number of events originated from the bridge regions, with the charge col-
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Figure 4.12: 5.5 MeV He2+ ion median energy maps of the Bridge Microdosimeter

spectra at various biases, windowingover the lower energy peak (left) and higher energy
peak (right).

lection region resembling the designed microdosimeter geometry. These findings show
that as the bias increases, the bridge regions become increasingly depleted, which was expected due to the larger distance from the p+ core electrodes. Higher energy events were
detected in these regions due to the horizontal component of the electric field increasing
with bias.
Despite these excellence performance characteristics, the issue of radiation damage is ever
present with silicon devices, especially those made from n-type silicon [109] [110]. The
effects of damage has previously been studied with previous thin detectors using the same
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IBICC setup [94], albeit with higher beam currents. During the course of these Bridge V2
irradiations radiation damage was obserbed, due to the continuous high LET flux incident
on the detector. This is visible in the median energy map in figure 4.13. A significant
loss of charge collection in the irradiated area can be seen when the device was not biased, occurring primarily in the bridges. At 10 V, the effects of this damage were still be
observed, but to a lesser extent. During these irradiations, a total of 868,613 events were
detected from high LET 5.5 MeV He 2+ ions. These were detected within the ~29 SVs
(including bridges), which resulted in a surface density of~ 2.5 x 109 particles per cm2 ,
occurring over a short few hours. Due to the very high LET of the He 2+ ions, the corresponding dose is of the order of ~ 100,000 cGy which corresponds to ~400-500 particle
therapy fractions, justifying its application both practically and economically. While further dedicated radiation damage studies are required to deduce any meaningful outcome,
these observations show that the bridge regions are the most susceptible to damage, resulting in a widening and decrease in energy of the lower energy peak. This damage
effectively results in a spectrum obtained with a lower bias voltage, previously seen in
figure 4.11.
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Figure 4.13: Charge collection maps showing the effects of radiation damage that occurred during radiation

4.4

Conclusion

Through the use of standard electrical characterisation methods, leakage currents of between 50 - 200 nA per array were observed for high performing samples (~200 pA/SV),
but many samples were seen to breakdown well before the nominal 10 V operating volt-
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age. This indicates that the reproducibility of the fabrication methods used require improving. C-V measurements of high performing samples revealed SY junction depletion
occurring between 4 - 5 V, which displayed good uniformity between samples. These results were favourable, allowing the device to be depleted at relatively low voltages, while
having flexibility for biasing at higher voltages and/or low noise multi-array usage.
Physical SEM measurements showed the remarkable improvements from the Bridge Vl
microdosimeter, with the complete removal of interstitial silicon between the SVs and
bridges, exposing the buried oxide layer below. The etching quality of the walls of the
sensitive geometry varied between samples with some having extremely uniform walls
and others having undulating characteristics. Some small, localised defects were discovered in some samples, however these were rare. Physical measurements of the device
geometry showed slight deviations between the design and fabricated product, with the
physical thickness measured across multiple samples to be (9.62

± 0.18) µm.

EDS mea-

surements also confirmed the expected composition of all components through a section
of the microdosimeter.
The charge collection characteristics of the device were revealed using the IBICC technique using the ANTARES heavy ion microprobe at ANSTO. Clean, isolated SVs and
bridges were observed for the first time at all biases with the absence of low energy
events, truly confirming the complete removal of interstitial silicon over the observed
regions of the device. It was revealed that higher biases were required to increase the
charge collection efficiency of the bridge regions, due to their greater distance from the
biasing p+ electrode and weaker electric field. The complete etching of silicon and the
additional n+ implantation in the walls of the entire device on its surface produced crisp
and square geometry, in comparison to the rounded, less defined structures seen in the
Bridge Vl device. In addition to the silicon removal, the n-stop layer significantly contributed to decreased charge collection in regions external to the sensitive geometry (e.g.
pads).
The results of this characterisation have shown remarkable improvements over the Bridge
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Vl microdosimeter, and especially over previous planar designs. This work has confirmed
that isolation of the sensitive geometry is of paramount importance for the removal of
invasive low energy contamination. This will both allow for true microdosimetric application in lower LET radiation fields, where low energy events are produced. These characterisation results also provide confidence that the Bridge V2 microdosimeter is suitable
for measurements in clinical heavy ion beams, presented in chapter 7.

Chapter 5
Characterisation of the Mushroom
Microdosimeter
The Mushroom microdosimeter was produced as a first step toward truly 3D microdosimeters. The fabrication of such delicate structures using micro-machining processes
had to be developed and tested before fully free-standing SY s could be reliably produced,
as discussed in section 1.2.2.4. The Mushroom microdosimeter takes the technology used
to develop the Bridge Y2 microdosimeter on step further, using DRIB etching to create an
annular trench outside of the SY and incorporates two 3D electrodes in the air-trench device, and the use of doped polysilicon to create a 3D outer electrode that defines the SY s
in the poly-trench device. However, the first revision of the Mushroom microdosimeter
investigated here does take one step back in the sense that it still retains silicon in between
its SYs, despite a trenched geometry.
This chapter presents the characterisation of multiple Mushroom microdosimeter variants, in terms of their electrical and physical properties, as well as their charge collection
characteristics. Refer to section 1.3.3 for a description of the Mushroom microdosimeter.
Methods used for the characterisation have been described in chapter 2.
Part of the work described in this chapter has been published [111], with data collection
performed in collaboration with Dr. Linh Tran (CMRP,UOW) and simulations performed
by Dr. David Bolst (CMRP,UOW).
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Electrical Characterisation

The leakage current of many devices (and device variants) where measured by applying a
bias between OV and + 10 V to the n+ core electrode while grounding the p+ electrode on
the SV periphery. Each array was biased individually and no significant punch-through
effects were observed. Figure 5.1 shows the 1-V characteristics of a variety of devices
including the 18 µm diameter air/poly-trench devices, 30 µm diameter air-trench/polytrench devices, as well as p-spray and p-stop variants. The colour of the curve indicates
the device variant.
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Figure 5.1: 1-V characteristics of multiple arrays of Mushroom microdosimeter samples
and variants, measured from the n+ core electrode. 1-V curves from the device variant
have been plotted in the same style. Some values at 0, 1 and 2 V have not been plotted
due to being negative.

At a first glance, it can be seen that the curves are generally grouped together within
bands of the same device variant, perhaps indicating fabrication uniformity across the
relatively small amount of samples. At 10 V, all poly-trench devices are grouped together
within 0.01-0.10 nA, which is between 10-100 times less than the air-trench devices, all
of which are above 1 nA. However, out of all 26 poly-trench devices measured, 5 of the
arrays reached compliance at O V and were not plotted. Out of the 16 air-trench devices
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measured, all devices operated without reaching compliance up to 6 Y. The seemingly
lower yield of the poly-trench devices may be a result of complications arising from the
more complex fabrication processes involved in filling the trench with doped polysilicon,
as well as deposition of aluminium over the polysilicon.
Given that 79% of all samples (33 / 42) had smooth 1-Y characteristics and reached a
leakage current of less than 10 nA at lOY, the majority of devices showed desirable characteristics which would enable low noise spectral measurements, and to be candidates for
further testing.
The single sensitive volume (SSV) variants were also measured, however due to the extremely small nature of these devices, the leakage current magnitude approached the lower
measurement limit of the Keithley current meter, indicating that instrument noise dominated these measurements. Between O and + 10 Y, values of less than 100 pA were seen.
This is higher than 111250th of the leakage current measured with the 1250 SY devices.
However, given that many of these SSY samples are built upon a large common die, it
is likely that contributions from the surrounding silicon contributed to these higher than
expected values.
Figure 5.2 shows the C-Y characteristics obtained the same 42 arrays, measured between
0 Y and +10 Y (or their respective compliance voltage). The variation in these curves
is large (~ 10 pF to ~60 pF) across devices types, which is not too surprising given all
devices have different geometry and/or materials. Given the small number of samples,
it is somewhat unexpected that within many of the device groups, there is large variation
between samples. All device types except the 18 µm air-trench/poly-trench p-stop and the
30 µm air-trench p-spray devices have significant variation between at least one of their
samples. This again the influence of the non-uniformity resulting from the fabrication
process. On average, the truly 3D devices (air-trench) possessed slightly lower capacitance for each device size which is expected for the 3D column electrode configuration.
However, the higher capacitance of the poly-trench devices may also be due to poor SY
yield as a result of potential fabrication complications discussed previously.
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Figure 5.2: C-V characteristics of multiple arrays of Mushroom microdosimeter samples
and variants,measured from the n+ core electrode.

Like ideal PN junctions, the capacitance of the Mushroom microdosimeters increases
relatively smoothly without the trough-like features previously seen in the Bridge Vl
and V2 Microdosimeters in section 4.1. The 1/c2 curves shown in figure 5.3 give some
insight into the approximate depletion voltage of these devices. It would appear that some
devices, namely the 30 µm air-trench p-spray devices (cyan) and 18 µm air-trench/polytrench p-stop devices (red/orange) are still depleting at 10 V, as seen by their curve's
positive gradient. However, this changing capacitance profile could be related to lateral
depletion of the surrounding silicon due to it not being removed in the etching process.
All other devices indicate depletion at between 2 and 5 V.

5.2

Design Verification Using Microscopy Techniques

SEM was used to verify design geometry, however due to the material cost involved in
sacrificing many devices, just a single 30 µm air-trench device was imaged to produce
plan view and cross-section view images of the device. In addition a SSV devices were
also imaged.
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Figure 5.3: Graph showing 1/ C2 vs. reverse bias, showing indications of varied depletion voltages across multiple Mushroom microdosimeter device types.

Figure 5 .4 shows optical images of the Mushroom microdosimeter device including bonding pads, as well as a magnified view. These show the arrayed nature of the device, with
its circular SVs and aluminium bus visualised clearly. No significant defects were observed.

(a)

(b)

Figure 5.4: Optical microscope images of the mushroom microdosimeter a) device and
b) SV arrays.

Figure 5.5 shows an SEM isometric view of the top surface of the 30 µm air-trench
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microdosimeter sample. This image shows successful etching of the annular trenches,
leaving behind a small silicon bridge and well-defined cylindrical SV, as per the design
(figure 1.20). The void in the centre of the SV can also be observed. The aluminium
tracks are seen to successfully propagate between each SV, making contact with the p+
electrode through the centre of the SV and with the n+ on the outer-right edge of each
trench. The aluminium, while making continuous contact in the image, appears to be less
uniform then observed in both the Etched and Bridge microdosimeter. Aluminium is also
seen on the inside edge of each trench, left over from the sputtering process.

Figure 5.5: SEM image (isometric view) showing the top surface of a Mushroom Microdosimeter (air-trench)

Measurements of these images were taken to verify the physical device geometry compared to design specifications. Figure 5.6 shows SEM images of a polished cross-section
through an SV core. Unfortunately aligning the plane through which the microdosimeter
was sectioned and the true geometrical SV centre was not possible due to time constraints,
hence why the central SV void cannot be seen. The average thickness of the device was
(9.1

±

0.1) µm, deviating from the design by 8.5 %. The dark layer at the base of the
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SY/bridge is the buried oxide layer, completely revealed by the successful full etching
of the silicon above it. Figures 5.6a and 5.6b shows SEM plan view images of the top
surface with measurements of the SV and pitch which deviated by just 2 - 4 µm from the
design, which was mainly due to the passivation layer on all sides of the silicon.

(a) SV Measurement

(b) Pitch Measurement

(c) Cross-section

Figure 5.6: SEM images of the Mushroom Microdosimeter with physical measurements.

A 30 µm SSV sample was also imaged using SEM, shown in figure 5.7. This displays
a greater degree of detail, clearly showing n+ implant location as well as DRIB etching
features of the trench and central void. The horizontal lines seen on the walls of these
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structures are the result of the repetitive nature of the DRIB technique, known as the
Bosch Process [112), used to create 3D silicon structures. The process involves using
short pulses of isotropic plasma etching which removes the silicon primarily in the vertical direction, followed by a protective passivation deposition on the substrate surface.
Broadly, these two steps are repeated up to hundreds of times with the number of repetitions and etching time determining the quality of the resulting structure. As the etching
cannot be isolated entirely in the vertical direction, it is common for structures to be left
with an undulating pattern where the plasma has laterally removed the passivation of the
previous layer [ 113] [ 114]. Less prominent undulation would be seen with shorter etching
times and a greater number of etching steps. Based on the SEM images here, approximately 10 etching steps were carried out, with each removing~ 0.9 µm per step.

Figure 5.7: SEM image (isometric view) showing the top surface of a SSV Mushroom
Microdosimeter (30 µm air-trench)

CHAPTER 5. MUSHROOM MICRODOSIMETER CHARACTERISATION

100

5.3 Charge Collection Characterisation
The Mushroom microdosimeter was irradiated using 5.5 MeY He 2+ ions generated and
raster scanned across the microdosimeter surface using the ANTARES heavy ion microprobe at ANSTO. By logging the known position of the beam when an event is detected,
the charge collection geometry was mapped at biases between O- 10 V. Charge collection
studies were performed on a variety of variant types including 30 µm air-trench p-stop,
30 µm poly-trench p-stop, 18 µm poly-trench p-stop and 18 µm poly-trench. All measurements were performed by biasing and reading out from an odd array, with the even
array left floating.
Due to the time consuming nature of the IBICC process, only 1 sample per device type
could be tested. While a single sample is certainly not sufficient to characterise a population, it provides indications as to the performance qualities of each variant. For most
measurements, there was unfortunately slight drift of the sample stage at a rate of approximately 0.5 µm per minute, resulting in a slight decrease in clarity, effectively due to
motion blur. This however does not significantly impact the qualitative analysis of these
results.

5.3.1

30 µm air-trench with p-stop

Acquisitions were performed at various voltages between O and 10 V, however all maps
obtained with biases between 1 and 10 Y showed no visible differences in observed features. Maps for OY and 10 Y are shown in figures 5.8.
The map obtained at O Y was expected, showing circular high energy charge collection
regions within the SYs, low energy collection in a strip between each SY, and a few low
energy events in the interstitial silicon between the SY s. Furthermore, minimal charge
collection was not seen in the even array, which was grounded. At 10 Y, the only significant difference is a reduction in the low energy events in between the SY s due to the
presence of the p-stop layer over the entire wafer, with no change in collection under
the aluminium bus between adjacent SYs. In both cases the SY is as desigued: a cylin-
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Figure 5.8: 5.5 MeV He2+ ion median energy maps of the 30 µm Mushroom Air-trench

Microdosimeter.The microdosimetershifted by approximately100 µmin the downward
direction between the OV and 10 V acquisition,hence the slightly different SV view.
drical SV with relatively uniform collection with dead regions is the centre and trench
regions.
When comparing the normalised spectrum of the device obtained at each voltage, shown
in figure 5.9, the similarities between the maps acquired at O V and 10 V were not surprising. Due to the 3D electrode configuration, thin silicon wafer and the short electrode
spacing, the Mushroom microdosimeters appears to be almost depleted due to its built-in
voltage. The spectra changed very little between 1 and 10 V, with the only discernible
difference being a slight increase in low energy events at 10 V, which resulted in a crosser
peak with slightly less net area due to normalisation. At OV, the low energy component is
slightly larger, with the high energy crosser peak having less energy and area, compared
to when biased.
The peak generated by ions fully crossing the active volume of the device was 1258 keV.
Using the geometry measured from SEM images (section 5.2), a Geant4 simulation was
carried out by David Bolst (UOW) to determine the expected energy deposition, taking
into account the measured aluminium and oxide over-layers. The simulated energy within
the SV was determined to be 1367 keV [111] which is slightly more than measured experimentally. Using this value and equation 2.1, the charge collection efficiency was
determined to be 92 % for this device.
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Figure S.9: 5 .5 MeV He2+ ion energy spectra of the 30 µm Mushroom Air-trench Microdosimeter spectra at various biases.

By only plotting events within specific energy windows over each region of the spectra
and excluding all other events in each map, the origins of charge collection region can be
identified. Figure 5.10 shows maps obtained with only events between 0 - 23 keV, 25 309 keV, 312 - 1118 keV and 1121 - 1573 keV. Very low energy events below 25 keV,
corresponding to the left side of the low energy peak, occurred in the interstitial silicon
between non-adjacent SVs. These events appeared to make a greater contribution to the
spectrum when the microdosimeter was not biased (0 V). Events corresponding to the
right side of the lower energy peak, up to around 309 keV, were produced from a lateral
strip of silicon between adjacent SVs. This strips appear to be somewhat non-uniform
across the SV rows (see the bottom most row), possibly due to non-uniform etching of
the annular sector trenches in this Mushroom sample. Events within the main part of the
spectral plateau occurred predominantly from the edges of the SV s, and events within the
crosser peak originated from throughout the entire SV.
No charge collection was observed around the die edges or bonding pads when biased at
lOV.
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Figure 5.10: 5.5 MeV He 2+ ion median energy maps of the Mushroom Air-trench Microdosimeter spectra at 10 V, windowing over 4 spectral regions.

5.3.2

30 µm poly-trench with p-stop

Acquisitions were performed at various voltages between O and 10 V, however as with
the air-trench devices, maps obtained with biases between 1 and 10 V showed no visible
differences in observed features. Maps for O V and 10 V are shown in figure 5 .11.
At O V, a very high density of low energy events was observed in the interstitial silicon,
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with well defined cylindrical SV s in which high energy events occurred. At 10 V, the map
completely changed, with the removal of almost all low energy events in the interstitial
silicon, except for a small annular area around the SV s. All charge collection occurred
only from biased odd SV s, despite He 2+ ions depositing energy within the floating even
SV s. A dead region outside of the SV was observed as expected, with degraded collection

at the SV centre. In contrast with the air-trench device (figure 5.8), this central electrode
was fabricated using ion implantation, leaving functional silicon underneath, as per its
design. Due to the strong recombination within the planar n+ electrode, there is effectively
a dead region of thickness ,....,
1 µm. The effects of this dead region come in the form of
slightly lower charge collection in the SV center, seen as the red spot in the centre of each
SV. All other features such as SV size, shape, pitch, etc are essentially identical to the
air-trench device.
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Figure 5.11: 5.5 MeV He 2+ ion median energy maps of the 30 µm Poly-trench Mushroom Microdosimeter.

To create a better comparison between the spatial charge distribution and the device geometry, the SEM image of the air-trench device is overlaid atop the poly-trench map. This
comparison could not be done with the air-trench map as higher magnification maps were
not collected with this device. The comparison is shown in figure 5.12, clearly showing
the charge collection volumes with respect to the physical geometry.
The dramatic change in charge collection with increasing bias can be seen when plotting
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the spectra together, as shown in figure 5.13. At O V there exists a dominating wide low
energy peak, with a similar plateau and crosser peak as seen with the air-trench device.
When the bias is increased to 1 V and above, this low energy peak decreases both in energy
and width. From this figure and figure 5.8, it is obvious that the poly-trench device and
the air-trench device are worlds apart in regards to their charge collection characteristics.
A spectral comparison between the poly-trench and air-trench device is shown in figure
5.14, showing greater charge collection efficiency and significantly reduced low energy
contribution in the poly-trench device. Once diminishing difference is that the width of
the poly-trench crosser peak is wider than the air-trench device, as can be seen by the
similar height of the normalised crosser peak in figure 5 .14, despite significantly less low
energy events.
The peak generated by ions fully crossing the active volume of the device is 1304 keV
across all biases, slightly higher than the air-trench device, indicating that the poly-trench
configuration provides greater charge collection efficiency within the SV. Using results
from the Geant4 simulations and equation 2.1, the charge collection efficiency was deter-
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mined to be 95 % for this device.
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Figure 5.13: 5.5 MeV He2+ ion energy spectra of the 30 µm Mushroom Poly-trench
Microdosimeter spectra at various biases.
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Figure 5.14: 5.5 MeV He2+ ion energy spectra of the 30 µm Mushroom Poly-trench
and Air-trench Microdosimeters at l0V.

By only plotting events within specific energy windows over each region of the spectra
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and excluding all other events in each map, the origins of charge collection region can be
identified. Figure 5.15 shows maps obtained with only events between 0 - 49 keV, 52 905 keV, 908 - 1205 keY and 1208 - 1661 keY.

It can be seen that very low energy events below 50 ke Y originate from within the annular
ring outside the poly-silicon filled trench. These events are thought to be produced from
diffusion of charge generated outside the SY, through the poly-silicon and into the drift
region. The rather crisp and well-defined annulus shape may simply be an artefact brought
about due to the LLT cutting off lower energy events. Regardless, a similar (low) LLT will
exist when utilising the device as a microdosimeter, so the charge distribution seen in the
map is representative of the collected events during a microdosimetric acquisition. Events
between 52 keY and 905 keY, corresponding to the plateau region in the spectrum, come
from the edges of the SY and may be due to dead regions within the p+ electrode or the
lower lateral electrical field strength at this distance. The region on the right side of the
plateau and the left side the crosser peak originated from the SY edges, but primarily
from centre of the SY s due to an effective decrease in the active silicon volume where the
n+ implant exists. Finally, the majority of the crosser peak comes from the SY volume,
excluding the centre and edges as previously discussed.
While the results obtained using this device are somewhat favourable, the quality of this
device was put into question after finding an area which possessed low yield, as shown in
the median energy map in figure 5.16. An entire row and the remainder of another are not
collecting. This is most likely due to a discontinuity of the aluminium bus, hence why a
number of adjacent devices in a row were functional and the remainder of the row were
non-functional.
No charge collection was observed around the die edges or bonding pads when biased at
lOY.
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Figure 5.15: 5.5 MeV He 2+ ion median energy maps of the Mushroom Air-trench Microdosimeter spectra at 10 V, windowing over 4 spectral regions.

5.3.3

18 µm poly-trench with p-stop

The 18 µm poly-trench p-stop device was also investigated, however the sample investigated exhibited signs of fabrication errors in the form of low yield, shown in the median
energy map in figure 5 .17. Despite the low yield, the charge collection characteristics of
the SV s were actually more favourable than the same 30 µm variant, as the low energy
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Figure 5.16: 5.5 MeV He 2+ ion median energy maps of the 30 µm Mushroom Polytrench Microdosimeter at 10 V, showing non-functional SVs in array rows.

annulus around the SV was not observed. This can be seen in the median energy map
in figure 5.18. This like likely due to smaller 18 µm diameter SV, resulting in a stronger
electric field on its periphery. All other characteristics were identical to the 30 µm device,
except for the physically smaller charge collection region.
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Figure 5.17: 5.5 MeV He 2+ ion median energy spectrum and map obtained with the
18 µm Mushroom Poly-trench Microdosimeter (p-stop) at 10 V, showing non-functional
SVs in array rows.
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Figure 5.18: 5.5 MeV He2+ ion median energy map of the 18 µm Mushroom Polytrench Microdosimeter (p-stop) at 10 V with corresponding spectra.

5.4

Conclusion

Through the use of standard electrical characterisation methods, 1-V and C-V characteristics for 42 Mushroom microdosimeter samples of various device variants were measured.
For air-trench samples, leakage currents between 5 - 20 nA per array were observed in
most samples with only 4/16 samples exhibiting defective characteristics. For poly-trench
devices, leakage currents of between 0.1 - 0.2 nA were observed for most devices with
5/26 showing defective characteristics. Within each device type, a relatively high degree
of uniformity was observed based on 1-V characteristics. However, C-V measurements
revealed relatively large variations in capacitance between 0-10 V. This could have significant implications when connecting both arrays on single device together with a single
readout, resulting in varied gain. For most samples, depletion was observed between 2 - 5
V. The lack of uniformity is somewhat concerning, however most of the observed characteristics suggest that operation at relatively low bias voltages is possible with low leakage
currents, allowing biasing at higher voltages and/or low noise multi-array usage.
Physical SEM measurements showed complete etching of the two annular trenches, producing a well-defined nearly free-standing cylindrical SV with a small bridge to allow for
n+ electrode connection. Complete vertical and horizontal etching showed great promise
to produce the surface area for 3D p+ and n+ regions. Physical measurements of the
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device geometry showed slight deviations between the design and fabricated product,
with the physical thickness measured across a single air-trench samples to be (9.1 ± 0.1)

µm.
The charge collection characteristics of multiple device variants were discovered using
the IBICC technique using the ANTARES heavy ion microprobe at ANSTO. In almost all
variants, expected charge collection geometry was seen through well-defined cylindrical

SYs.
The 30 µm air-trench p-stop device showed well defined cylindrical SYs with high charge
collection efficiency of 92 % at 10 V. However, a low energy component was observed,
generated in between adjacent SY s, due to the residual silicon bridges left after etching
which support the aluminium bus. Dead regions in the central core and outer trenches
were seen, confirming the complete removal of silicon during the etching process; this is
an important process on which present and future 3D technology heavily relies.
The 30 µm poly-trench p-stop device showed quite different however more favourable
characteristics. When biased at 10 Y well defined cylindrical SYs were observed with
charge collection efficiency of95%. The only low energy component observed originated
from a thin annulus around each SY, which contributes significantly less to its overall
response compared to the 30 µm air-trench p-stop device. There was evidence of some
fabrication issues in the form of a small proportion of non-functional SYs.
The 18 µm poly-trench p-stop device also showed signs of poor yield, however the SY
characteristics were the most favourable of any device, possessing well defined cylindrical
SYs with minimal low energy components. The desirable charge collection properties
and small SYs of this device provide great potential for its application in high dose rate
radiation environments.
The IBICC technique is an extremely useful tool which provides detailed charge collection characteristics of the microdosimeter structures, and verifies the expected function
of their design. Although only a small number of samples were investigated, results obtained for all microdosimeter variants assisted in explaining the unique features seen in
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MCA spectra acquired during alpha spectroscopy measurements.
With the information learned from this characterisation, a new variant is planned to be
developed, whereby complete trenches will be formed around the SY, filled with polysilicon and the surrounding silicon etched away and replaced with PMMA, creating a more
tissue-equivalent substrate [76].

Chapter 6
Automating Microdosimetric
Measurements
As microdosimetric acquisitions are generally performed in charge particle therapy facilities that are almost exclusively overseas, beam time is considered extremely valuable and
sought after. As a result, experimental efficiency was optimised in order to make the most
of the allocated beam time. Previously, experimentation with microdosimetric devices
have involved the use of a PMMA phantom with rigid housing, which required sometimes lengthy in-person adjustment of the apparatus to change experimental variables.
This chapter briefly describes implemented design improvements to the microdosimetric
experimental setup in order to increase productivity, allowing for more comprehensive
research outcomes.

6.1 Software Development
A software package, called the "CMRP Microdosimetry Suite", was developed in-house
with an aim to quickly and efficiently acquire and process MCA energy spectra into the
various microdosimetric quantities and representations, as outlined in subsection 1.1.3.
The suite was used to acquire spectra with the direct control of an Amptek 8000A MCA,
and in real-time, generate microdosimetric data for analysis and inform real-time decisions regarding the irradiation e.g. beam current, detector location, etc. As an MCA spectrum was being obtained, using known microdosimeter parameters such as chord length,
113
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CCE correction and energy calibration, microdosimetric quantities were calculated (with
uncertainty) and displayed during the acquisition. These quantities included f(y),

Yn, YF

, y*, RBE10 and the microdosimetric spectra. Batch processing on a whole data set after

the experiment provided complete depth dose profiles and spectra comparison. Screen
shots showing the various operating modes are shown in figure 6.1.
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·- ·►--

l

l
-

l-

(a) MCA Acquisition

(b) Microdosimetric calculations

(c) Motion control

Figure 6.1: Screenshots of the CMRP Microdosimetry Suite.

While this software was extremely useful, there was still a need to have to physically
change the experimental setup in between device irradiations, in order to vary the detector
position with the phantom. Every time the detector had to be moved inside the phantom,
a user had to wait for the dose rate in the beam room to drop below an acceptable level,
wait for a heavily shielded door to open slowly and then proceed to change the setup. This
process at HIMAC for example took between 3 and 5 minutes each time, and sometimes
up to 10 minutes depending on the beam current used. In addition, while the dose rate
was below acceptable limits at room dose meter, the localised dose rate at the collimator
or phantom could sometimes be greater than 100 mSv per hour, increasing the risk of
exposure to the person adjusting the setup. The solution to this problem relied on creating
a new phantom that was portable and could be controlled remotely. The decision was
made to move away from a solid PMMA phantom to a water phantom, which would
ultimately improve efficiency and capability. However, with this decision came challenges
including the physical design of the movement stage, water proofing of the electronics and
writing control software - all on a very tight timeline and budget.

CHAPTER 6. AUTOMATING MICRODOSIMETRIC MEASUREMENTS

6.2

115

Electronics Development

A new electronics probe was developed by CMRP to replace the Amptek A250 front-end
electronics with a application-specific, compact and low noise alternative for use in water
phantom experiments. The MicroPlus Probe, shown in figure 6.2, provided a means to
place any microdosimeter housed on a DIL-20 package on its PCB, with jumpers used to
enable or disable the use of any of the microdosimeter arrays. Only a very small number
of passive components are placed within a 5 cm distance of the microdosimeter in order
to prevent active and more radiosensitive integrated circuits (amplifiers, etc) from being
irradiated in a 10 cm x 10 cm ion beam, and to minimise radiation-induced activation.
The probes I/0 connector is a single D-subminiature 9-pin (D9) connector, providing a
means to read out the pre-amplified microdosimeter signal, and facilitate the necessary
power rails for the electronics. An in-house shaping amplifier was also created, which
connected to this D9 connector to convert the microdosimeter tail pulse to a Gaussian.
Coaxial breakout connectors from the shaper box passed this shaped signal to an Amptek
8000A MCA for processing and analysis.

Figure 6.2: Image of the MicroPlus Microdosimeter Probe showing the location of the
microdosimeter.
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6.3 Mechanical Development
A waterproof PMMA sheath was designed by former CMRP research fellow Dr. Michael
Weaver and fabricated at the UOW workshop, shown in figure 6.3. The sheath model
was split along its length to enable the cutouts for electrical components and the microdosimeter to be machined, and then screwed together and sealed with silicon. The volume
of PMMA on the front of the sheath was machined out to create a 0.5 mm thick PMMA
window on top of the microdosimeter, ensuring that the majority of the media in front of
the detector was water. A mounting zone with four M3 holes was created at the top of
the sheath to allow it to be mounted to a motion stage, as well as secure the shaper box
on top of the probe. The sheath is covered in aluminium foil (expect the 0.5 mm PMMA
window) and is grounded to form a Faraday cage to reduce EM pickup.
1/0 D-Sub

Figure 6.3: Render of the MicroPlus Microdosimeter Probe PMMA sheath with MicroPlus probe inside.

A low-cost motion stage was then created from a Makerbot Replicator 3D printer and
PMMA water tank, controlled remotely using Arduino-driven stepper motors with limit
switches for X-Z homing of the stage. The MicroPlus sheath geometry was designed to
be mounted on the motion carriage with it's Y-axis fixed, positioning the microdosimeter
in the center of the water tank. The CMRP Microdosimetry Suite was used to control
the microdosimeter depth and lateral position within the tank, as well as perform homing,
automated calibration of the steps/mm, as well as execute custom motion profiles. An
Ethernet interface allowed remote operation over long distances, often useful at beam
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lines and clinical treatment rooms where mazes exist. Due to the open-loop nature of
the movements (no encoders), a camera was mounted on top of the stage in order to
verify that movement commands were actually undertaken. In addition, over-layer offsets
could be added to the motion control system to ensure the microdosimeter was positioned
at an water-equivalent depth for particular beams. This meant that the water-equivalent
thickness of upstream media such as the PMMA tank wall, sheath window, light-tight
film on microdosimeter surface, air gap, etc were all accounted for when positioning the
microdosimeter. The motion stage is shown in figure 6.4, as well as a custom rebuild of
the stage using 3D-printed parts to increase motion reproducibility and ruggedness during
transport.

(a) Initial Build

(b) Rebuild

Figure 6.4: Images of the initial motion stage design and the rebuild version.
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6.4 Associated Simulations
With these mechanical upgrades came the introduction of materials that are not waterequivalent, such as the tank walls, PMMA sheath, foil, etc. In order to put the microdosimeter at a particular depth in water, the water equivalent thickness of the materials
must be known for the beam type under investigation. This was determined by simulations
performed by Dr. David Bolst (CMRP, UOW) with pristine proton and carbon beams of
various energies. For each material simulated, the pinnacle of the Bragg peak was used as
a measure of ion range and use to calculate the water equivalent ratios (W ER) as defined
as WERx

= Rx/ RH2 o. Tables 6.1 and 6.2 show the WER

values for a variety of different

materials and beam energies for proton and carbon ion beams. Given the relatively low
energy dependence of this value, the values over all energies were averaged for each ion
species and used to offset the microdosimeter position system, to take these materials into
account. Comparisons with the ratios of NIST projected ranges are all within 1%.
Table 6.1: Simulated ranges and water-equivalentratios calculated for carbon ions of
various energies in various materials

Material
Water
Aluminium
PMMA
Latex
HDPE
Graphite (1.7 g/cm 3)
Graphite (0.82 g/cm 3)

50MeV/u
WER
Range(mm)
7.5
3.6
6.4
7.9
7.4
3.9
10.5

1.00
0.48
0.85
1.05
0.99
0.52
1.40

150MeV/u
Range(mm)
WER
53.0
25.0
45.3
55.8
52.6
27.0
76.4

1.00
0.47
0.85
1.05
0.99
0.51
1.44

290MeV/u
Range(mm)
WER
162.8
76.0
139
171.5
161.8
82.9
235.7

1.00
0.47
0.85
1.05
0.99
0.51
1.45
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Table6.2: Simulatedranges and water-equivalentratios calculatedfor protons of various
energies in various materials

Material
Water
Aluminium
PMMA
Latex
HDPE
Graphite (1.7 g/cm 3)
Graphite (0.82 g/cm 3)

30MeV
Range(mm) WER
8.9
4.4
7.6
9.1
8.7
4.5
12

1.00
0.49
0.85
1.02
0.98
0.51
1.37

lO0MeV
Range(mm) WER
76.8
36.9
66.3
80.2
76.2
38.8
105.1

1.00
0.48
0.86
1.04
0.99
0.51
1.44

200MeV
Range(mm)
WER
285.7
121.8
221.2
269.4
256.6
130.2
356.8

1.00
0.47
0.86
1.04
0.99
0.50
1.38

Chapter 7
Microdosimetric Applications in Heavy
Ion Therapy
While the He2 + ions generated by the ANTARES accelerator have been shown to be
useful for characterising the charge collection in the silicon microdosimeters, tandem accelerators are not capable of generating high energy heavy ions used for the treatment of
cancer in heavy ion therapy (and the mixed secondary spectrum), for which these microdosimeters were designed.
This chapter presents experimental work from the utilisation of multiple microdosimeters including the Etched microdosimeter, Bridge V2 microdosimeter and Mushroom
microdosimeter, as well as a thin 3D detector, using a 290 MeV/u SOBP

12C

beam at

the Heavy Ion Medical Accelerator in Chiba (HIMAC), Japan. Microdosimetric spectra were obtained in PMMA and water phantoms at many locations along the central
axis of the beam, where

12C

ion LET changes with depth, especially at the end of the

SOBP, generating a spectrum of secondary particles along their passage. In addition, lateral profile measurements in-field and out-of-field were performed, as well as a selection
of distal locations. Using the obtained spectra, microdosimetric quantities such as

Yn

were calculated, as well as the derivation of RBE 10 for HSG cells, using the modified
microdosimetric-kinetic model. Using these values and measured physical dose, the biological dose profile was approximated as a function of depth in water phantom. The
results obtained from each microdosimeter were compared with each other, and with pre120
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Figure 7.1: Image of the HIMACBio-Cavebeam room

viously obtained TEPC measurements, which provided insights into the impacts of the
various microdosimeter designs on their potential for use in hadron therapy QA.
Parts of the work described in this chapter have been published in multiple journal articles
[98, 105, 106, 115], with data collection performed in collaboration with Dr. Linh Tran
(CMRP, UOW).

7.1

The HIMAC Bio-Cave Facility

The Heavy Ion Medical Accelerator in Chiba (HIMAC) is located at the National Institute
of Radiological Sciences (NIRS) in Japan. It was built in 1994 and was dedicated to
research and treatment of cancer using particle therapy, and also served to replace the
existing fast neutron therapy facilities at NIRS [116]. As of 2015, it has treated more
than 10,000 patients using

12C

ions [117]. Whilst this is its primary focus, HIMAC is

also capable of accelerating a vast array of conventional and exotic ion species to the
Bio-Cave, where radiobiological experiments are carried out, shown in figure 7 .1.

The HIMAC accelerator consists of a linear accelerator for low Me V/u ions and an Alvarez type linac for medium MeV/u ions, which also acts as an injector to the two main
synchrotrons. The maximum energy deliverable is 400 MeV/u. In order to generate a
typical clinical

12 C

ion field (e.g. 10 cm x 10 cm, 290 MeV/u SOBP with 6 cm modula-

tion) from the HIMAC Bio-Cave beam port, the following processes are undertaken, and
is illustrated in figure 7 .2 [ 118]:
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Figure 7.2: Schematic of the IIlMAC Bio-Cave beam line components, adapted from
[118] (not-to scale).

1. An approximately monochromatic 290 Me V/u beam with spot size 3.4 mm

a enters

the evacuated beam line
2. X and Y wobblers are used to spread out the pencil beam into a larger field
3. The beam then passes through a tantalum scatter to improve lateral dose uniformity
4. The beam is then collimated by a thick brass collimator with diameter 100 mm
5. A neutron shutter then reduces neutron flux generated within this brass collimator
and then the beam is collimated again by a thick brass collimator
6. An aluminium ridge filter then selectively degrades the beam, producing a weighted
spectrum of ions necessary to produce the required modulation (SOBP)
7. A PMMA range shifter then shifts the range of the SOBP (if required)
8. A final 5 cm thick brass collimator shapes the beam into the desired field size close
to the sample being irradiated

7 .2

Microdosimetric Application in a 290 Me V/u

12

C Ion

Beam at HIMAC (PMMA Phantom)
7.2.1 Materials and Methods
Etched Microdosimeter and Bridge V2 Microdosimeter samples were selected for irradiation based on properties revealed in chapter 3 and chapter 4, respectively. The microdosimeters were housed in aluminium cases of dimensions

~ 20 cm x 4 cm x 3 cm with
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a wall thickness of 1.5 mm. A small 2 cm x 2 cm window was cut out just above the microdosimeter location and covered with thin aluminium foil. This formed a Faraday cage,
whilst also minimising beam perturbation through the foil. Housed within the same case
was an Amptek A250 preamplifying circuit, with its output connected to the case breakout ports. A battery-powered Cremat-150 shaping amplifier circuit was used to convert
the amplified tail pulse into a Gaussian, with a pulse-height energy spectrum created using an Amptek 8000A Pocket MCA. The calibration process was performed as outlined in
chapter 2, however through the use of a portable battery-powered pulser, calibration peaks
were created at the beginning of the experiment. The microdosimeters were all operated
at 10 V, requiring only one calibration to be carried out per microdosimeter.
The phantom used was a modular PMMA slab phantom consisting of 13 slabs ranging
from 2 mm to 48 mm. A 48 mm PMMA slab was first placed on the back of the sample stage to provide appropriate scatter material. A 30 mm PMMA slab with a cut-out
allowed for two detector cases to be inserted from the top. The effective depth of the
microdosimeter was changed by varying the amount of PMMA slabs that were upstream
of the microdosimeters. The depth was able to be discretely varied between 2 mm to 178
mm using unique combinations of the PMMA slabs. Of course, with the use of a solid
phantom and encapsulated detector sheath, a small air gap between the front of the detector window and phantom and a larger air gap behind the detector the the 48 mm slab
existed. The phantom can be seen in figure 7.3.
A 290 MeV/u

12

C beam with 6 cm SOBP width was used with the final brass collimator,

producing a field size of 10 x 10 cm 2 • Lineal energy spectra were obtained at various
depths from O - 150 mm depth in PMMA with each microdosimeter surface perpendicular to the beam (face-on). Acquisitions were carried out until sufficient statistics were
obtained, which varied with depth. A fixed LLT for each microdosimeter was used for
acquisitions. Using the obtained energy spectra, lineal energy spectra were generated using the mean chord length, as per equation 1.8. Using these lineal energy spectra, the
dose-mean lineal energy

Ynwas calculated

at each position along and downstream of the

SOBP. A conversion factor of 0.63 [74] was used to convert the lineal energy deposited
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Figure 7.3: Image of Microdosimetersplaced within the PMMAphantomin the HIMAC
Bio-Cave

within the silicon to that in tissue, with additional CCE corrections applied for each microdosimeter. Uncertainties in Yn and RBE10 were calculated using equations A.13 and
A.20, respectively. Uncertainty in the PMMA thickness was estimated to be 0.1 mm per
sheet, ranging from 0.2 mm to 1.0 mm over all depths.

7.2.2 Results and Discussion
7 .2.2.1 Etched Microdosimeter
Displayed in figure 7.4 are the microdosimetric spectra obtained at various depths between
0 mm and 141.0 mm in PMMA, produced from energy deposited in the detector when
exposed to a 290 Me V/u

12C

beam. As seen in figure 7.4a, the first 5 depths show quite

similar characteristics with two similar features: a low energy component and a higher
energy component. While both components change significantly with depth, the high
energy component has more significance as it is produced from primary
the detector, depositing energy and then exiting the detector - these

12C ions

12C ions

entering

are known as
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Figure 7.4: Microdosimetric spectra obtained using the Etched Microdosimeter at various depths in PMMA with a 290 MeV/u

12

C beam.

crossers. The measured crosser lineal energies deposited ranged from ~20 keV/µm up to

~ 1000 keV/µm.

As the microdosimeter was moved deeper within the PMMA, the lineal

energy deposited increased as a result of increasing stopping power (LET), which can be
seen by the increasing peak position in the microdosimetric spectra. Therefore, the lineal
energy deposited in the detector increased, as seen by the increasing peak position. This
peak continued to shift towards higher lineal energies until a depth of 129.0 mm (figure
7 .4b) where all the carbon ions stopped - these

12

C ions are known as stoppers.

This can also be seen in figure 7 .5, through the dose mean lineal energy depth distribution,
showing entrance

Yn at ~13 keV/µm and increasing to a maximum of 68 keV/µm. A

ridge can also be seen at approximately 75 mm where the SOBP plateau starts and high
dose area begins. The

12

C ions undergo nuclear interactions with the PMMA phantom,

the probability of which increases with depth, resulting in the generation of neutrons
and fragments. This produces a charged particle spectrum primarily consisting of ions
between hydrogen and boron, with the fragment fluence increasing up until just before
the carbon stops within the microdosimeter [119]. This fragmentation process, while
only consisting of light ions contributes ~20% of the dose close to end of the SOBP [120].
These light fragment ions are able to travel beyond the point at which the primary beam
stops, depositing energy distal to the SOBP. Fast neutrons that are produced from within
the beam line components and PMMA phantom create secondary ions [121], contributing
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Figure 7.5: Dose-mean lineal energy at various depths in PMMA obtained using the
Etched Microdosimeter in a 290 MeV/u 12C beam.

to these distal spectra in figure 7 .4b, and subsequent non-zero

YDvalues.

Previous experiments performed using similar thinned silicon detectors [103] and TEPC
[122] in a 290 MeY/u

12

C ion beam tell a different story, recording spectra with a clearly

defined and dominating crosser peak throughout most depths, and very wide ranging fragmentation spectral features. However, the spectra obtained with the Etched Microdosimeter is for the most part dominated by the low energy peak. From previous IBICC results
in section 2.3, it is undoubtedly a result of the low charge collection component due to
unbiased SYs, and to a lesser extent the low CCE of the SY periphery. Due to the small
size of each SY and the proportion of events generated from the SY periphery and unbiased arrays being large compared to the high CCE events within the SY, reduced average
lineal energy deposition can be seen.
The result of this has been observed in the microdosimetric spectra but can also be seen
the

YDdistribution,

as well as the RBE10 depth distribution shown in figure 7.6. While the

shape of both distributions is expected, the YDvalues are significantly lower, and naturally
so too are the RBE10 values. RBE10 values derived using microdosimetric spectra with
a TEPC have previously been acquired with this beam, yielding
peaking at ~2.5 near the distal edge of the SOBP [122].

~1.2 at entrance

and
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7 .2.2.2 Bridge Microdosimeter
Shown in figure 7.7 is the microdosimetric spectra obtained using the Bridge microdosimeter at various depths between O mm to 141 mm in PMMA. In contrast with the
Etched microdosimeter results, the microdosimetric spectra contains only a single peak
in each spectrum, produced from

12

C ion crossers. This is expected due to the extremely

well-defined, high CCE SVs of the Bridge microdosimeter (see section 4.3). The single
peak can be seen to increase in lineal energy with depth, due to increasing particle LET.
Contributions from fragments and neutrons can also be seen at greater depths in the form
of a lower energy shoulder between ~3-20 keV/µm. The decrease in peak height is due
to the increase in high LET events, which have a greater influence on the normalisation
of the microdosimetric spectra (yd(y)

oc /).

After a depth of 130 mm in PMMA, the

primary beam had stopped and the spectra comprised of energy deposition events from
fragments and secondary particles from neutron interactions.
Shown in figure 7 .8 is the
measured

YDdistribution obtained with the Bridge Microdosimeter. The

YDvalue at entrance was ~12 keV/µm, increasing to ~22 keV/µm at the start

of the SOBP at ~75 mm, and reaching a maximum value of 157 keV/µm at a depth of
130 mm. In comparison with the Etched microdosimeter, the YDvalues are quite similar
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Figure 7.7: Microdosimetric spectra obtained using the Bridge Microdosimeter at various depths in PMMA with a 290 MeV/u 12C beam. The yd(y) axis scale was changed
between graphs to improve visualisation, at the cost of easy comparison.

up until a depth of ~90 mm. After this, the

Yn values

obtained from the Bridge micro-

dosimeter start to increase at a much greater rate, with the maximum
times greater than that of the Etched microdosimeter.

Yn value being

~2.3

The similarities at lower depths

could indicate that the Etched microdosimeter may have had an inherent under-response
for higher LET particles, which was not investigated using IBICC.
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Figure 7.8: Dose-mean lineal energy at various depths in PMMA obtained using the
Bridge Microdosimeter in a 290 MeV 12C beam.

Using the lineal energy spectra obtained with the Bridge microdosimeter, the RBE10 distribution for HSG cells was derived using the MKM model, shown in figure 7.9. Entrance
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values of RBE 10 were ~1.1, similar to the average value used in proton therapy, and
reached a maximum of 2.53 at 130 mm. As

Yn values for the Bridge microdosimeter

were higher, it is not surprising that the RBE10 values are also much greater than those
obtained using the Etched microdosimeter, by a factor of~ 1.4.
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Figure 7.9: Derived RBE10 at various depths in PMMA obtained using the Bridge Microdosimeter in a 290 MeV 12C beam.

RBE values using the same method, beamline and conditions were previously obtained
by Kase using a TEPC [122]. A comparison between these TEPC values and those derived with microdosimetric spectra from the Bridge microdosimeter is shown in figure
7 .10. The Etched microdosimeter values are also shown, emphasising its underwhelming
microdosimetric performance. In contrast, the derived RBE10 values using the Bridge microdosimeter results compare reasonably well with with that of the TEPC, in both shape
and magnitude.
Due to the phantom used and the physically thin sensitive volume of the microdosimeter,
more detailed acquisitions were able to be performed very close to the edge of the SOBP,
where LET is highest. As opposed to the 12.7 mm diameter TEPC, the volume-averaging
effect when using the physically thin microdosimeter is presumed to be negligible, which
may explain the slightly greater RBE10 value at the edge of the SOBP. However, with
using the PMMA phantom, as opposed to the water phantom that the TEPC measurements
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were performed in, there is undoubtedly differences in the fragment and neutron spectra
within the phantom. This may have contributed to the greater RBE10 values downstream
of the SOBP distal edge.
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Figure 7 .10: Comparison of derived RBE 10 values for HSG cells using the Bridge Microdosimeter, Etched Microdosimeter and a TEPC for a 290 Me V

12

C beam.

These results show that the Bridge microdosimeter is a device that has the potential to
estimate

Yn and RBE10 values relatively quickly, which could open pathways for micro-

dosimetric quality assurance techniques.

7 .3

Microdosimetric Application in a 290 Me V/u

12

C Ion

Beam at HIMAC (Water Phantom)
The development of both the MicroPlus probe and the movable phantom described in
chapter 6 opened avenues for fast experiments with different microdosimeters/detectors
using the 290 MeV/u SOBP

12

C beam at HIMAC. Measurements were performed at vari-

ous positions in a water phantom along its depth, laterally and at out-of-field locations, as
well as the estimation of biological dose using measurements from an ionisation chamber
and RBE10 values derived from microdosimetric spectra.
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(b) Beam's eye view of MicroPlus probe

Figure 7.11: Image of Microdosimeter attached to the motion stage, inside the water
phantom before being irradiated with a 290 Me V/u SOBP field at HIMAC.

7.3.1

Materials and Methods

The following experiments involved the use of the Bridge V2 microdosimeter, U3DThin
detector (discussed in section 1.2.2.4), a 30 µm Mushroom air-trench microdosimeter and
an 18 µm poly-trench Mushroom microdosimeter. The samples used were selected based
on their properties, characterised in previous chapters. In addition, a PTW 31006 pinpoint
ionisation chamber was used for measuring the physical depth-dose profile of the beam
in a water phantom.
Two PMMA holders were made for the Bridge and Mushroom microdosimeters The
Bridge/Mushroom microdosimeters were mounted to the MicroPlus Probe PCB and inserted into the water proof sheath.
For the Bridge and Mushroom microdosimeters, each sample was mounted to the MicroPlus probe PCB and inserted into the waterproof sheath (see figure 6.3). Each sheath
was wrapped in aluminium foil which was grounded to eliminate RF pickup, placed inside
a latex condom to prevent possible leaks in the sheath water proofing, and then attached
to the motion stage. A custom PMMA holder was designed to house the U3DThin detector in an aluminium case, with associated spectroscopic and power equipment attached,
as described in section 7 .2.1. For all detector types, the calibration method described in
section 7 .2.1 was used. An image of the setup can be seen in figure 7 .11.
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beam with 6 cm SOBP width was used, with the final brass collimator

producing a field size of 10 cm x 10 cm. The spectroscopic equipment described in
chapter 6 was used to obtain lineal energy spectra from each microdosimeter, generated
using the thickness of each microdosimeter as the mean chord length (see section 1.2.2.2).
Simulation studies carried out by Dr. David Bolst (CMRP, UOW) revealed that a siliconto-tissue conversion factor of 0.57 was a more appropriate factor to use for

12C

ion therapy

[58] than 0.63 used in previous experiments. Using the lineal energy spectra, the dosemean lineal energy YDwas calculated at various positions in-field and out-of-field, as well
as derived RBE10 values for HSG cells, using the MKM.
Uncertainties in

YDand RBE10 were calculated using equations A.13 and A.20, respec-

tively. Uncertainty in the motion stage movements alone was estimated to be less than
~0.5 mm. The basis of this estimation involved tracking the physical position of the top
of the waterproof sheath, which extended out of the water phantom. The exact microdosimeter location inside the phantom was unable to be measured directly, but by measuring the thickness of all layers in front of each microdosimeter, the effective point of
measurement relative to the top of the sheath was determined. Using conversion factors
from table 6.1, and providing water-equivalent thicknesses of all over-layers to the control software, the microdosimeters were able to be moved to a specified water-equivalent
depth inside the phantom. The uncertainty was determined to be at most ~ 1 - 2 mm.
Acquisitions were performed in a sequential manner, ensuring mechanical issues such as
backlash were minimised. As such, it is estimated that most uncertainty is related to the
absolute position of the microdosimeter within the phantom, not the relative distances
between each acquisition location.

7.3.1.1

Central Axis Microdosimetric Measurements

Using each of the microdosimeters and the U3DThin detector, acquisitions were obtained
at various depths along the central axis of the field, starting from entrance to downstream
of the SOBP distal edge. A stepwise approach was used, however exact acquisition locations varied between microdosimeters due to physical constraints of each detector sheath.
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Regardless, the entire profile along the beams central axis was measured using each device. Acquisitions were carried out until sufficient statistics were obtained, which varied
with depth and microdosimeter type.

7.3.1.2

Biological Dose Determination

The biological dose, known as RBED is the product of the RBE and physical dose. The
RBE was calculated using equation 1.24 and physical dose was measured using the PTW
31006 pinpoint ionisation chamber. By measuring the physical dose at the same effective
point of measurements as that of a microdosimetric acquisition, the RBED was calculated
at various depths using the Bridge microdosimeter and U3DThin detector.

7.3.1.3

Lateral Measurements and Dose Equivalent Determination

The lateral profile of the field was measured using the 30 µm air-trench Mushroom microdosimeter, with measurements obtained between O mm and 75 mm from the center
of the field. These measurements were performed at two depths, entrance depth (19.41
mm) and near the distal edge of the SOBP (146 mm). Out-of-field acquisition locations
are shown in figure 7 .12. Measurements at distances further out-of-field could not be
obtained due limitations of the physical size of the water phantom and motion stage limits. Microdosimetric spectra were obtained at these locations and lateral

Yn and derived

RBE10 distributions were generated. In addition, the dose-equivalent at out-of-field locations were calculated, using the method outlined in section 1.1.5.

7.3.2

Results and Discussion

7.3.2.1

Central Axis Microdosimetric Measurements

Bridge V2 Microdosimeter
Figure 7.13 shows the microdosimetric spectra obtained with the Bridge microdosimeter
in a 290 MeV/u

12

C ion SOBP field. The spectra acquired in water was found to be quite

similar to those previously measured in PMMA, however the range of the ions in the water
was ~ 1.17 greater. This can be seen with the relatively large increase of high LET events
at ~87 mm as the detector enters the SOBP, which previously occurred at ~75 mm in
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Figure 7.12: Schematic showing the out-of-field (OOF) acquisitions locations for a 290
MeV/u 12C SOBP field at HIMAC.

PMMA. The spectra recorded in-field showed the primary

12C

ion crosser peak shifting

towards higher lineal energies as ion LET increased with depth. The relative contribution
from neutrons between 1-20 keV/ µm also increased with depth, due to the greater volume
of water upstream in which interactions with beam took place. The spectra past the distal
edge of the SOBP consisted of much lower lineal energy events, with a peak occurring
at ~25 keV/µm, generated from heavier fragments, as well as some lineal energy events
between 1 - 10 keV/ µm generated from neutrons and lighter fragments.
Figure 7.14a shows the corresponding

YDdistribution, which is extremely similar to the

previous results obtained using the PMMA phantom (figure 7 .8). The YDat the shallowest
depth was ~ 18 keV/ µm, followed by an increase to ~40 keV/µmat the start of the SOBP,
where the lowest energy ions stopped. Within the first 40 mm of the SOBP plateau, the YD
rises gradually until within ~ 10 mm of the end of the SOBP, where it reaches a maximum
of ~ 160 keV/ µm. Of course, this maximum occurred at a greater depth of 145 mm,
compared to when using the PMMA phantom.
The corresponding RBE10 distribution is shown in figure 7 .14b. RBE10 values at the
entrance were ~ 1.2, reaching a value of ~ 1.6 at the start of the SOBP peak. RBE10
increased in the SOBP plateau, reaching a maximum value of 2.58 at the edge of the
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Figure 7.13: Microdosimetric spectra obtained using the Bridge Microdosimeter at var•
ious depths in water with a 290 MeV/u 12C beam. The yd(y) axis scale was changed
between graphs to improve visualisation, at the cost of easy comparison.

SOBP. Distally, the RBE 10 values were ~1.4, naturally much lower due to the absence
of high LET

12

C ions, however still greater than for photons, highlighting one of the

disadvantages of heavy ion therapy.
Both the RBE10 and

YDdistributions

obtained within the water phantom decreased past

the distal edge, confirming that the increase in

YDand

RBE10 past the distal edge in the

PMMA phantom was likely due a different secondary spectra produced from within the
PMMA material itself (e.g. high LET carbon recoils).

U3DThin Detector
Figure 7.15 shows the microdosimetric spectra obtained using the U3DThin detector in
a 290 MeV/u

12

C ion SOBP field. The spectra are quite similar compared to the Bridge
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Figure 7.14: Yn and derived RBE10 distributions obtained using the Bridge Microdosimeter at various depths in water with a 290 MeV/u 12C SOBP beam.

Microdosimeter for all depths, including those obtained past the distal edge. For these
out-of-field measurements, the spectra contain more counts due to the much larger area
of the U3DThin device compared to the Bridge microdosimeter.

Fluctuations seen at

lower lineal energies are a binning artefact due to relatively large linear bins of the MCA
spectrum.
One observable difference between the U3DThin spectra and those from the Bridge microdosimeter is the presence of a peak close to ~700 keY/µm in the U3DThin spectra,
at the SOBP edge. This is likely the carbon edge peak, caused by the highest energy

12

C

ions stopping within the U3DThin sensitive volume. The absence of this peak in other
microdosimeters could simply be due to slight deviations in acquisition locations but also
could be related to the U3DThin geometry. Due to its elongated parallelepiped detection
volume, particles incident at oblique angles are more likely to stop within the detector,
resulting in a significant energy deposition. In contrast, the Bridge microdosimeter has
the majority of its silicon outside of its well-defined SY s removed, resulting in decreased
probability of obliquely incident particles stopping within the device.
This enhanced response is evident in the

YDand derived

RBE10 distributions seen in figure

7 .16. An effect of the U3DThin elongated parallelepiped SY geometry can be seen when
comparing the

YDvalues

with the Bridge Y2 Microdosimeter.

The

YDof

both devices
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Figure 7.15: Microdosimetric spectra obtained using the U3DThin Detector at various
depths in water with a 290 Me V/u 12C beam. The yd (y) axis scale was changed between
graphs to improve visualisation, at the cost of easy comparison.

was found to be equal at depths before the start of the SOBP, where the

12C

ion LET

is relatively low and energy is deposited primarily by crossers. However, the U3DThin
detector measured greater

Yn values within the SOBP, where

12

C ions began to stop,

likely due to the increased energy deposition of oblique particles, as well as straggling.
However, the average chord length was assumed to be equal to the thickness of the thin
detector. Within the first ~40 mm of the SOBP, U3DThin

Yn values were on average

larger than the Bridge values by ~10% due to the reasons outlined above. A maximum
value of 224 keV/µm was measured, ~40% greater than the value obtained with the
Bridge microdosimeter. Despite this much larger difference, due to the overkilling effect
incorporated into the MKM, the maximum derived RBE10 value with this detector was
2.69, only slightly greater than that obtained with the Bridge Microdosimeter.
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Mushroom Microdosimeters
Figures 7.17 and 7.18 show the rnicrodosirnetric spectra obtained with the 30 µm airtrench Mushroom rnicrodosirneter and 18 µm poly-trench Mushroom rnicrodosirneter in
a 290 MeV/u

12C

ion SOBP field, respectively. This was the first

12C

ion irradiation per-

formed with this detector technology. Both sets of spectra were extremely similar to that
obtained with the Bridge rnicrodosirneter, showing clear tracking of the main crosser peak
with increasing depth, as well as the detection of fragments and neutrons, both in-field and
distal to the SOBP edge. Extra measurements downstream were obtained through utilisation of the beamline PMMA range shifter for the 30 µm air-trench device, enabling
the measurement of lineal energy spectra much deeper than previously achievable. For
both rnicrodosirneters, the measurements at 150 mm and 160 mm are similar to that obtained by the Bridge rnicrodosirneter, showing a gradual decrease in high LET events as
fragments stop within the phantom. This is further emphasised at 249 .42 mm, where low
lineal energy events from neutrons dominated the spectrum.
Using the lineal energy spectra obtained,

YDand

derived RBE10 distributions were ob-

tained for both Mushroom rnicrodosirneters, shown in figure 7.19. At entrance and shallower depths, as seen with other rnicrodosirneters,

YDvalues

were seen to remain fairly

constant at between ~15 - 20 keV/µm, before reaching the start of the SOBP where

YD
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Figure 7.17: Microdosimetric spectra from the 30 µm Air-trench Mushroom microdosimeter in a 290 Me V/u 12C beam. The yd (y) axis scale was changed between graphs
to improve visualisation, at the cost of easy comparison.

increased to ~44 keV/µm. From this point, the

Yn values

obtained using the poly-trench

Mushroom microdosimeter were slightly higher for most of the SOBP. At the end of the
SOBP, the air-trench device reached ~178 keV/µm and the poly-trench device reached
~ 171 ke V / µm at a slightly earlier depth. As both microdosimeters were utilised separately, each had a different hardware and tank setup, resulting in a slight positional offset
( <0.5 mm), which is emphasised here at the end of the SOBP where dramatic changes in
field quality exists.
The RBE 10values display a very similar trend before the SOBP, starting at~ 1.15 and increasing to ~ 1.45 at the proximal edge of the SOBP. The RBE10 values of the poly-trench
device are again slightly higher than the air-trench device, and reaching a maximum value
of ~2.69. The air-trench device, however peaked at just ~2.50, which is lower than other
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Figure 7.18: Microdosimetric spectra from the 18 µm Poly-trench Mushroom microdosimeter in a 290 Me V/u 12C beam. The yd (y) axis scale was changed between graphs
to improve visualisation, at the cost of easy comparison.

microdosimeters utilised in this study. As reiterated throughout this work, overkilling occurring above 150 keV/µm does play a role in the reduction of RBE10 calculated using
the MKM. In addition, the contribution oflow energy events in the air-trench device, seen
from IBICC results (section 5.3.1), produces a lower

YFvalue (equation 1.10) which is

seen especially in the air-trench spectra within the SOBP. This resulted in an air-trench

y* value that was ~33% lower than the poly-trench device, which ultimately reduced the
RBE10 value. An example showing the exaggerated low energy response in the air-trench
device at depths of 130 mm and 140 mm is shown in figure 7.20.
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Comparison with TEPC
The derived RBE10 distributions obtained with all detectors is compared with that obtained using the TEPC in figure 7 .21. Error bars have been omitted for clarity, however
uncertainties of these values are between 5 - 15 %. These uncertainties are a combination
of relatively large errors in LQM parameters for HSG cells [123], as well as y* , which
is governed by statistics of the lineal energy spectra and also the size of tissue-equivalent
size and shape or the SV. The TEPC size is equivalent to a ~2 µm diameter tissue sphere,
while the SOI microdosimeters are equivalent to a

~ 17 µm

tissue cylinder, leading to
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differences in stochasticity of the deposited energy and variance in the SV chord length
distribution.
The RBE 10 distribution obtained using the microdosimeters are generally in good agreement with the TEPC results, showing a similar shape and features with respect to the
SOBP profile, as well as magnitude. However, all silicon detectors showed an enhanced
response in the SOBP and at the distal edge, with the U3DThin detector and poly-trench
Mushroom microdosimeter producing maximum RBE10 values of ~2.69. Maximum values with the microdosimeter were different to the TEPC in part due to the low granularity of TEPC measurements at the edge of the SOBP. However, even if a greater density
of measurements were performed, volume averaging would most likely produce lower
RBE10 values due to the relatively large diameter of the TEPC. In addition, differences in
values over the entire distribution will differ slightly due to differences in the SV geometry [124]. Investigations into how the average chord changes as a function of depth have

shown that at distal locations, the field is more isotropic. As a result, the average cord
length decreases at depths beyond the distal edge of the SOBP, which would decrease
lineal energy and provide lower RBE10 values [58].
3
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Figure 7.21: Comparison of derived RBE10 distributions from thin silicon detectors with
values obtained with the TEPC for a 290 MeV/u 12C ion SOBP beam.
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Biological Dose Determination

The measured physical dose measured with a PTW 36001 pinpoint ionisation chamber is
shown in figure 8.1. Due to a miscalculation in the effective point of measurement of the
chamber, the measured dose at specific depths did not match those of the microdosimeters.
While not ideal, a fit was applied to the obtained dose profile and dose was interpolated
at the required positions.

This increases uncertainty in RBED, especially at shallower

depths due to less granular measurements compared to those in the SOBP.
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Figure 7.22: Normalised depth-dose profile for the 290 MeV/u SOBP beam at HIMAC.

Using the measured dose and the derived RBE 10 distributions of the Bridge Microdosirneter and U3DThin detector, the RBED distribution was calculated, shown in figure 7 .23.
Uncertainty in the obtained values were based on RBE10 uncertainty and have been omitted for clarity (values ranged between 5 - 15 %). For the purposes of comparison, both
RBED distributions have been normalised to the RBED value measured by the Bridge microdosirneter in the centre of the SOBP. The distributions measured by each detector are
similar, however an enhanced dose response is seen with U3DThin device due to greater
derived RBE10 values. This is a known limitation of this technology as oblique ion tracks
can a deposit greater energy in through the bulk silicon [91], emphasising the importance
of 3D cell-sized SV s that these SOI microdosirneters possess.
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These dose profiles resemble the SOBP shape, showing an rapid increase at approximately
80 mm up to the start of the SOBP plateau. Between the depths of ~85 - 120 mm, the
RBED is roughly constant as expected but decreases slightly with depth, followed by a
sharp increase at the SOBP edge. The RBED values decrease rapidly after this increase, as
expected. As seen in figure 7 .24, data from TEPC and HSG cell measurements performed
in the same beam [122] also deviated from the flat TFS-calculated RBED distribution in
a similar fashion to that obtained with the Bridge microdosimeter and U3DThin detector.
This may be associated with difficulties in determining accurate fluence weights for each
pristine Bragg peak, especially for higher energy Bragg peaks which provide the major
contribution to physical dose proximal to the SOBP distal edge. The sharp increase in
RBED obtained with the thin silicon detectors at the distal SOBP edge may also be attributed to the ability of this technology to measure field characteristics in much greater
detail than the TEPC, without volume-averaging effects.
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Figure 7.23: Normalised biological dose distributions for the 290 MeV/u SOBP beam
at IDMAC, measured using the Bridge microdosimeter and U3DThin detector.

7.3.2.3

Lateral Measurements and Dose Equivalent Determination

Shown in figure 7 .25 is the microdosimetric spectra obtained using the Mushroom microdosimeter at a depth of 19.41 mm and 146 mm, moving laterally across the 290 Me V/u
12

C SOBP field.
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At a depth of 19.41 mm, the in-field (0-50 mm) spectra are extremely similar, comprised
of a large peak at ~ 14 ke V/ µm with a low energy tail caused by fragments and neutrons.
Low energy events also likely contribute to the signal acquired using this device, as seen
in section 5.3.1. At a distance of 5 mm from the field edge (55 mm off-axis), some
12C ions were still detected, however with slightly higher LET due to scattering. At 10
and 15 mm out-of-field, no evidence of the primary carbon beam was seen, with a low
lineal energy spectrum comprised of events from fragments and secondary particles from
neutron interactions. Due to the relatively low LET of the primary beam at this shallow
depth, the particles that make up the secondary spectra out-of-field are actually higher
LET, as can be seen from the higher lineal energy tail in spectra from 5 mm out-of-field
onwards. This can also be seen in figure 7.2£,a as YDis ~14 keV/µm inside the field, and
then increases to ~31 keV/µm at 10 mm out-of-field, then finally decreasing as the higher
LET particles reach their range. The corresponding RBE10 values in figure 7.26b inside
the field are~ 1.15 with a slight increase to 1.26 at 10 mm out-of-field.
At a depth of 146 mm, which is very close to the SOBP edge, the spectra is comprised
of a very wide carbon peak above 100 keV/µm that consists of both ions that cross the
microdosimeter volume and a few that stop within it At this depth, the

YDactually

de-
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creases slightly when moving towards the field edge and then drops dramatically from
~170 keV/µm at the field edge down to ~53 keV/µm at 5 mm out-of-field and then to
~26 keV/µm at 10 mm out-of-field. The RBE10 , however increased towards the edge of
the field up to 2.4 and then decreases down to a minimum of 1.26 at 10 mm out-of-field.
The increase in RBE10 with a decreasing

YDis due to the overkilling

effect which occurs

at lineal energies above 150 keV/µm. The spectra at 10 and 15 mm out-of-field for both
depths are very similar, resulting in extremely similar
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and RBE10 values.
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Figure 7.25: Microdosimetric spectra from the Mushroom microdosimeter in a 290
MeV/u 12C beam at IIlMAC, obtained at different depths as a function of lateral position. The yd(y) axis scale was changed between graphs to improve visualisation, at the
cost of easy comparison.

The

YDand derived

RBE10 distributions at both depths is shown in figure 7 .26.

Using the lateral out-of-field spectra, the dose-equivalent was calculated at locations 5
mm, 10 mm and 25 mm from the field edge, shown in figure 7 .27a. The calculated values
were normalised per Gy at the center of the SOBP, measured using an ionisation chamber.
At a depth of 19.41 mm, the dose-equivalent was determined to be 16.8 mSv/Gy (Q =
4.4) at 5 mm out-of-field and decreased to 3.6 mSv/Gy (Q = 4.0) 25 mm out-of-field. At
a depth of 146 mm, the dose-equivalent was determined to be 137 mSv/Gy (Q = 7.1) at 5
mm out-of-field and decreased to 2.3 mSv/Gy (Q

= 5.4) 25 mm out-of-field.

As seen by

the similar spectra andyD values obtained at 10 mm out-of-field (figure 7.26a), so too are
the calculated dose-equivalents, yielding very similar values of ~5.5 mSv/Gy (Q = 5.0).
Due to the contribution of lower energy, higher LET 12C ions scattered at greater depth, it
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Figure 7.26: Lateral Yn and derived RBE10 distributions obtained using the Mushroom
microdosimeter in a 290 MeV/u 12C beam at different depths.

is not surprising that the both the dose-equivalent and quality factor are greater at a depth
of 146 mm. However, at 25 mm out-of-field, the quality factor is larger at deeper depths,
while the dose-equivalent is larger at shallower depth. This can be explained due to the
greater contribution of heavier fragments and particles from fast neutron interactions, seen
as higher lineal energy events in the spectra. As Q is dependent on both the lineal energy
and dose-weighted lineal energy distribution, these higher energy events naturally cause
Q to increase.

In addition, using the spectra distal to the SOBP edge (depths 150 mm, 160 mm, 180.24
mm and 249.42 mm in figure 7.17c), the dose-equivalent was calculated, normalised per
Gy at the centre of the SOBP, shown in figure 7 .27b. The physical dose is shown for
reference. Values at 150 mm were 137 mSv/Gy and decreased to a value of 13 mSv/Gy
at a distance of 250 mm. Close to the SOBP edge, dose is highest in part due to Carbon
ions reaching the microdosimeter due to range straggling, but mainly due to contributions
from fragments such as boron and beryllium. Lighter fragments and particles from fast
neutron reactions contribute to the dose-equivalent further downstream after all
stopped.

12

C ions
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7.3.3

12

C ion SOBP distal edge at IIlMAC.

Conclusion

This work presented various applications of a range of microdosimeters in the measurement of microdosimetric characteristics of a 290 MeV/u

12

C ion SOBP field at HIMAC,

Japan.
Microdosimetric measurements were performed inside a modular PMMA phantom, using
the Etched microdosimeter and Bridge V2 microdosimeter to characterise the beam along
its central axis. Microdosimetric spectra obtained with the Etched microdosimeter confirmed its flaws, revealing a dominating low energy component as seen in IBICC results
in chapter 3. While characteristic features of the SOBP

12

C ion beam such as the carbon

peak and fragment tail could be recognised through the microdosimetric spectra, the low
energy component dominated causing
recording a maximum

YDand RBE10 values to be vastly underestimated,

YDand RBE 10values of just 68 keV/ µm 1.7 5, respectively. In con-

trast, results of the Bridge V2 microdosimeter were much more impressive, measuring a
maximum

YDvalue of 157 keV/µm at the SOBP edge which corresponds

to an RBE10

of 2.53. Both the shape and magnitude of the RBE10 distribution agreed well with goldstandard TEPC measurements performed previously. These results validated the design
and fabrication of the Bridge V2 microdosimeter, especially its 3D-like electrode configuration and the removal of surrounding silicon, providing high CCE and a reduction of
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low energy artefacts.
With the development of improved spectroscopic electronics, a remote and automated
motion control stage and waterproof hardware, measurements with the same beam were
performed with various microdosimeters in a water phantom. The Bridge microdosimeter performed well as expected, yielding similar results to those obtained in the PMMA
phantom. The maximum

YDvalues obtained were 159 keV/µm. Through the use of the

water phantom, downstream

YDand RBE10 values decreased as expected, as opposed to

when the PMMA phantom was used. The U3DThin device response showed an enhanced

YDresponse, likely due to its slab-like geometry, allowing for obliquely incident 12C ions
to deposit energy over a much greater distance than its nominal 10 µm cord length. The
effect of this resulted in the detection of the carbon edge at multiple depths at the end
of the SOBP, not seen by other microdosimeters. The maximum

YDand derived RBE10

value measured was 224 keV/µm and 2.69, respectively. The first deployment of two
Mushroom microdosimeter variants resulted in extremely similar results with maximum

YDvalues between ~170 - 180 keV/µm. However, maximumRBE10 values differed with
the 18 µm poly-trench device producing a value of ~2.69 and the 30 µm air-trench device
a value of ~2.50. It was concluded that this difference is due to difference in YFvalues
obtained as a result of enhanced low energy charge collection in the air-trench device, as
well as positional uncertainty of the microdosimeter in this rapidly changing part of the
beam. All RBE 10 values agreed well with results obtained using a TEPC.
By measuring the physical dose along the central axis of the field, estimated radiobiological depth profiles were calculated with the RBE10 values derived from the microdosimetric spectra obtained using the Bridge microdosimeter and U3DThin detector. These
distributions resembled the familiar SOBP profile, however with a decline in dose near the
end of the SOBP, followed by a sharp rise. Generally, the obtained distributions agreed
well with those obtained with the TEPC, as well as those obtained in HSG cell experiments. The increase of biological dose at the end of the SOBP was not seen in TEPC or
cell measurements, likely due to very high resolution measurements possible through the
use of the movable phantom and thin silicon detectors.
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Lateral measurements across the field to out-of-field locations at entrance depths and at
the end of the SOBP revealed large differences in obtained microdosimetric spectra. Dose
equivalents between at 2 mm past the distal edge were measured to be 137 mSv/Gy which
decreased to 13 mSv/Gy at a depth of 250 mm. At these depths, the spectra measured was
created from straggling

12

C ions and heavier fragments, with contributions from frag-

ments and neutron interactions dominating at deeper locations.
The diverse range of measurements performed show the versatility of these silicon microdosimeters, and their potential for use in quality assurance in heavy particle therapy.
Measurements of

Yn and derived RBE10 provide much more information relevant to cell

damage as opposed to physical dose measured with an ionisation chamber which is the
clinical standard. High resolution acquisitions at the SOBP edge showed the true potential and advantage of SOI microdosimeters over the larger, commercial TEPCs which
have volume-averaging, considered to be the gold standard microdosimeter.

Chapter 8
Microdosimetric Effects of Motion in
12

C Ion Beams

While the stationary measurements previously acquired showed some great potential for
using silicon microdosimeters for characterising heavy ion beams, the static conditions
under which they were performed are not representative of what actually occurs during
treatment. This chapter describes investigations performed using the Bridge and Mushroom Microdosimeters in passive and active scanning 290 MeV/u

12

C ion fields, where

the microdosimeter position is varied during the measurement. The aim of these measurements was to replicate the motion that a hypothetical organ would make during a heavy
ion therapy treatment and observe its effect on microdosimetric spectra and derived quantities.
Parts of the work described in this chapter have been published [125], with data collection
performed in collaboration with Dr. Linh Tran (CMRP, UOW).

8.1 Introduction
A factor that can affect the dose delivered to the treatment volumes and out-of-field
organs-at-risk is organ motion. This is true for all radiotherapy modalities, however it
is especially important in particle therapy in which increased RBE occurs in the Bragg
peak due to bulk energy deposition of high LET particles. Furthermore, due to the PBS
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delivery systems having to swap energy layers, there is time in between the delivery of energies of different ranges, making this delivery method is more sensitive to motion effects
[126].

One method of motion management, typical to particle therapy, is to use the superposition
of the clinical volumes in all motion phases to construct an internal target volume (ITV).
The ITV is then used to help generate a treatment plan delivering dose to the target,
irrespective of its motion phase. This ensures that tumour volume is covered, however it
does not take into account the difference in range and LET of the particles incident on the
volume. Methods have been proposed to incorporate these changes including the use of
phase-divided clinical treatment volumes, which provided more conformal plans which
are suitable for intensity modulated proton therapy [127, 128]. Organ tracking using
fiducial markers combined with phase gating, as is seen in conventional radiotherapy, can
also be used to on deliver the beam during specific motion phases [129]. Motion during
a single fraction is also an issue due to the interplay effect, which is often remedied in
active delivery systems using rescanning. This involves delivering fractions of the dose
at different phases and under different conditions, leading to an averaging effect on the
overall dose delivered. The respiratory trace can be used to monitor the phase at which
multiple fractions are delivered and ensure that they are delivered in a pseudo-random
manner [130].
While there a number of motion management strategies, the effect that organ motion has
on particle spectra and the RBE needs further investigation. Theoretical calculations and
cell studies have been undertaken to investigate motion in particle therapy [131, 132].
These methods involve obtaining 4D CTs to record and bin the organ motion into discrete
respiratory phases using deformable image registration algorithms. For each phase, planning is performed and dose algorithms applied with respect to a reference phase, normally
at exhale (50%). In treatment, motion is measured and the phase determined, such that
the appropriate treatment plan was delivered. Simulations with motion unsurprisingly revealed sub-volumes in the target volume were both underdosed by as much as 18% and
overdosed by 9%, which is prohibitive in treatment. Conventional consequences of un-
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derdosing the target include a lack of local disease control and treatment efficacy, where
an increase in dose can lead to an increase of normal tissue complication probability and
worsening severity of any toxicity. However, cell experiments concluded that the overall
effect was an underdose of just 1.7%, which is comparable to maximum allowable limits
in routine QA.
Respiratory motion is prevalent in radiotherapy delivery and can cause decreased treatment efficacy as it not only affects the ability to accurately deliver the treatment beam to a
target volume in the lung, but also causes the movement and deformation of surrounding
organs [129]. Motion amplitudes of up to 20 mm have been observed for the pancreas
[133] and up to 17 mm for liver [134], with this motion being determined by patient specific anatomy and physiology. Studies have shown that for the majority of lung tumours,
the maximum amplitude was less than 13.4 mm and was characterised as sinusoidal [135].
The results of which could cause large errors in delivered dose to the tumor and critical
organs, especially if close to the Bragg peak.
Motion effects are most detrimental when there is a large density difference between the
tissue that is planned to receive dose and the tissue that actually receives the dose. The
result of this tissue interchange is that the path length of the ion is changed and hence the
location of its Bragg peak is not the planned location. The overall result is a dose distribution that no longer conforms to the planned target volume and hence, can negatively
impact tumour control and induce effects in healthy tissue. Naturally, this makes lung
treatments very susceptible to motion effects due to their heterogeneous surroundings and
the large magnitude of movement.
Organ motion has not previously been investigated in terms of the effects of the lineal
energy spectrum and other quantities derived from microdosimetry. This section presents
work undertaken at the Heavy Ion Medical Accelerator in Chiba (HIMAC), Japan and
Gunma University Heavy Ion Medical Center (GHMC), Japan to investigate the effect that
motion has on microdosimetric spectra and RBE 10 using passive beam and PBS delivery,
respectively.
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8.2 Motion Effects in Passive Delivery at IDMAC
8.2.1 Materials and Methods
Experiments were performed at the Heavy Ion Medical Accelerator in Chiba, NIRS,
Japan, utilising a passively scattered

12C

ion beam to irradiate a Bridge microdosime-

ter. The microdosimeter was mounted on the Microplus probe PCB, which in preliminary
testing prior to the experiment, proved to have excellent microphonic properties, allowing
high measurement quality independent of motion. A 10 x 10 cm 2 field with a 6 cm SOBP
and maximum energy of 290 Me V /u was created with a ridge filter. The absorbed dose
was measured using a PTW pinpoint ionisation chamber and is shown in figure 8.1.
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Figure 8.1: Normalised depth-dose profile for the 290 MeV/u SOBP beam at IDMAC.

The effect of lung motion on a hypothetical critical organ, which was considered to be
positioned just distal of the SOBP, was investigated. Using the movable water phantom
described in section 6.3, the microdosimeter was placed at the distal edge of the SOBP
along the central axis of the beam (148 mm depth), and a lineal energy spectrum was
acquired while the microdosimeter was stationary. A continuous lung motion movement
trace was then applied to the microdosimeter and a spectrum was acquired. The breathing
trace consisted of motion in a single plane, 7 mm upstream and 1 mm downstream from
the SOBP distal edge, obtained from a clinical 4D-CT data set (as described in [136]).
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The aim of measuring both scenarios was to determine what microdosimetric changes
happen in reality when an organ moves, changing the particle spectra that is incident
upon it.
Further testing evaluated motion with the dosimeter centred about a depth of 134 mm,
with a 30 mm linear motion profile applied, moving the microdosimeter between depths of
119 mm and 149 mm. This set of measurements emulated the microdosimetric changes to
the target volume itself undergoing motion. Acquisitions were performed when stationary
at 134 mm depth and while performing the described motion, as done previously.
Changes to microdosimetric quantities within a spherical treatment volume when introducing motion were also investigated. A laterally changing particle field was produced
using a spherical polyethylene bolus, placed in front of the water phantom, centred along
the central axis of the beam. The microdosimeter was positioned at various off-axis locations in the water tank, labelled A and B in figure 8.2b, corresponding to depths of 92
mm and 122 mm, respectively. A linear motion profile was applied at each depth, moving
the microdosimeter between points 20 mm to 40 mm off-axis, towards the edge of the
bolus.
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Figure 8.2: Schematics describing the microdosimeter motion during irradiation with a
290 Me V/u SOBP beam at HIMAC

For all motion configurations, microdosimetric spectra were obtained while stationary and
while undergoing motion. The motion profiles used for all motion types can be seen in
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figure 8.2a. Using the spectra, the dose-mean lineal energy Ynwas determined, as well as
the RBE10, derived using the MKM model (see section 1.1.4).

8.2.2 Results and Findings
Figure 8.3 shows a comparison of the microdosimetric spectra when undergoing lung
motion and when stationary. A significant difference was observed between the stationary
spectra at 148 mm (1 mm downstream of the distal edge) and when undergoing lung
motion between 141 mm and 149 mm. When the microdosimeter moves upstream, it
enters the highest LET region of the field, with large amounts of energy deposited by 12C
ions near the end of their range. Due to the 8 mm motion,

12C

ions of lower energies that

reach their range are also incident on the microdosimeter, resulting in a dominating wide
peak in the microdosimetric spectra, centred at ~70 keV/µm.
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Figure 8.3: Microdosimetric spectra obtained at the distal edge with the Bridge Microdosimeter stationary and when undertaking lung motion along the central axis of a 290
MeV/u SOBPbeam atlilMAC.

In the stationary case, the microdosimetric spectra is comprised of lower lineal energy
events from neutron interactions and fragments, as the

12C

ions have primarily stopped

1-2 mm upstream. From this observable change in field quality, for a hypothetical organat-risk just downstream of the treatment volume (SOBP), there would be significantly
more dose delivered to the non-target volume in a clinical scenario. Not only would dose
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Table 8.1: Ynand RBE10 values for all stationary and motion configurations using a 290
MeV/u SOBP beam at HIMAC.

Configuration

Yn (keV/µm)

RBE10

Lung Motion (depth)
Stationary

± 9.57
± 5.11
61.41 ± 3.30
68.89 ± 4.79
48.30 ± 2.46
44.22 ± 2.32
84.34 ± 6.90
74.23 ± 4.60

2.24 ± 0.30
1.41 ± 0.12

Linear Motion (depth)
Stationary
Linear Motion A (lateral)
Stationary
Linear Motion B (lateral)
Stationary

96.98
31.98

1.90 ± 0.22
1.94 ± 0.23
1.70 ± 0.18
1.64 ± 0.16
2.03
2.00

± 0.25
± 0.25

be considerably higher in this case, but the biological effect would be enhanced due to the
high LET of particles incident on it when entering the field. The Yn and RBE10 values
were calculated using each of the spectra, seen in table 8 .1. The motion is seen to increase
the Yn value by a factor of ~3 and RBE10 value by a factor of ~1.6. The less dramatic
increase in RBE is due to the overkilling effect of events above 150 keV/µm, which the
MKM model takes into account. These results show the significant and potentially damaging effects of motion if not taking into account in the CTV or by using other methods
discussed previously.
Figure 8.4 shows the rnicrodosimetric spectra obtained at 134 mm depth and when undergoing longitudinal motion with a total magnitude of 30 mm. Due to this location being at
a depth approximately 2/3 into the SOBP, the effect of motion is less dramatic. In contrast with the lung motion, the spectra obtained when undergoing motion actually contains
more lower lineal energy events. As the physical dose is weighted higher at the shallower
depths (figure 8.1) as dictated by the ridge filter design, there is a greater number oflower
LET

12C

ions. This can be seen in the decrease in Yn from 68.9 keV/µm when in motion

to 61.4 keV/µm when stationary, corresponding to a very slight RBE decrease from 1.94
to 1.90 (table 8.1). Despite this exaggerated, high amplitude motion, an organ moving in
this manner would have experienced a slightly degraded biological effect, which suggests
that sensitivity to motion along the central axis of the beam is low for sub-volumes well
within the target volume.
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Figure 8.4: Microdosimetric spectra obtained within the SOBP with the Bridge Microdosimeter stationary and when undertaking linear motion along the central axis of a 290
MeV/u SOBPbeam atlllMAC.
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Figure 8.5 shows the microdosimetric spectra when the microdosimeter is stationary and
when undergoing lateral motion at points A and B. Corresponding

YDand RBE10 values

are shown in table 8.1. At both points, the YDvalues acquired during motion were greater
than the corresponding stationary measurements, showing a relative increase of 9 .2 % at
point A and 13.6% at point B. When undergoing motion, the spectra in both cases shifts
towards higher lineal energies due to the contribution of high LET

12C

ions stopping at the

end of their range, towards the edge of the treatment volume, created due to the spherical
bolus. An increase in low lineal energy events was also observed when in motion from
point B, due to a higher contribution of fragments and neutrons produced from particle
interactions further upstream.

8.3 Motion Effects in Active Delivery at GHMC
8.3.1

The Gunma University Heavy Ion Medical Center Facility

The Gunma University Heavy Ion Medical Center (GHMC) was built in 2010 and is
located Gunma, Japan, oferring treatment from 2016. It was designed initially for prostate
patients and has treated a total of ~4000 [137]. The centre has 3 treatment rooms, each
containing a passive delivery system which, in essence is the same technology used in the
HIMAC bio-cave, although many parameters differ slightly e.g. distances between beam
forming components such as ridge filter, range shifter, etc.
The only ion species GHMC uses for treatment and research is

12C

. It generates the ions

using a compact electron-cyclotron resonance ion source which is injected into a radiofrequency quadrupole linac to boost to 600 keV/u, then to a compact alternating phase
focussing linac accelerates the ions to 4 Me V/u. These ions are injected into the main
63.3 m diameter synchrotron, and are able to be accelerated up to a maximum energy of
400 MeV/u, with a maximum dose rate of 5 GyE/min [138]. There also exists a vertical
beam port which is used for the research and development of active delivery pencil-beam
scanning (PBS) carbon therapy. This beam port with research water phantom is shown in
figure 8.6.
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Figure 8.6: Photograph of the vertical beam port room with adjustable water phantom
used for research and active delivery development at GHMC.

8.3.2 Materials and Methods
Further investigation into the effect of motion was also performed at GHMC. however
with a actively delivered scanning

12

C beam. This marked the first use of solid state

microdosimeters in an active delivery carbon therapy facility. A single 290 MeV/u layer
was used with a ripple filter. used to smear energy layers together. The depth-dose profile
obtained with a PTW thin-window. Advanced Markus chamber can be seen in figure 8.7.
showing a relatively wide Bragg peak due to the ripple filter. A 10 x 10 cm 2 field was
delivered at a dose rate of~ 1 Gy/s.
In order to avoid pileup. a single sensitive volume variant of the mushroom microdosimeter was used to record the lineal energy spectra. See section section 1.3.3 for a description
of this technology and figure 5.7 for an SEM image of the single SV. Microdosimetric
spectra were obtained at depths of 110.9 mm.120.9 mm and 130.9 mm when undertaking
motion and when stationary. Unfortunately locations at the distal edge were not obtained
due to experimental time limitations.
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Figure 8.7: Normalised depth-dose profile for the 290 MeV/u SOBP PBS field at
GHMC.

While previous experiments used the phantom described in section 6.3, the scanning beam
port at GHMC is vertical in nature, preventing the use of this phantom and other more conventional phantoms used in radiotherapy. As such, varying the microdosimeters effective
depth was achieved by remotely adjusting the water level of a phantom which was located
above the microdosimeter and below the vertical beam port, seen in figure 8.8a.
The microdosimeter was housed in a small PMMA casing and attached to a Thor Labs
motion stage, allowing the microdosimeter to be moved laterally, shown in figure 8.8b.
The beam delivery system's research-mode was required to use the vertical water phantom and to adjust other settings necessary for the experiment. As a result, a patient plan
(which is delivered using multiple energy layers) could not be expressly delivered, and
only a 290 MeV/u

12C

ion energy was used. A modulated, clinical field was simulated

using a patient specific polyethylene bolus (figure 8.9a), such that the field changed as
the microdosimeter was moved laterally. Due to limitations on the speed and number
of motion profiles that could be used with the Thor Labs motion stage, the lung motion
profile seen in figure 8.2a was approximated in the lateral direction with two linear motions, shown in figure 8 .9b. The stationary location of the microdosimeter with respect
to the motion profile was at O mm displacement, corresponding to a bolus thickness of
16.6 mm, shown in figure 8.9b. As such, the effective depth both increased and decreased
when in motion, dictated by the bolus thickness (13 - 21 mm) along the microdosimeters
trajectory.
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(b) Microdosimeter attached to lateral motion stage

Figure 8.8: Images of the phantom/beam port and microdosimeter used at GHMC.
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Figure 8.9: Render of the patient-specific bolus used to vary the ion range and motion
profile used at GHMC

8.3.3 Results and Findings
It was realised that as the phase of the motion and the scanning were not synchronised, the
effect of motion in a scanning delivery could not necessarily be quantified as reliably as
in section 8.2.2. However, examples of motion effects were investigated using a scanning
field which has a scanning speed much greater than the speed of target motion. Figure
8.10 shows the microdosimetric spectra obtained when stationary and when undergoing
lateral motion at a depth of 110.9 mm. The spectra is characterised by a narrow peak
produced from carbon ions crossing the microdosimeter thickness and a lower energy tail
from neutrons and fragments. As seen from table 8.1, both the

Yn and RBE10 values

varied only slightly between the stationary and moving acquisitions. The main difference
between the two measurements is that when undergoing motion, there were a greater

CHAPTER 8. INVESTIGATING MOTION IN HIGH ENERGY

12

C ION BEAMS 163

number of high LET events and primary crossers as seen by the taller primary peak and
small higher energy shoulder at ~40 keV/ µm. This may be due to the microdosimeters
movement into a location where the bolus thickness was greater, and where incident ions
have can deposit greater energy deposition within the microdosimeter due to increased
stopping power. As a result, there was a greater proportion of lower lineal energy events
when stationary.
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Figure 8.10: Microdosimetric spectra obtained at a depth of 110.9 mm with the Single
SV Mushroom Microdosimeter stationary and when undergoing motion for a 290 Me V/u
PBS beam at GHMC.

Table8.2: YDand RBE10 values for all stationary and motion configurations using a 290
MeV/u PBS beam at GHMC.

Configuration

Yn (keV/µm)

RBE10

Motion (110.9 mm)
Stationary

21.13 ± 0.43
19.96 ± 1.15

1.30 ± 0.09
1.26 ± 0.08

± 3.37
± 6.63
31.48 ± 3.47
34.13 ± 3.54

1.30 ± 0.09
1.34 ± 0.10

Motion (121 mm)
Stationary
Motion (131 mm)
Stationary

28.35
40.16

1.39 ± 0.11
1.37 ± 0.10

Figure 8.11 shows the microdosimetric spectra obtained when stationary and when undergoing motion at a depth of 120.9 mm. The shape of the spectra is similar to that
at 110.9 mm, however with an enhanced lower energy component from neutrons and
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YDvalue when stationary was ~40 keV/µm

and decreased to ~28 keV/µm when undergoing motion, showing extremely different
results. This difference is a combination of the effects of motion, but mostly due to increased random high LET events above 1000 ke V/ µm were detected when stationary,
which dramatically changes the amplitude of lower lineal energy features in the microdosimetric spectra. The effect on RBE 10 is less dramatic due to the MKM taking into
account overkilling above 150 keV/ µm. Despite this large difference, effects of motion is
normally managed with fast rescans and is in effect averaged over the many energy layers
used for the plan.
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Figure 8.11: Microdosimetric spectra obtained at a depth of 120.9 mm with the Single
SV Mushroom Microdosimeter stationary and when undergoing motion for a 290 MeV/u
PBS beam at GHMC.

Figure 8.12 shows the microdosimetric spectra obtained when stationary and when undergoing motion at a depth of 130.9 mm. The difference between the two spectra is small
and mainly differs due to variation in higher lineal energy events. Both

YDand RBE10

values agreed within error.
The low energy component in all of the spectra presented is greater than expected for
an actively delivered beam when compared to results in previous chapters in which the
beam was passively delivered. Due to the scanning nature of ion delivery, the small
microdosimeter is not being irradiated by the beam for most of the acquisition; only for
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Figure 8.12: Microdosimetric spectra obtained at a depth of 130.9 mm with the Single
SV Mushroom Microdosimeter stationary and when undergoing motion for a 290 MeV/u
PBS beam at GHMC.

fractions of a second is the pencil beam incident on the microdosimeter. As a result,
the field incident on the microdosimeter for most of the acquisition is effectively out-offield. Hence, the measured spectra contain relatively higher contributions from low lineal
energy events produced from neutron interactions and fragments within the phantom,
resulting in lower

Yn and RBE 10 values compared

to passively delivered beams.

8.4 Conclusion
This work presented the first investigation into the microdosimetric effects of motion in
12

C ion therapy, in both passive and active delivery modalities. These results show the

importance of accounting for motion when planning for and delivery treatments, and provides insight into the microdosimetric impact of these effects through the microdosimetric
spectra obtained.
Using a passively delivered 290 MeV/u

12

C SOBP beam at HIMAC, significant increases

in Ynand RBE10 values were observed when the microdosimeter mimicked a lung motion
trace, moving into the field. This showed how unaccounted motion could vastly affect the
beam quality in a real cancer treatment for an OAR. Acquisitions at shallower depths with
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linear motion along the central axis actually showed a decrease in YDand RBE10 values
due to the time spent at shallower locations where particle flux is greater but

12C

ion en-

ergy is higher. Lateral linear motion profiles were also applied to the microdosimeter at
various depths with a bolus used create a laterally changing field. In both of the configurations, motion toward the field edge increased

YDby ~9-13% and RBE10 values by just

~1.5-4%.
Using a high dose rate PBS-delivered 290 MeV/u

12C

beam at GHMC, the effects of mo-

tion were much less obvious. However, differences in

YDand RBE10 were less varied

between stationary and moving acquisitions due to the fast scanning speed. Furthermore,
in all acquisitions, an enhanced low energy response was observed due to the microdosimeter effectively being out-of-field for most of the acquisition. Due to the scanning
nature of PBS delivery, more development is required to synchronise motion and beam
scanning to produce more meaningful and reproducible results.
Obtained results show that this device is suitable for investigating interplay effects by
mimicking organ motion due to its lightweight construction and the stable microphonic
properties of the MicroPlus probe front-end. The high spatial resolution of the SOI microdosimeters has also been shown to be important for understanding the interplay effect,
especially close to treatment volume borders. These results show that the effects of motion in a measurement can be detected using a solid state microdosimeter, and can result
in both increases and decreases to microdosimetric quantities depending on the nature of
the movement with respect to the beam.

Chapter 9
Microdosimetric Applications in
Mono-Energetic

12

C Ion Beams

This chapter presents the results of experiments performed using mono-energetic

12

C

ions of different energies, delivered using a variety of delivery techniques. These include
microdosimetric measurements at HIMAC using a passively-delivered mono-energetic
290 MeV/u
MeV/u

12C

12C

beam, and at GHMC using an actively-delivered mono-energetic 290

beam. In addition, microdosimetric measurements were performed at the

Australian National University Heavy Ion Accelerator Facility (Canberra, Australia) using
low energy 70 MeV

12C

ions, which have a much shorter range and significantly less

straggling compared to 290 MeV/u

12C

beams.

Parts of the work described in this chapter have been published in multiple journal articles
[98, 115], with data collection performed in collaboration with Dr. Linh Tran (CMRP,
UOW).

9.1

Microdosimetric Measurements in a 70 MeV

12

C Ion

Beam
9.1.1

The ANU Heavy Ion Accelerator Facility

The Heavy Ion Accelerator Facility (HlAF) has been operating since 1973 and is maintained on the Australian National University campus in Canberra, Australia. It houses a
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superconducting booster linac and a 14UD pelletron accelerator [139]. The research undertaken at this facility generally falls under nuclear and particle physics, as well as mass
spectrometry and accelerator research. Thie 14 UD pelletron accelerator is vertically oriented and nonnally operates above 15.5 MV, able to deliver many ion species to over 9
beam lines. For studies related to carbon therapy, it can produce

12

C ions with energy

exceeding 70 Me V. An schematic of the facility is shown in figure 9 .1.
ANU HEAVY ION
ACCELERATOR
FACILITY

SUPERCONDUCTING

LINEAR ACCELERATOR
90ACHAOMAT

Figure 9.1: Schematic of the ANU Heavy Ion Accelerator Facility (taken from [140])

9.1.2 Materials and Methods
Microdosimetric acquisitions were performed using 70 MeV/u

12

C ions, generated using

the HIAF at ANU. Due to the extremely low ion energy, the whole beam line and sample
chamber was under vacuum. As a result, every time the experiment setup needed to be
modified (e.g. detector change, physical verification of setup), the chamber had to be depressurised and then the air pumped out to resume the experiment. The sample chamber
is shown in figure 9 .2.
The Bridge V2 microdosimeter was selected to detect the low energy
der to shift the microdosimeter along the

12

12

C ions. In or-

C ion Bragg peak, different thicknesses of
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Figure 9.2: Image of the sample chamber and beam line at the ANU Heavy Ion Accelerator Facility

low-density polyethylene (LDPE) were used. Given that the range of these carbon ions
is rv 180 µm, using phantoms that are common in particle therapy treatment and research
was not plausible. However, the chamber featured a remotely controlled vertical stage,
upon which a "ladder" type fixture was be attached. Different thicknesses of LDPE film
were placed between the rungs of the ladder, enabling the effective depth of the microdosimeter to be varied, simply by varying the vertical position of ladder. High precision
thickness LDPE film was used, with thickness measured using a micrometer with an uncertainty of ±2 µm.
As microdosimetry is spectroscopic in nature, the microdosimeter could not be irradiated
directly due to the prohibitively high flux of the accelerator. This would have resulted
in significant pileup effects, and most likely device damage, inhibiting meaningful data
acquisition. Calculations were performed by HIAF physicists and it was determined that
by passing the beam through a 1 mg/cm 2 gold foil, an acceptable reduced flux would exist
at the microdosimeter if it were placed at an angle of 20 degrees, due to elastic scattering.
Given the very small size of the microdosimeter die, the spread in both incidence angle
and energy was determined to be acceptable. This setup can be seen in figure 9 .3a.
A detector bracket was designed and fabricated to hold the microdosimeter at the same
height as the beam line port. A Cremat preamplifing and shaping circuit was placed the
backside of the detector bracket, minimising the chance of damage from the harsh radi-
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ation environment within the chamber. Based on CAD drawings provided, a mechanical
stage was designed to be able to position and orientate the detector at the specified 20
degree angle, normally incident to the beam, with an acceptable flux. The mounted microdosimeter and LOPE ladder is shown in figure 9.3b.

(a)

(b)

Figure 9.3: Experimental setup showing sample chamber, LOPE ladder and microdosimeter setup at the ANU HIAF.

Lineal energy spectra were obtained for a period of 300 sat each depth, and microdosimetric spectra and associated quantities were calculated from these spectra. Calibration
was performed exactly as in chapter 2.

9.1.3

Results and Discussion

The microdosimetric spectra obtained using the Bridge microdosimeter is shown in figure
9 .4. Each spectrum in figure 9 .4a contains a low energy peak and a high energy peak. The
high energy peak is due to high LET

12C

ions crossing the microdosimeter volume. As

seen by the high energy shoulder, there are a small proportion of carbon ions that have
higher LET, most likely due to interactions with the experiment setup in the beams path
(e.g. traversing the edges of the aluminium LOPE ladder), as well as range straggling.
This peak shifts towards higher lineal energies and widens as the LOPE film thickness
increases. This is due to an increase in

12C ion

LET after losing increasingly more energy
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12

C ion peak decreased

in energy and widened, eventually disappearing after 200 µm as the

12

C ions stop. At

greater depths, the spectra are dominated by low energy electron events. While previous
IBICC results showed minimal erroneous low energy events occurring within the microdosimeter SVs, the low energy peak recorded in these spectra is likely due to electron
spray generated during the scattering process with the gold foil (as well as the chamber
and surrounding media). As can be seen from the microdosimetric spectra at 400 µm,
the main peak actually decreases in energy, indicating that higher LET particles were
stopped by an increase in LDPE, confirming the primary source of these particles was the
scattering foil.
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Figure 9A: Microdosimetric spectra obtained with the Bridge microdosimeter in a 70
Me V 12C beam through various thicknesses of LDPE at the ANU IIlAF. The yd (y) axis
scale was changed between graphs to improve visualisation.

The trends observed in the microdosimetric spectra can be seen in the Yn distribution,
shown in figure 9.5a. The Yn of the beam without any interaction with LDPE was 190
keV/µm and reached a maximum of 473 keV/µm at a depth of 165 µmin LDPE. At this
depth, the

12

C ions traversing the microdosimetric volume come to a stop very close to

the end of the 10 µm SV thickness, or very close to it. With an increase in LDPE thickness, the carbon peak in the spectra shifts towards lower lineal energies due to the

12C

ions coming to rest within a smaller fraction of the microdosimetric volume (stoppers),
resulting in less energy deposition. It can be seen that due to factors including a small
degree of obliquity and energy spread from the scattering process, as well as range strag-
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ions come to a stop over a distance of just ~20 µmin LDPE. After the

ions completely stop within the LDPE, the

YDvalues decrease to~

naturally much less than values seen in high energy

12C

12C

6 keV/µm. This is

experiments in chapter 7 due to

the very low ion energy, effectively resulting in a neutron and fragment-free beam.
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Figure 9.5: Yn and RBE10 distributions obtained with the Bridge microdosimeterin a 70
MeV 12C beam through various thicknesses ofLDPE at the ANU HIAF

The RBE10 distribution derived using the microdosimetric-kinetic model is shown in figure 9.5b. A maximum derived RBE10 value of 2.57 was observed without the presence of
any LDPE (entrance). This is approximately the same values obtained at the distal edge
of the 290 MeV/u SOBP field, seen in section 7.3.2.1. As the microdosimeter depth was
increased, the RBE 10 decreased down to 1.77 at 150 µmin LDPE. While the very high
LET particles produced an increase in YDwith depth, due to the overkilling effect in the
MKM of events above 150 keV/µm, they* value decreases which results in a decreased

RBE10 . At a depth of 185 µm, which is 20 µm past the depth where the greatest YDvalue
was recorded, the RBE10 reaches a local maximum of 2.32. The derived RBE10 value at
greater depths decreased to ~ 1.00 (i.e. same biological effect as 200 kV x-rays), which
is not surprising given that the

12C

ions have stopped and these spectra are comprised of

events due to electron interactions, not heavy charged particles.
These results show that the 70 MeV particles are present in any therapeutic

12C

ion beam

can deposit significant energy within critical structures over a distance of ~ 10-20 µm.
For the purposes of characterising or investigated phenomena in high LET fields, it is
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clear that the measurement device must have a physical sensitive volume comparable the
distance over which this energy is deposited, and thin over-layers compared to the ion
range. As a result, thin microdosimeters have a large advantage over larger detectors and
conventional TEPCs, due to wall perturbation (including other wall effects discussed in
section section 1.2.1.2) and volume-averaging.
While investigation at these depths is not necessary to validate current methods of accounting for patient setup, motion and the other sources of positional uncertainty, it highlights the potential of these very low energy, high LET particles to damage healthy tissue. A comparison between the microdosimetric spectra obtained with the Bridge microdosimeter in the middle of a 290 MeV/u

12C

ion SOBP beam and at 170 µmis shown

in figure 9.6. This figure shows the vast difference between the particles which deposit
energy within the middle of a treatment volume and only those at the end.
Microdosimetric spectra produced by 290 MeV/u
events from primary

12C

12C

ions are comprised of not only

ions, but also by fragments, neutrons and electrons. This makes

it impossible to measure the RBE associated with

12C

ions alone, especially at the end of

their range where secondary contributions are highest (e.g. at the edge of a 290 MeV/u
SOBP). This emphasises the uniqueness of these results, showing successful application
of SOI microdosimeters for studying radiobiological effects of low energy

12

C ion beams

with minimal straggling.

9.2

Microdosimetric Measurements in Mono-energetic 290
Me V/u

12

C ion beams

Microdosimetric measurements were performed using a mono-energetic 290 MeV/u

12C

beam in two facilities using different beam delivery technologies; passive scattering and
pencil beam scanning. The aim of this study was to investigate the difference in beam
characteristics through the lens of microdosimetry.
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Figure 9.6: Microdosimetric spectra obtained with the Bridge microdosimeter at a depth
of 170 µmin LOPE using a 70 MeV 12C beam and in the middle of a 290 Me V/u SOBP
field.

9.2.1 Materials and Methods
At HIMAC, a 30 µm poly-trench Mushroom microdosimeter was used to investigate a
passively scattered 10 x 10 cm 2 mono-energetic 290 MeV/u
was generated exactly the same way that 290 MeV/u

12C

12

C ion field. This field

SOBP fields are generated,

however with the aluminium ridge filter removed. Measurements were performed using
the experimental setup described in section 7.3 .1.
The Mushroom microdosimeter was also irradiated at GHMC, however with a with a
290 MeV/u 12C pencil beam with a 3.3 mm a and intensity of 106 particles/spill. An
aluminium ripple filter, which is commonly used at this facility, was used to spread the
range of the ions, which is used to effectively smearing energy layers together when
multiple layers are used. An adjustable water column was used to adjust the effective
depth of the microdosimeter by up to 0.1 mm increments, shown in figure 8.8a. The
MicroPlus probe sheath was inserted into a PMMA block and placed directly under the
water phantom in order to minimise the air-gap in between. In addition, the physical dose
of the beam was measured using a parallel plate ionisation chamber, commonly used at
this facility for QA. The uncertainty in microdosimeter and chamber position was much
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less in this experiment due to the accuracy in which the phantom water level could be
changed.
In both cases, the lineal energy spectra was used to calculate microdosimetric quantities
and derived RBE10 using the microdosimetric-kinetic model along the central axis of each
beam.

9.2.1.1

Results and Discussion

290 MeV/u

12

C Pencil Beam at GHMC

The physical dose profile along the central axis of the beam was obtained using a parallel
plate ionisation chamber, shown in figure 9.7. This data was obtained by varying the
amount of water above the chamber, which was housed in a small PMMA block. A
maximum physical dose occurred at a depth of 155.2 mm in water. The width of the
Bragg peak is relatively broad due to the beam passing through the ripple filter.
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Figure 9.7: Normalised depth-dose profile for the 290 MeV/u prisitne beam with ripple
filter at GHMC.

Figure 9.8 shows microdosimetric spectra obtained as a function of depth. Figure 9.8a
clearly shows the progression of the

12C

crosser peak shift from low lineal energy of~ 10

keV/µm at 34.9 mm up to approximately ~35 keV/µm at a depth of 145 mm. As seen
from the depth-dose profile in figure 9.7, the dose increases as the start of the Bragg peak
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occurs after this point. Figure 9.8b shows the spectra within the Bragg peak. As the

12

C

ion LET increases with depth, the cross peak is continually seen to shift to deposit greater
lineal energy within the microdosimeter. The effect of the ripple filter is observable from
these spectra, as high LET

12

C ions deposit large lineal energies over a relatively large

range between 154 mm up to a depth of 158.4 mm. The
evidence of

12

12C

bump at ~600 keV/µm is

C ions reaching their range and stopping within the microdosimeter sen-

sitive volume. After the distal edge, as seen in figure 9 .Sc, a large wide peak is seen at
160.4 mm, created due to fragments generated upstream. This peak is persistent even up
to 185 mm(~

30 mm downstream of the distal edge), however with increasing lower

lineal energy components from neutron interactions.
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Figure 9.8: Microdosimetric spectra from the Mushroom microdosimeter in a 290
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improve visualisation.

The corresponding Yn distribution is shown in figure 9 .9. Entrance values of~ 13 ke V/ µm
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were observed, after increasing to ~37 keV/µmjust before the Bragg peak, and reaching
a maximum of ~ 141 keV/ µm at ~ 157 .5 mm. Due to the ripple filter, this approximate

YD

value was recorded at 3 depths, between 157 mm and 158.4 mm. This is not surprising
given the extremely similar microdosimetric spectra. Again, this is due to the effect of the
ripple filter. These median of these 3 measurements was recorded at a distance of ~ 2.4
mm beyond the maximum physical dose recorded.
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Figure 9.9: YDdistribution obtained using the Mushroom microdosimeter in a pristine
290 MeV/u 12C ion at GHMC

The corresponding RBE 10 distribution is shown in figure 9.10. The derived RBE 10 at
entrance was ~1.12, increasing to ~1.61 at the start of the Bragg peak, reaching a maximum of ~2.37 at 156 mm. The spread of RBE10 values at the filtered Bragg peak is much
less than seen in YDdistribution due to the overkilling effect. In contrast with the maximum

YD, the maximum

RBE10 value was recorded just ~0.8 mm beyond the maximum

physical dose. This shows a highly desirable and advantageous characteristic of

12

C ions

such that the maximum RBE value occurs extremely close to where maximum physical
dose is deposited; the relative position of the maximum RBE compared to the Bragg peak
decreases in depth with increasing atomic number of an ion[141].

290 MeV/u

12

C Field (Passive Scattering) atlDMAC

The microdosimetric spectra obtained in the passively scattered mono-energetic 290 Me V/u
12C

ion field at HIMAC is shown in figure 9 .11. As expected, at entrance and shallower

depths the spectra is primarily comprised of the

12

C ion crosser peak ~12 keV/µm, shift-
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Figure 9.10: RBE 10 distribution obtained using the Mushroom microdosimeter in a pristine 290 MeV/u 12 C ion pencil beam at GHMC.

ing towards higher lineal energies as ion LET increases with depth. At a depth of 150 mm,
the spectra is dominated by a wide plateau-like structure between ~200 - 800 keV/µm,
due to high LET

12C

ions reaching their range or nearing it; a small peak can be seen

at the highest lineal energy where the ions have stopped within the detector. Most

12C

ions were seen to stop within a distance of 2 mm between 149 mm and 151 mm. Beyond
this, the spectra consists of a small number of higher lineal energy events from

12

C ions,

but is primarily made from boron and beryllium fragments which made up the wide ~25
keV/µm peak, with helium and protons from neutron interactions producing the lower
lineal energy shoulder [124].
The corresponding

YDdistribution is shown in figure 9.12. Note that the effective range

of the passively scattered beam is shorter due to the beam modifying devices such as
the 0.8 mm tantalum scatter used in the process of producing the 10 x 10 cm 2 field.
Unfortunately, the dose profile was not measured in this field.
were

YDvalues the entrance

~12 keV/ µm, increasing to ~30 keV/ µm just before the Bragg peak, then reaching

a maximum of ~291 keV/µm. This is considerable higher than any other high energy
beam measured in this thesis. As seen from the spectra, the lower lineal energy component
is extremely small in comparison with the SOBP delivery, which is partly due to having
minimal beam modifying devices that the ions interact. In addition, as the beam is monoenergetic, there is less variance in the distribution of ion ranges, resulting in a decreased
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Figure 9.11: Microdosimetric spectra from the Mushroom microdosimeter in a 290
Me V/u 12C pristine beam at HIMAC. The yd (y) axis scale was changed between graphs
to improve visualisation.

The derived RBE10 distribution for HSG tumour cells is shown in figure 9 .12b and expectedly shows a similar distribution as YD. The derived RBE10 value at entrance was ~1.13,
increasing to ~ 1.48 just before the Bragg peak at 130 mm, then reaching a maximum of
~2.95 at the Bragg peak. This maxima occurs 1 mm before the maximum

YDvalue

due

to the overkilling effect at high lineal energies.
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Figure 9.12: YDand derived RBE10 distributions obtained using the Mushroom microdosimeter in a mono-energetic 290 Me V/u 12C beam at IIlMAC.
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Comparison of 290 Me V/u Beams

The

YDvalues for each 290 MeV/u 12C ion beam is shown in figure 9.13, as well as for a

290 MeV/u

12

C ion SOBP field. Due to the differing ranges for each field, the depths of

each distribution has been aligned to their respective maximum
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Figure 9.13: YDdistributions obtained using the Mushroom microdosimeter in a monoenergetic 290 MeV/u 12C ion pencil beam, mono-energetic 290 MeV/u 12C ion field and
290 MeV/u 12C ion SOBP field. The depth of each dataset has been normalised to the
depth at which its maximum YDoccurs.

At the entrance, all beam types have approximately the same YDvalues as the LET of the
ions do not differ significantly at shallow depths. This can be seen in the very similar
spectra obtained with all beams in figure 9.14a. The YDof the SOBP was seen to increase
very slightly with depth, with a large increase at the start of the SOBP, where the lowest
energy

12

C ions come start to stop. As expected, the mono-energetic beams produce only

very slight increases in YDvalues up until approximately 80% of their range, after which
dramatic increases occur in the Bragg peak. The SOBP YDpeak is somewhat less defined,
however is wider than both of the 290 Me V/u fields due to the contribution of

12

C ions

which have stopped slightly upstream.
Compared to the passively delivered mono-energetic field, the pencil beam has significantly lower

YDin the peak partly due to the beam modification performed by the ripple

filter and due to the beam geometry. The ripple filter creates a broader

12C

ion spectrum

which is due to straggling only, ultimately reducing the measured maximum

YDvalue.

CHAPTER 9. MONO-ENERGETIC

12

C ION BEAM MEASUREMENTS

181

At almost all locations at the end of the Bragg peak, there exists a significant fraction of
lower lineal energy events from

12

C ions which comprise the microdosimetric spectra,

as exemplified in figure 9.14b. Without the ripple filter, the fractional contribution from
high LET

12

C ions close to the end of their range at the edge of the Bragg peak is higher,

resulting in a high
wide

YD. The effect of the ripple filter can also be seen by the relatively

YDpeak in comparison with the sharp YDpeak produced with the passively scattered

beam. In all cases, energy spread, scatter and range straggling contribute to the finite
width of the Bragg peak.
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Figure 9.14: Microdosimetric spectra at entrance obtained using the Mushroom microdosimeter in a mono-energetic 290 MeV/u 12C ion pencil beam, mono-energetic 290
MeV/u 12C ion field and 290 MeV/u 12C ion SOBP field.

Some interesting differences were also observed in the microdosimetric spectra produced
from neutron interactions and fragmentation, which can be seen in figure 9.14b. Regardless of the delivery technology, there is expected to fragments and neutrons produced
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within the phantom used in each experiment, however significantly more is expected in
beams which that use beam modifying devices. In each microdosimetric spectra, the proportion of events produced from neutron interactions and fragments differs significantly.
The fractional contribution in the microdosimetric spectra from heavier fragments such as
boron and beryllium between~

10 and ~70 keV/µm is quite different, and surprisingly

highest when using the pencil beam at GHMC, which may be explained by its geometry.
While the effect of Coulomb scattering on the trajectory of

12C

ions is much less than

for lighter ions, a higher fraction of the ions in the pencil beam which are near the end
of the their range will not be detected due to lateral disequilibrium, which does not occur in large passively scattered fields. At the same time, the partial fraction of fragments
and recoil protons from neutron interactions produced inside the phantom will not be reduced due to the much greater scattering potential of these particles. This results in an
enhanced partial contribution from lower lineal energy events which also acts to reduce
the YDvalue. In addition, the differences in lower lineal events may also be attributed in
part to differences in secondary spectra, as a result of using the PMMA block to house the
detector, located outside of the water phantom at GHMC. In contrast, at HIMAC with the
passively delivered beams, the microdosimeter was housed only within a small PMMA
sheath, which was placed within the water phantom. Increased YDbeyond the distal edge
was also observed within the PMMA phantom in section 7 .2.2.
One of the main advantages of active scanning delivery is the production of the ion energy
layers required to establish tumour coverage directly from the synchrotron, minimising
the need for beam modifying devices in the bearnline. However in the pencil beam spectra in this experiment, especially at the Bragg peak and distally, the lower lineal energy
component is not insignificant. In fact, the proportion of neutron events and lighter fragments, such as helium, differs greatly across the three fields. The SOBP beam, which has
the greatest amount of beam modifying devices (ridge filter and scatterer), clearly shows
a relatively large proportion of events produced by neutrons between 1-10 keV/µm, followed by the pencil beam with ripple filter, then the passively delivered mono-energetic
beam with very little neutron events. This is emphasised with comparison of the spectra
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just beyond the distal edge, shown in figure 9.14c.
The RBE10 of each field is quite different as can be seen in figure 9.15. Despite having
a

Yn approximately two times greater than the other beams, the RBE10 of the mono-

energetic passively delivered 290 MeV/u 12C beam is only ~1.2 times greater than the
other beams. Again, this shows that substantially high Yn does not result in a proportionally enhanced RBE10 value, due to overkilling above 150 keV/µm for the MKM. Maximum RBE10 occurs for the passively scattered beam due to a less varied lineal energy
distribution from high LET

12

C ions brought about due to minimal beam modification de-

vices. In all cases, the uncertainty becomes greatest in the Bragg peak, as the distribution
of energy deposition events in the microdosimeter spans a wide range. This is especially
true for events with high lineal energy, in which a lower number of events occur, which
increases uncertainty dramatically. In addition, LQM parameters for HSG tumour cells
obtained also play a large part in the uncertainty [122].
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Figure 9.15: RBE 10 distributions obtained using the Mushroom microdosimeter in a
mono-energetic 290 MeV/u 12C ion pencil beam, mono-energetic 290 MeV/u 12C ion
field and 290 MeV/u 12C ion SOBP field. The depth of each dataset has been normalised
to the depth at which its maximum YDoccurs.

9.3 Conclusion
Measurement of low energy 70 MeV 12C ions was performed using the Bridge V2 microdosimeter at ANU HIAF. Significant changes in microdosimetric spectra were able to
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be observed as the effective microdosimeter depth in LDPE was varied between O - 400

µm. The 10 µm thick sensitive volume of the microdosimeter minimised beam perturbation (due to thin over-layers) and volume-averaging effects. Measured

YDvalues of up to

473 kev/µm were obtained at a depth of 170 µm, decreasing to ~6 keV/µm due to the
absence of neutrons and fragments, unlike in

12C

therapy treatments. Using the MKM,

maximum derived RBE 10 values of 2.57 occurred at the entrance as the higb LET of the
ions at great depths reduced they* , followed by RBE10 , due to the overkilling effect.
These results truly showcase the potential for thin silicon microdosimetric devices to be
used for the measurement of higb LET particles with high granularity.
Measurements were also performed using the Mushroom microdosimeter in passively
delivered mono-energetic 290 MeV/u

12C

ion field and mono-energy 290 MeV/u pen-

cil beam with ripple filter, commonly used in active scanning delivery systems. In the
passively delivered field, a maximum

YDvalue of ~291 keV/µm was measured, corre-

sponding to a maximum derived RBE10 value of ~2.95. This was ~0.8 mm beyond the
maximum physical dose measured with an ionisation chamber, expected due to the known
relationship between Bragg peak depth and RBE for
For the actively delivered field, a maximum

12C

ions.

YDof just ~141 keV/µm was measured,

corresponding to a derived RBE10 of 2.37. These lower YDand RBE10 values were due to
the effect of the ripple filter, which increased the variance of the lineal energy distribution
at the Bragg peak. The effect of the ripple filter was also seen by a wider

YDand RBE10

peak in comparison with the passively delivered field. The partial contribution to the
microdosimetric spectra of fragments and neutrons using the active delivery was relatively
greater than that produced from the passively delivered beam, likely due to differences in
beam geometry and small differences in experimental setup. Comparison of the distal
spectra with those obtained in a passively delivered SOBP field revealed a much greater
contribution of lower lineal energy events from neutron interactions in beam modifying
materials such as the ridge filter, scatters, etc.
These results from these various applications show that CMRP silicon microdosimeters
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12C
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ion fields of

different energies, as well as those produced using the different beam delivery technologies in

12C

ion therapy.

Chapter 10
Microdosimetric Application in Proton
Therapy
This chapter presents work resulting from utilisation of the Bridge V2 microdosimeter in
clinical proton therapy beams. The Bridge V2 microdosimeter was utilised in the measurement of microdosimetric quantities and distributions within the fields generated by
a passively scattered proton delivery system and a proton pencil beam scanning (PBS)
system at Massachusetts General Hospital (Boston, MA, USA). Measurement of quantities relevant to microdosimetry and radiation protection was also performed downstream
and out-of-field using a modem proton PBS system at Mayo Clinic (Rochester, MN,
USA).
The work described in this chapter has been published in multiple journal articles [125,
142] with data collection performed in collaboration with Dr. Linh Tran (CMRP, UOW),
and simulations performed by Dr. David Bolst (CMRP, UOW).

10.1

In-field Measurements in Passive Scattering and Pencil Beam Scanning Fields

As discussed in section 1.1.2, proton therapy provides highly conformal dose delivery
to specific tumour types, reducing delivered dose to healthy tissue and critical structures
near by. This is especially useful for organs at risk downstream of the Bragg peak, as
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there is no fragment tail. However, during a protons journey through the body, inelastic
collisions can contribute to dose through the production of secondary protons, neutrons,
light nuclei and nuclei recoils, the magnitude of which varies with depth [143]. These
secondary particles often travel at more oblique angles and have lower energies, resulting
higher LET. Despite this, the energy they can provide to the media is small in comparison
to primary and secondary protons [24].
As with all particle therapy planning systems, the radiobiological effect is taken into account which comes about from an increased number of double strand breaks from the
dense ionisations caused by high LET particles. Traditionally, the RBE value used for proton therapy treatments is planned using 1.1 which is based on measurements performed
during the initial development of the technology. A comprehensive analysis of many studies found that for a typical proton SOBP field, this a reasonable and valid RBE value to
use. However, values across many different cell lines showed average RBE values of up
to ~1.35 at distal edge and ~1.7 in the distal fall-off [144], with small and highly modulated fields producing higher RBE values. Other studies have also shown that a value
of 1.1 underestimates the effect of increased LET at depth and distal regions, as well as
for fractionated treatment regimes beams [145]; in fact, RBE has been shown to increase
with smaller fractions [146]. Despite the relatively small volume over which large RBE
variations occur, these studies have led to support for in the inclusion of variable RBE
treatment planning and for precision dosimetry.

In treatment planning, a quantity that has been used for taking into account the variable
biological effect of charged particles is the dose averaged LET, LETo [147]. As its name
suggests, this quantity is calculated by weighting the LET of each particle as a function
of the energy deposited within a volume of interest, and is calculated based using Monte
Carlo simulations or analytical models; it cannot be measured. However, it is similar to
the dose-mean lineal energy in cases where delta electron ranges are smaller than the SY
size [148]. While there exists many QA tools that have been implemented in a clinical
setting for measuring quantities such as fluence, proton range an absorbed dose [149-

151], there is yet to be a device implemented which can routinely measure the physical
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YD. As introduced in section

1.2.1, the TEPC is the gold standard for measuring microdosimetric quantities and has
been applied in clinical fields [152], monoenergetic protons fields at HIMAC [123] as
well as in-field and out-of-field measurements of monoenergetic fields of heavier ions
[51, 153]. Despite attempts to miniaturise the TEPC [66, 67], it's physical size produces
volume-averaging over the greatly changing regions of the proton Bragg peak. As such,
experimental microdosimetric quantities of a proton PBS field have not been measured in
this region with high spatial resolution.
The Bridge Microdosimeter was utilised in a variety of proton fields in order to showcase
its ability to characterise mixed radiation fields in proton therapy with high resolution.
Both proton PBS and double scattering delivery systems were used to obtain lineal energy
spectra and were used to calculate

YDand derive estimated RBE using the MKM model.

Geant4 simulations were conducted for validation. These measurements were performed
at Massachusetts General Hospital (MGH), Boston, USA.

10.1.1 Materials and Methods
The MGH proton facility cyclotron produces a proton beam with an energy of 235 MeV,
which is degraded and transported to the treatment room. This treatment room is either
equipped with a PBS (active) or double scattering (passive) delivery system. For passive
delivery, an IBA universal nozzle and range modulation is used to form a SOBP with a

5 x 5 cm2 brass aperture placed as close to the patient as possible in order to reduce
proton penumbra [154]. For PBS delivery, a relatively large pencil beam with a FWHM
between 10 and 35 mm can be produced, with the cyclotron able to produce ions with a
range between 7 - 32 cm in water. This beam is quite large in comparison to more modem
facilities and is useful for the treatment of larger tumours [31].
Measurements in this study were performed using beam spot size (FWHM) of 25.9 mm
at isocenter in air, with a range of R9!Jof 124.6 mm (range at which the dose delivered
is 90 % of the maximum dose) which corresponds to an energy of 131 Me V - this beam
type is referred here as the "spot" beam. A beam current of less than 0.1 nA was used to
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avoid pulse pile-up which would act to increase the lineal energy measured. In addition,
measurements were performed using a 5 x 5 x 5 cm 3 SOBP beam delivered using double
scattering delivery - this plan is referred to as the "cube" plan which is shown in figure
10.1 for reference. The dose delivered to the target cube was 1.82 Gy in the middle of
the SOBP. It was the intention that measurements in the same field delivered using PBS
would also be carried out, but due to the treatment planning system limitations, this plan
could not be delivered with a low current; pile-up effects would have dominated the lineal
energy spectra acquired.

Figure 10.1: Treatment plan for the 5 x 5 x 5 cm 3 proton PBS field at MGH.

The Bridge V2 Microdosimeter (section 1.3.2) was used to measure selected characteristics of these beams. Due to relatively low LET of protons used in proton therapy, the
minimal low energy response of the Bridge V2 microdosimeter, as seen in section 4.3,
made it the ideal candidate for measurement in a proton field. For all field types, the
microdosimeter was placed inside the water tank described in section 6.3 and the motion
stage was used to vary its depth within the water. The setup is shown in figure 10.2.
Microdosimetric acquisitions were performed at many depths in the water tank, with increased density in the Bragg peak. At each acquisition location, a lineal energy spectrum
was obtained which was used to calculate Yn (equation 1.15. In addition, using the MKMbased method (section 1.1.4), the lineal energy spectra was used to derive approximate
RBE for the HSG cell line. However as the RBE for protons is lower, and is dependent
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(a) PBS setup

(b) Double scattering setup

Figure 10.2: Experimental setup showing the PBS gantry and Microdosimeter in water
tankatMGH

on delivered dose, the general expression for RBE was used, shown in equation 10.1.
Measured LQM parameter values were obtained from [123].

(10.1)
where:
DR = Dose delivered with 200-kV x-rays

= Dose delivered with protons = 1.82 Gy
ap = Linear function of saturation-corrected dose-mean lineal energy (equation
aR = LQM a parameter for HSG cells= 0.164 Gy- 1
/3p= /3R= LQM /3parameter for HSG cells = 0.05 Gy- 2

Dp

1.21

In order for these quantities to be associated with biological effects, the response in silicon
was converted to that of an equivalent tissue volume. This was performed by David Bolst
(UOW), by simulating a 150 MeV PBS spot proton field and recording the response in
different sized tissue and silicon microscopic volumes. The conversion factor is the ratio
of the length of a microscopic tissue volume to that in a silicon volume which produced
the same response in both materials. This factor was determined to be of 0.58 [58] and
was fairly constant over the range of proton energies used in this study.
In addition, the PBS delivery system was modelled using Geant 4 version 10.0, and was
tuned using depth-dose data obtained in the beam with an IBA Zebra multilayer ionisation chamber. The initial proton energy was modelled as Gaussian with 1 %

<J.

The
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proton spot size was matched to the actual beam used (25.9 mm FWHM) and the phantom
was modelled as a 30 x 30 x 30 cm 3 cube placed 40 cm away from the beam nozzle.
Calculation of Yn was used to verify experimental results.

10.1.2 Results and Findings
10.1.2.1 PBS Spot Measurements
In order to provide context, the depth-dose profile of the PBS spot beam measured using
an IBA Zebra ionisation chamber is shown in figurel0.3. The simulated beam is also
shown. Very good agreement is seen between the simulated and measured profile. There
exists some deviation between measured and simulated during the build up region (simulation degraded response) which is most likely attributed to small differences between the
physical setup and the modelled geometry.
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Figure 10.3: PBS Spot beam depth-dose profile measured with a Zebra multilayer ionisation chamber compared to simulated dose profile

Figure 10.4 shows the microdosimetric spectra obtained at depths 22 mm to 150 mm in
water. The shallowest depth of 22 mm is limited by the physical construction of the water
phantom and waterproof sheath, with the maximum depth of 150 mm depth corresponding
to ~25 mm downstream of the distal edge. Each of the in-field spectra shows a clear peak
which is generated by protons depositing energy within the 10 µ.mthick microdosimeter
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SV. As the depth is increased, this peak shifts to the right and becomes wider due to the
decreasing energy of primary protons as well as neutron interactions and secondary proton
production. Simulations also revealed that at these shallow depths, electrons provided
small contributions to the higher energy tail between ~0.5 and ~3 ke V/ µm up until ~ 120
mm. The range of lineal energy events observed at entrance is between ~0.5 to ~5
keV/µm, and increases up to ~0.6 to ~45 keV/mum at the distal edge of the BP.
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Figure lOA: Microdosimetric spectra obtained using the Bridge Microdosimeter in the
PBS Spot beam at MGH. The y-axis limits differ between the figures in order to visualise
the spectra at greater depths, unfortunately at the cost of being able to directly compare
between figures.

A dramatic difference between microdosimetric spectra 129 mm and 137 mm exists due
to this transition between locations near the distal edge and further downstream. While
not represented in the spectra, the dose downstream is obviously much less than in the
field, however at these downstream locations there particles with a range of lineal energies from ~0.4 keV/µm and up to ~200 keV µm. As the primary beam has stopped, it
can be deduced that this spectra is generated from mainly secondary proton and helium
production [124]. Higher lineal energy events can also be generated from oxygen and
silicon recoils, as well as alpha particles from the Si(n, a) reaction. These high energy
events can drastically change

YDvalues and uncertainties

which has been observed with

TEPC measurements [123].
From the measured microdosimetric spectra, the

YDdistribution

was calculated and is

shown in figure 10.5. Simulated results are also shown for comparison, and the absorbed
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YDvalues were seen to be ~2

ke V / µm at the entrance with values slightly decreasing at around 90 mm, then increasing
sharply starting from around 120 mm, near to the Bragg peak maximum.

YDreached

a maximum of ~10 keV/µm at a depth of 129 mm. Simulated results generally showed
good agreement with measured results (within 3 - 10 %). However a select few data points
had large deviations between measured and simulated (within 15 - 30 % ) in the critical
region near the Bragg peak. These deviations are likely due to the sharp

YDgradient in

this region and uncertainty in microdosimeter position, especially due to the relatively
short motion stage movements between these positions.
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Using the lineal energy spectra, equation 10.1 and the depth dose profile with maximum
dose of 1.82 Gy, an the estimated RBE was derived as a function of depth, shown in figure
10.6. Between the depths of 20 - 110 mm the RBE stayed constant at ~0.96. These low
RBE values are due to reference 200-kV x-rays having ay* value of 4.34 keV/µm at these
depths [51], which is greater than the measured value with protons. At a depth of 122 mm,
corresponding to R90, the derived RBE was~ 1.04 and increased at a rate of ~0.06 mm-

1

thereafter. The RBE reached ~ 1.57 in the distal falloff at 129 mm, corresponding to 13%
of the maximum dose. This RBE increase is due to both an increase in proton LET but
also due to decreasing dose at this depth, of which RBE is dependent. The importance
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of microdosimetric measurement can be seen by comparing RBE values derived with the
same dose e.g. in the leading edge of the Bragg peak at 123 mm and the distal edge at 126
mm. The derived RBE values at these depths is ~1.1 and ~1.4, respectively, showing that
that large changes in lineal energy spectra, and hence

YD, can produce

large variations in

RBE while physical dose is the same.
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Figure 10.6: Derived RBE obtained using the Bridge Microdosimeter in the PBS Spot

beamatMGH.

10.1.2.2 Double Scattering SOBP Measurements
Figure 10.7 shows the microdosimetric spectra obtained at depths 22 mm to 150 mm in
water for the passively delivered SOBP beam. The microdosimetric spectra at shallower
depths is characterised by a quite narrow peak centred about ~0.7 keV/µm with a high
energy tail which spans the lineal energies until ~10 keV/µm. As the microdosimeter is
moved deeper within the phantom, this large peak naturally shifts towards higher lineal
energies and broadens, however not significantly. Due to the stochastic nature of microdosimeter and the dose-weighting of yd (y) plots, high energy events can drastically
change the shape of the spectra. This is seen in the spectrum obtained at 30 mm where
a few events of lineal energy ~ 100 keV/ µm reduce the height of the main peak centred
~0.7 keV/µm.
For the first ~50 cm, the SOBP beam consists of protons of multiple different energies,
however with very little variation in LET [24] which is seen by the very little change in
microdosimetric spectra. However, once reaching the plateau of the SOBP (~70 cm), the
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Figure 10.7: Microdosimetric spectra obtained using the Bridge Microdosimeter in the
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order to visualise the spectra at greater depths, unfortunately at the cost of being able to
directly compare between figures.

field starts to change as the low energy pristine beams reach deposit most of their energy
in their Bragg peak. This can be seen in the spectra as the primary peak shifts towards
higher lineal energies and their tail increases in width between the depths of 60 mm and
110mm.
Towards the end of the SOBP plateau, which has an R90 of 126 mm, the spectra are
extremely similar to that of the PSB spot beam. The primary peak continues to increase
in energy and significantly widen as the higher energy pristine beams start to reach their
range. Past the distal edge the spectra are comprised from neutron interactions within the
phantom as well as beam modifying devices upstream.
The

YDdistributions

physical dose. The

for these spectra are shown in figure 10.8, plotted with the measured

YDvalues

are seen to start at just under 2 keV/µm which is expected

for this beam. The YDvalue obtained at 30 mm, as previously mentioned, is larger than the
surrounding points due to an increase in high lineal energy events which is thought to be
produced from the stochastic nature of this measurement process, not due to unexpected
physical phenomena. In addition to the higher

YDvalue

due to the greater weighting of

these events, the uncertainty is also increased disproportionately. At 60 mm depth, where
the SOBP plateau starts, a stepped increase of YDto ~2.4 keV/µm was observed. After
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this point, YDincreases gradually to ~2.9 keV/µm at 110 mm depth and then increases
rapidly. This rapid increase is due to the measured spectra comprising almost entirely of
higher LET protons from the highest energy layer. A maximum YDvalue of ~7 .2 ke Vlµm
was measured at 130 mm depth (4 mm past R90), which did not change drastically further
downstream.
The YDvalues at R90 is ~2.8 keV/µm less than that at the same respective R90 for the
spot beam. An enhanced YDvalue in the spot beam generally could be due to effects
associated with pileup, however current was reduced to extremely low levels to avoid
this. The difference is more likely simply due to the difference between the beams, in
particular more straggling with the double scattered beam, resulting in a wider lineal
energy distribution and reduced YD.
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Figure 10.8: Average dose-mean lineal energy
scattered SOBP beam at MGH.

YDdistribution measured for the double

Estimated RBE values were derived for the SOBP beam, shown in figure 10.9. Derived
RBE values between depths of 22 mm and 110 mm remained relatively constant between values ~0.98 and ~1.02. At a depth of 126 mm, corresponding to R90, the RBE
was ~1.12 and reached a maximum of ~1.41 at a depth of 140 mm. These values are
slightly lower than the PBS spot beam which is not surprising given the YDvalues are also
higher.
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10.2

Out-of-field Measurements in Pencil Beam Scanning
Fields

Delivery of dose to out-of-field (OOF) healthy tissue is always detrimental to treatment
outcome across all radiation therapy modalities, and naturally increases the risk of secondary malignancy, especially in children [155]. The ions used in charged particle therapy undergo interactions with materials in the beam line, treatment head, beam-shaping
devices and within the patient. Unlike most conventional photon therapies, these interactions are both electronic and nuclear in nature. While most processes are due to multiple
Coulomb scattering, reactions with target nuclei can generate neutrons and fragments that
will deliver excess dose to both target and non-target regions distally and laterally within
a patient [156]. Naturally, the absence of materials upstream of the patient reduces neutron and fragment production and is one of many reasons why particle therapy modalities
are moving from passive scattering to active scanning techniques to deliver and shape the
beam to the target [31, 157].
Many studies with protons have been undertaken to measure the out-of-field dose delivered to tissue external to the target volume [57, 154, 158-160], however due to differing
measuring techniques, beam geometries, proton energies and acquisition locations, it is
difficult to compare them directly. Furthermore, most measurements are taken around
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the room, far outside the patient which is not particularly relevant to treatment outcomes.
Whilst there can be large differences in delivery systems and in-beam devices, most studies obtained similar dose-equivalent values up to the order of 10 mSv/Gy close to the
field, and decreasing to minima of between 0.001 - 0.1 mSv/Gy at distances of 10-100
cm lateral to the field. Due to the absence of beam modifying materials, active scanning
systems produce less neutrons and as a result, lower dose-equivalent values, however the
extent to which this is true has been disputed in the past [161, 162].
As discussed in section 1.1.3, microdosimetry is one technique that can be utilized to
evaluate out-of-field and in-field quality of mixed radiation fields. It can be used for radiation protection purposes to calculate dosimetric quantities such as the dose-equivalent.
Previous work with silicon microdosimeters has been undertaken by the CMRP to measure microdosimetric quantities in-field [163] and out-of-field [57, 160] in passively scattered proton fields, however studies have not been carried out using proton pencil beam
scanning (PBS). This work demonstrates the usefulness of the SOI microdosimeters in
assessing beam quality in proton PBS therapy systems. The dose-equivalent and other
microdosimetric quantities have been determined in out-of-field locations using a spreadout Bragg peak proton PBS field at Mayo Clinic, Rochester, USA.

10.2.1 Materials and Methods
The relatively new proton therapy facility uses intensity modulated PBS to deliver dose
to patients without the use of patient-specific beam shaping devices. The plan that was
chosen delivered a uniform dose of 2.2 Gy to a volume of 10 x 10 x 6 cm 3 using intensity
modulation between 40-100 mm (SOBP), with proton energy layers between 71.3 - 118.4
Me V. The depth-dose profile along the central axis of the field and lateral dose profile at
the field centre for the plan are shown in Fig. 10.lOa and 10.lOb, respectively.
The Bridge V2 Microdosimeter (section 1.3.2) was used chosen to measure selected beam
characteristics of this beam. Due to relatively low LET of protons used in proton therapy,
the minimal low energy response of the Bridge V2 microdosimeter, as seen in section 4.3,
made it the ideal candidate for measurement in a proton field.
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Due to the extremely high count rates associated with PBS delivery, out-of-field measurements were performed to investigate radiation effects that would occur in healthy tissue
surrounding a treatment volume. The out-of-field measurements were taken laterally at
10, 30, 60 and 120 mm from the field edge at depths close to the beam entrance (25 mm)
and on the plateau region of the SOBP (80 mm). In addition, two locations downstream
of the SOBP distal edge of the SOBP (40 and 55 mm downstream), laterally in-field were
also investigated. The phantom described in section 6.3 was used to hold and vary the
lateral and axial position of the microdosimeter with respect to the beam isocenter. The
acquisition locations can be seen schematically in figures 10.lla and 10.llb.
At each acquisition location, the dose equivalent was determined using equations in section 1.1.5.
The PBS delivery at Mayo Clinic was modelled using Geant4 version 10.2p2, by David
Bolst (UOW). The positional sigma of the beam was calculated based on the starting
combination of energy and position, with the FWHM value ranging between 6-16.5 mm.
The phantom was modelled as a slab of 40 x 40 x 30 cm 3 water placed in air 80 cm away
from the beam nozzle. The response of the bridge microdosimeter from being irradiated
by the SOBP was simulated.
Uncertainty in the spectra and associated quantities is based on the statistical error asso-
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ciated with the counts in each channel, dependent on a number of factors including delivered dose, detector area and acquisition time, which was varied between 5 - 15 minute
per acquisition. Errors in

YDand Q were determined using standard error propagation

techniques described in Appendix A.1, and are again dependent on the counts in each
channel in each spectrum. There is also assumed uncertainty of ~ 1 mm in depth and
lateral position of the microdosimeter, based on the repeatability of movement, as well
as uncertainty in measurement of the over-layers above the microdosimeter. There is an
inherent uncertainty in the silicon-to-tissue conversion factor of ~2%.

10.2.2 Results and Discussion
10.2.2.1 Downstream of the SOBP
Table 10.1 presents the dose-mean lineal energy YD, average quality factor Q and dose-equivalent H from acquisitions located downstream at depths of 110 mm and 150 mm,
with corresponding microdosimetric spectra shown in figure 10.12.

Table10.1: Microdosimetric quantities obtained at 110 and 150 mm depth, downstream
of the SOBP field.

Depth (mm)
110
150

YD(keV/µm)
21.9 ± 3.4
27.2 ± 5.7

Q
5.4 ± 0.6
6.1 ± 0.9

H/Dose (mSv/Gy)
0.99
0.62

± 0.11
± 0.09

The generation of higher LET particles is seen to be more prevalent at 150 mm as can
be seen by higher

YDand Q values, however H is lower, resulting in less dose delivered

out-of-field from neutrons, per treatment Gy. In both spectra, high LET events above 100
keV/µm are most likely from alpha particles produced through (n, a) inelastic reactions
within the silicon, carbon and oxygen. Despite these events, the spectra are mainly dominated by lower lineal energy events originating from recoil protons produced through
elastic (n,p) reactions inside the water phantom.

10.2.2.2 Lateral to the Field Edge
Microdosimetric spectra produced from out-of-field acquisitions at each lateral location
for depths 25 mm and 80 mm are shown in figure 10.13 and figure 10.14, respectively.
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Figure 10.12: Microdosimetric spectra obtained downstream at depths 110 and 150 mm
of a proton PBS SOBP field.

For these acquisitions, the spectra are characterized by a low lineal energy peak with a
higher lineal energy tail. For both depths, the microdosimetric spectra obtained at 10
mm out-of-field spans a large range of lineal energies from approximately 0.7 keV/µm
to 70 keV/µm, produced by laterally scattered primary protons due to the relatively wide
penumbra. At a depth of 80 mm in water, the microdosimetric spectrum for 10 mm outof-field is naturally broader compared to that at 25 mm depth as the scattered protons have
lower energy, and hence higher LET at greater depths. Moving further laterally from the
field edge, at 30, 60 and 120 mm, the spectrum is dominated by recoil protons induced by
neutrons and are extremely similar for both 25 mm and 80 mm depths.
Figure 10.15 shows the

YDdistributions for out-of-field positions at 25 mm and 80 mm

depths in water. Despite the detector being located at significantly different parts along
the SOBP profile (see figure 10.11), the
mm from the field edge,

YDdistributions are extremely similar. At 10

YDincreases from approximately 5.8 keV/µm and reaches a

maximum of 7.5 and 7.8 keV/µm for 25 mm and 80 mm depths, respectively, followed
by a gradual fall-off with distance. Overall, for each lateral location, the YDvalues at 80
mm depth are greater than those at 25 mm depth by between 2 - 7%, however agree within
experimental error.
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water
The dose-equivalents for each set of out-of-field acquisitions at 25 mm and 80 mm depths
are also presented in figure 10.15. Maximum values were measured at 10 mm from the
field edge, reaching values of 3.1 mSv/Gy and 5.3 mSv/Gy at depths 25 mm 80 mm, respectively. For perspective, a total treatment of 60 Gy using this field would give a 300
mSv dose-equivalent to a point of healthy tissue located 10 mm from the field edge. As
expected, the dose-equivalent rapidly falls off with distance from the field edge, converging to approximately 0.04 mSv/Gy at 120 mm out-of-field for both depths.
Similar treatment plans (Prostate and Medulloblastoma) have been investigated previously [154] which compared equivalent dose using active scanning and passive scattering
at lateral locations at very similar depths to the microdosimetric acquisitions performed
here (22.3 mm and 84 mm). The study unsurprisingly confirmed that active scanning delivery had decreased equivalent dose by around a factor of 10 for distances up to 60 cm
from the field edge. While the experiment performed only sampled relatively close to the
field edge (albeit clinically relevant) and used non-ideal SOBP beams, the microdosimetrically derived equivalent dose distribution found using the Bridge microdosimeter agrees
well in both magnitude and shape.
Figure 10.16 shows a comparison of the experimental and simulation results for 25 mm
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and 80 mm depths. Good agreement between the experimental and simulation results was
observed for 25 mm depth, however at 80 mm, the simulated

YDvalues are slightly higher

than the experimental results. This may be explained by a few high LET events which
can significantly change the YDvalue and can lead to substantial

YDuncertainties.
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Figure 10.16: Experimental and simulated dose-mean lineal energy distributions obtained lateral to a proton PBS SOBP field at depths of 25 mm and 80 mm in water in
experiments and simulation

Figure 10.17 shows the simulated contributions from different particle types with respect
to lateral position at both 25 mm and 80 mm depths in water. It can be seen that at 25 mm,
there is a greater contribution from secondary protons which have greater LET. At 80 mm
depth, a slightly higher contribution is seen from primary protons and less from secondary
protons, however the primary beam has a higher LET from traversing at extra 55 mm of
water. The balance of contributions between the primary beam and secondary protons
keeps lateral

YDdistributions

values at both depths relatively similar. Contributions from

heavier ions remains minimal at both depths, with slight increases at lateral distances past
80 mm from the central axis.

10.2.3 Conclusion
In-field measurements with the Bridge V2 microdosimeter were performed using a PBS
beam and passively scattered proton field at Massachusetts General Hospital. With the

CHAPTER 10. MICRODOSIMETRIC APPUCATION IN PROTON THERAPY
100,---.--......,,----.---,----.---,

i::::::=:=::=s;:;=::::::-r----r----.-~

100

901P------'I:

90

lw __

~

i

-Total
-~ 70 --·-Socondary H
c

80 ,------,

-Total
70 --Seoondsy
---Ho
~ 60 ......
-u
C

.g

ii

~ eo ::.::~
~ 50 -Be
--·-Bo
~ 40 ---c

H

C

-··N

a

40

==

C

-~ 30

-o

j
iii

30

-o

1ii

!

c3 50

---•--Prim

M

!

20
10

ot:===;:::::;~:;;:.=~-.::-.---.-_..
0

206

20
40
60
80
100
Lateral Distancefrom Central Axis (mm)

---c
.....,-N

--Pih

H

20
10

120

(a) 25 mm depth

o'=====::::::::::~--...i:::..IO:!oQia:,al
0

20
40
80
80
100
Lateral Distancefrom c.entralAxis (mm)

120

(b) 80mmdepth

Figure 10.17: Simulated lateral dose particle-type contribution profiles for the Mayo
Clinic SOBP proton PBS field at 25 mm and 80 mm depth.

proton pencil beam, relatively constant

YDvalues of~ 2 keV/µm were recorded for the

majority of the protons journey, with a sharpincrease to ~ 10 ke V/ µm just after the maximum measured physical dose. With the passively scattered SOBP beam, the

YDvalues

continually increased from ~2 keV/µm due to the contribution of higher LET protons
that stopped within the SOBP, reaching a maximum of ~7.2 keV/µm after the SOBP distal edge. Obtained RBE values in the PBS spot beam were ~0.96 in the build up region,
reaching a maximum of ~ 1.57 slightly downstream of the Bragg peak. Obtained RBE
values in the SOBP double scattered beam were ~1.0 in the build up, reaching maximum
of ~1.4 after the distal edge of the SOBP. Comparison ofyD and RBE values derived using the microdosimetric-kinetic model showed good agreement with Geant4 simulations
for pencil beam measurements. In both cases, the measurements pedormed in this work
used to derive RBE for HSG tumour cells confirm the varying nature of proton beam RBE
with depth as described in the literature. In addition, the thin sensitive volume of the microdosimeter enabled detailed measurements to be pedormed along the depth of a water
phantom with minimal volume averaging effects.
Out-of-field measurements with the SOI microdosimeter in a proton PBS field were carried out for the first ti.me at Mayo Clinic, which revealed quite an interesting

YDdistribu-

tion laterally to the field at different depths. For both depths at 10 mm from the field edge,
the microdosimetric spectra was dominated by laterally scattered primary protons, resulting in a relatively low

YD. Moving further out between 30 mm - 120 mm from the field
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YDincreased due to the fast neutron contribution (lower energy recoil protons), fol-

lowed by a gradual fall-off with distance. The measured

YDdistributions at 25 mm depth

are in slightly better agreement with predicted Monte Carlo simulations than 80 mm depth
due to possible lack of statistics that may affect neutron spectra and lead to slightly increased probability of Si( n, a) events. Despite this, Geant4 simulations validated these
microdosimetric measurements and gave confidence to the microdosimetric derivation of
radiation protection related quantities. The dose-equivalent for proton PBS delivery systems showed significant decreases from other passive scattering systems and agreed well
with studies performed at other facilities [154]. These studies allowed for measurement
of quantities related to radiation protection as well as high resolution probing of proton
Bragg peaks at which dramatic increase of dose and YDexists.
These measurements show that for physical measurement of microdosimetric spectra is
possible in PBS and passively delivered proton beams. Furthermore with the advancement of smaller sensitive volume technology from CMRP, measurement of in-field PBS
beams have also been performed [ 164]. The work performed here shows a glimpse of the
possible role that solid state microdosimeters could play in proton therapy. The measurement of YDand, with more comprehensive data sets, RBE derivation via the MKM model
could be used in routine quality assurance to assess beam quality, or even routinely verify
proton treatment plans, especially those with unique and challenging properties e.g. heavily modulated beams, areas close to critical structures or organs at risk at the distal edge
of the beam. Solid state microdosimeters enable the measurement of quantities relevant
to the biological endpoint of cellular damage which ionisation chambers cannot provide.
While silicon microdosimeters can not replace conventional QA equipment, these results
certainly showcase the utility of a microdosimeter as a QA tool in proton therapy.

Chapter 11
Conclusion
This thesis presented the characterisation of three new SOI microdosimeters and their
utilisation in a variety of different proton and

12

C ion therapy applications.

As a way of fine tuning manufacturing process at SINTEF, the Etched Microdosimeter
was fabricated, and its electrical, physical and charge collection properties were characterised. Electrical characterisation showed very low leakage current and capacitance, with
a very low depletion voltages, and SEM imaging showed seemingly successful fabrication results. However, charge collection studies revealed properties similar to previous
generation devices, having poor charge collection on the periphery of each SY, as well as
collection from unbiased arrays due to capacitance-resistive charge sharing.
Meanwhile, with the etching issues that were encountered during Bridge Yl microdosimeter fabrication remedied, the Bridge Y2 microdosimeter was fabricated. This device was
the first microdosimeter with the majority of silicon surrounding its SYs removed, using deep ion reactive etching, which allowed for electrode implantation processes to be
performed on the SY walls, creating a 3D-like configuration. Electrical characterisation
showed favourable properties and SEM imaging showed remarkable improvements from
the Bridge Yl microdosimeter, with the complete removal of interstitial silicon between
the SY s and bridges, exposing the buried oxide layer. Charge collection characterisation
showed well-defined, isolated SYs and bridges, with high yield and the absence of a large
low energy component that plagued previous generations. This allowed for true micro-
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dosirnetric application in lower LET radiation fields such as proton beams, where low

energy events are produced.

The first revision of Mushroom rnicrodosimeters were fabricated, including numerous

variants including a 18 or 30 µm diameter and two electrode configurations; one with

the p+ and n+ 3D electrodes along the depth of the device with silicon removed in a

central and outside trench and two (air-trench), and another with a planar n+ electrode
with the outside trench filled with p-doped polysilicon to form the p+ electrode (poly

trench). Electrical characterisation revealed greater differences in leakage current and

capacitance over all samples, however this was somewhat expected due to the geometrical

and design differences between the variants. Physical SEM measurements of the air
trench device showed complete etching of the two annular trenches, producing a well

defined nearly free-standing cylindrical SY with a small bridge to allow for n+ electrode

connection. Charge collection characterisation results revealed good charge collection

efficiency in most devices, however undesirable charge collection behaviour was were

observed with the 30 µm air-trench variant, consisting of a large low energy component

generated in between adjacent SVs. However dead regions in the central core and outer

trenches were observed, confirming the complete removal of silicon during the etching

process; this is an important process on which present and future 3D technology heavily
relies. The 30 µm poly-trench device showed more favourable characteristics, however

a low energy component was still observed, originating from a thin annulus around each

SY. The 18 µm poly-trench device was also characterised, showing extremely poor yield,

however the SY characteristics were the most favourable of any device, possessing well

defined cylindrical SVs with minimal low energy components and no charge collection

from SYs in the unbiased array. With the information learned from this characterisation, a
new variant is planned to be developed, whereby complete trenches will be formed around

the SV, filled with polysilicon and the surrounding silicon etched away and replaced with

PMMA, creating a more tissue-equivalent substrate [76].

These rnicrodosirneters were put to the test with the aim of estimating RBE10 in 12C ion

therapy fields. The response of all rnicrodosirneters was measured in a 290 MeV/u

12
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to distinguish due to fast scanning speeds compared to target motion as well as their phase
difference. These results show the importance of mitigating motion during treatment
and provides insight into the impact of these effects through the microdosimetric spectra
obtained.
The Bridge V2 microdosimeters were also utilised in proton beams delivered via both
double scattering and pencil beam scanning technology. Due to the removal of silicon
in the Bridge V2 microdosimeter microdosimeter, it was possible to measurement microdosimetric quantities in these low LET beams. Using the microdosimetric-kinetic model,
the RBE distribution along the depth of a water phantom was derived for HSG cells irradiated by a PBS spot beam (assuming 1.82 Gy delivered). Values of ~0.95 were obtained
for most of the protons journey, reaching a value of 1.57 just after the Bragg peak. For
a double scattering SOBP proton beam, derived RBE values were ~ 1.0 for most of the
proton range, increasing to up to ~1.4. In both cases, deviation from the value of ~1.1
was observed, which is commonly used in proton therapy treatment planning. Radiation
protection and microdosimetric quantities were also measured for out-of-field locations
using pencil beam scanning proton fields. It was found that the dose-equivalent decreased
rapidly moving laterally out of the field as expected, however Yn values actually peaked
at 30 mm from the field edge at various depths, due to the contribution of secondary
particles (scattered primary protons and recoil protons produced by neutrons) outside the
field.
The diverse range of work presented in this thesis has shown the versatility of SOI microdosimeters developed at CMRP, and their potential to be a used as a tool for quality
assurance in proton and

12

C ion therapy.
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Appendix

A.1

Uncertainties in Microdosimetric Quantities

Error propagation of microdosimetric quantities is something that is overlooked as they
are derived from spectra. This appendix analytically derives the uncertainties in all microdosimetric quantities, RBE 10-related quantities, RBEn-related quantities and radiation
protection-related quantities that are displayed in this thesis in the form of values or data
points in graphs. Some uncertainty expressions become extremely long and due to formatting reasons the use of the square root operator and ½exponent may be used interchangably within the same derivation.
As a reminder, the general form of an uncertainty expression for the functional f (x,y,y) =
xy / z where

x, y and z are independent

is:

2

Af(x,y,z) =

2

2

( :x [.f(x,y,z)]Ax) + ( :x [.f(x,y,z)]Ay) + ( :x [.f(x,y,z)]Az)
(A.l)

A.1.1

Uncertainty in Spectrum Counts

The uncertainty for the counts C; in channel i of a spectrum is:

(A.2)
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A.1.2 Uncertainty in Spectrum Area
The area under a spectrum with n channels is defined as:

(A.3)

i=l

The uncertainty in this area is:

(A.4)

A.1.3 Uncertaintyin/(y)
The normalised spectrum f(y) is defined as:

(A.5)

The contribution of uncertainty given by the area term below will be ignored it is generally
<1 %. The uncertainty in f(y) is hence:

2

(a~;[~]
Ac;)

Af(y) =
-

AC;

(A.6)

A

.,/C;
A

A.1.4 Uncertainty in YF
The frequency-mean lineal energy

YFis defined

as:

(A.7)
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The uncertainty in YF is hence:

2

a

AyF = ( ( f~y1) [y1f(y1)Ay]
Af(y1))

+ ( af~Y2) [y2f(y2)Ay]Af(y2)) + ...

1

2

+ ( af~Yn) [ynf(Yn)Ay]Af(Yn))

2

)

~

(A.8)

2 + ...+ (y1Af(Y1))2
= Ay✓(y1Af(Y1))2 + (y2Af(Y2))
where Ayis the width of the lineal energy hin.

A.1.5 Uncertaintyind(y)
The dose-mean lineal energy is defined as:

d(y) = yf(y) =
YF

yf(y)

Jf(y)dy

(A.9)

The dose-mean lineal energy uncertainty is hence:

Where <It(y)YFis the covariance between f(y) and YF· By definition, for a random variable
X and constant c, <Icx = 0, so:

(A.11)
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Uncertainty in Yv

The dose-mean average lineal energy is defined as:

Yn =

lo~

yd(y)dy

n

(A.12)

= LYd(y)Ay
i=O

where Ayis the width of the lineal energy hin.
The uncertainty in Yn is hence:

2
Ayn= ( ( ad~yi) [y1d(y1)]
M(y1))

2

+ ( ad~y2)

[yid(y2)]M(y 2))

+ ...

1

+ ( ad~Yn)[ynd(yn)]M(yn))

2)~

(A.13)

= Ay✓(y1M(y1)) 2 + (y2M(y2))2 + ...+ (ynM(yn))2
A.1.7

Uncertainty in yd(y)

The uncertainty in yd(y) is:

a

Ayd(y) = ad(y) [yd(y)]M(y)
=yM(y)

(A.14)
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A.2

Uncertainties in RBE10-Related Quantities

A.2.1

Uncertainty in y*

The saturation-corrected dose-mean lineal energy y* is defined as:

Therefore the uncertainty in y* is expressed as:

Ay*=

(A.16)

A.2.2

Uncertainty in LQM parameter a

The uncertainty for the LQM saturation-correct

a parameter

is defined as:

(A.17)
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a is:

(A.18)

A.2.3

Uncertainty in RBE10

The RBE 10 quantity is defined as:

DR IO
2f3D10,R
= -----.==a==e======~RBE10 = -'2
D10
Ja -4{31n(0.1)-a

(A.19)

The uncertainty expression for RBE10 used in this thesis stems from uncertainty in a
alone:

MUJE10 =

~[
aa

_
-aJa

2

Ja

2

f3Drn,R
-4f31n(0.1)-a

] Aa

(A.20)

2f3D10,R
Aa
2 -4{31n(0.1) + a 2 -4{31n(0.1)

A.3

Uncertainties in RBEv-Related Quantities

A.3.1

Uncertainty in Dose to Silicon, Dsi

The dose in silicon is calculated from MCA spectra and is defined as:

(A.21)
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The uncertainty for dose in silicon stems from spectrum counts alone:

(A.22)

A.3.2 Uncertainty in Dose in Tissue, Dre
The dose in tissue is calculating use tissue-equivalent convertion factor:

(A.23)

The uncertainty expression is therefore:

(A.24)

A.3.3 Uncertainty in Survival, S
The survival S is defined as:

-?

S = e-aD-Jl,r = e

-(11-0+_L_y•)n-Jl&
~

The survival uncertainty stems from the uncertainty of

2

AS=

ao,rn and D:

2

2

as At7o) + (as
ardArd) + (as
aDAD)
( aao
(A.26)

2

=S

(A.25)

2
2+ (
{33 y"DArd) +(-(a+2{3D)AD) 2
(DA17o)
p1r:rd

A.3.4 Uncertainty in RBEv
The RBEn quantity is defined as:

✓ ai-4/3

RBEn=~------

In (S)-

2f3Ds

aR

(A.27)
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The RBEn uncertainty stems from the uncertainty of S and D:

MBEn=

(

aRBEn

as AS

)

2

+

(aRBEn

)

2

ans MJs
(A.28)

A.4

Uncertainties in Radiation Protection-Related Quantities

A.4.1

Uncertainty in Q

The average quality factor Q is defined as:

(A.29)

A.4.2

Uncertainty in Dose Equivalent H

The Dose Equivalent H is defined as:

(A.30)

The uncertainty expression is hence:

(A.31)

